{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "ann_path='/root/autodl-tmp/train/train_v1.0.json'\n",
    "with open(ann_path, 'r') as file:\n",
    "    ann = json.load(file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'questionId': 337,\n",
       "  'question': 'what is the date mentioned in this letter?',\n",
       "  'image': 'documents/xnbl0037_1.png',\n",
       "  'docId': 279,\n",
       "  'ucsf_document_id': 'xnbl0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['1/8/93'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 338,\n",
       "  'question': 'what is the contact person name mentioned in letter?',\n",
       "  'image': 'documents/xnbl0037_1.png',\n",
       "  'docId': 279,\n",
       "  'ucsf_document_id': 'xnbl0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['P. Carter', 'p. carter'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 339,\n",
       "  'question': \"Which corporation's letterhead is this?\",\n",
       "  'image': 'documents/mxcj0037_1.png',\n",
       "  'docId': 280,\n",
       "  'ucsf_document_id': 'mxcj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Brown & Williamson Tobacco Corporation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 340,\n",
       "  'question': 'Who is in  cc in this letter?',\n",
       "  'image': 'documents/mxcj0037_1.png',\n",
       "  'docId': 280,\n",
       "  'ucsf_document_id': 'mxcj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['T.F. Riehl'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 341,\n",
       "  'question': 'what is the subject of  this letter?',\n",
       "  'image': 'documents/mxcj0037_1.png',\n",
       "  'docId': 280,\n",
       "  'ucsf_document_id': 'mxcj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Review of existing Brainstorming Ideas/483'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 343,\n",
       "  'question': 'What is the number at the bottom of the page, in bold?',\n",
       "  'image': 'documents/mxcj0037_1.png',\n",
       "  'docId': 280,\n",
       "  'ucsf_document_id': 'mxcj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['499150498'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 388,\n",
       "  'question': 'How many points are there in modifications to readout instrumentation',\n",
       "  'image': 'documents/sxxj0037_2.png',\n",
       "  'docId': 297,\n",
       "  'ucsf_document_id': 'sxxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['5.', '5'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 399,\n",
       "  'question': 'what is the date in the letter',\n",
       "  'image': 'documents/nhxj0037_1.png',\n",
       "  'docId': 314,\n",
       "  'ucsf_document_id': 'nhxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['June 11, 1990', 'June 11,1990'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 400,\n",
       "  'question': 'To whom this is addressed',\n",
       "  'image': 'documents/nhxj0037_1.png',\n",
       "  'docId': 314,\n",
       "  'ucsf_document_id': 'nhxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Dr.K.S.Houghton'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 401,\n",
       "  'question': 'Who sent the letter?',\n",
       "  'image': 'documents/nhxj0037_1.png',\n",
       "  'docId': 314,\n",
       "  'ucsf_document_id': 'nhxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Ted Sanders'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 402,\n",
       "  'question': 'Which part of Virginia is this letter sent from',\n",
       "  'image': 'documents/nhxj0037_1.png',\n",
       "  'docId': 314,\n",
       "  'ucsf_document_id': 'nhxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Richmond'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 411,\n",
       "  'question': 'What sort of communication/letter is this ?',\n",
       "  'image': 'documents/mxxj0037_1.png',\n",
       "  'docId': 352,\n",
       "  'ucsf_document_id': 'mxxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['INTER-OFFICE CORRESPONDENCE'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 412,\n",
       "  'question': 'What is the date mentioned in the letter?',\n",
       "  'image': 'documents/mxxj0037_1.png',\n",
       "  'docId': 352,\n",
       "  'ucsf_document_id': 'mxxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['April 27, 1990'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 413,\n",
       "  'question': 'Which test is used to evaluate ART menthol levels that has been shipped?',\n",
       "  'image': 'documents/mxxj0037_1.png',\n",
       "  'docId': 352,\n",
       "  'ucsf_document_id': 'mxxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['A second Danchi Test'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 414,\n",
       "  'question': 'What is the subject of the document/letter?',\n",
       "  'image': 'documents/mxxj0037_1.png',\n",
       "  'docId': 352,\n",
       "  'ucsf_document_id': 'mxxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Flavor Development Monthly Summary for April, 1990'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 416,\n",
       "  'question': 'what is the index for Retention of Franchise',\n",
       "  'image': 'documents/rzbj0037_9.png',\n",
       "  'docId': 355,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['100', '(100)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 417,\n",
       "  'question': 'What is the source',\n",
       "  'image': 'documents/rzbj0037_9.png',\n",
       "  'docId': 355,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['USMM 1/95-6/95, 12-Month Data'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 418,\n",
       "  'question': 'The number mentioned on the right of the leftside margin?',\n",
       "  'image': 'documents/rzbj0037_9.png',\n",
       "  'docId': 355,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['314002838'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 419,\n",
       "  'question': 'Heading of the document',\n",
       "  'image': 'documents/khxj0037_3.png',\n",
       "  'docId': 298,\n",
       "  'ucsf_document_id': 'khxj0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': [\"Domestic Product Development (cont'd.)\",\n",
       "   \"DOMESTIC PRODUCT DEVELOPMENT (cont'd.)\",\n",
       "   'Domestic Product Development'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 420,\n",
       "  'question': 'what mm Marlboro Menthol were subjectively smoked by the Richmond Panel',\n",
       "  'image': 'documents/khxj0037_3.png',\n",
       "  'docId': 298,\n",
       "  'ucsf_document_id': 'khxj0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['80mm and 83mm'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 421,\n",
       "  'question': 'Cigarettes will be produced and submitted to O/C Panel for what purpose?',\n",
       "  'image': 'documents/khxj0037_3.png',\n",
       "  'docId': 298,\n",
       "  'ucsf_document_id': 'khxj0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['evaluation of lip release'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 422,\n",
       "  'question': 'Another model of the 83mm with zero ventilation will be made at Semiworks within how many weeks',\n",
       "  'image': 'documents/khxj0037_3.png',\n",
       "  'docId': 298,\n",
       "  'ucsf_document_id': 'khxj0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['next 2-3 weeks', 'within the next 2-3 weeks', '2-3 weeks'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 424,\n",
       "  'question': 'Under BOLD, primary production of Blend #24- will be completed by which date',\n",
       "  'image': 'documents/khxj0037_2.png',\n",
       "  'docId': 299,\n",
       "  'ucsf_document_id': 'khxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['6/7/90'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 426,\n",
       "  'question': 'During the process of prototype production and ringtipping, some cigarettes were observed to have burn holed in which paper',\n",
       "  'image': 'documents/khxj0037_2.png',\n",
       "  'docId': 299,\n",
       "  'ucsf_document_id': 'khxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Cigarette paper', 'cigarette paper'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 434,\n",
       "  'question': 'Heading of the document?',\n",
       "  'image': 'documents/nmcj0037_1.png',\n",
       "  'docId': 303,\n",
       "  'ucsf_document_id': 'nmcj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Memorandum', 'MEMORANDUM'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 435,\n",
       "  'question': 'Where was the conference held?',\n",
       "  'image': 'documents/nmcj0037_1.png',\n",
       "  'docId': 303,\n",
       "  'ucsf_document_id': 'nmcj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['B&W headquarters', 'B&W Headquarters'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 437,\n",
       "  'question': 'How many distinct mechanisms appear to play a role in the breakup of a smoke column into a multi-dimensional flowfield?',\n",
       "  'image': 'documents/nmcj0037_1.png',\n",
       "  'docId': 303,\n",
       "  'ucsf_document_id': 'nmcj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['At least two', 'Two'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 438,\n",
       "  'question': 'One variable that has implicitly not been controlled?',\n",
       "  'image': 'documents/nmcj0037_1.png',\n",
       "  'docId': 303,\n",
       "  'ucsf_document_id': 'nmcj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['influence of the test chamber (glass mouth) geometry.',\n",
       "   'The influence of the test chamber (glass mouth) geometry'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 442,\n",
       "  'question': 'What is the full form of PUF?',\n",
       "  'image': 'documents/qhxj0037_2.png',\n",
       "  'docId': 312,\n",
       "  'ucsf_document_id': 'qhxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['POLYURETHANE FOAM', 'polyurethane foam'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 443,\n",
       "  'question': 'Which hetero-atoms  does polar compounds contain?',\n",
       "  'image': 'documents/qhxj0037_2.png',\n",
       "  'docId': 312,\n",
       "  'ucsf_document_id': 'qhxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['nitrogen, sulfur and oxygen.', 'NITROGEN, SULFUR AND OXYGEN'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 446,\n",
       "  'question': 'What is the full form of POVC?',\n",
       "  'image': 'documents/qhxj0037_2.png',\n",
       "  'docId': 312,\n",
       "  'ucsf_document_id': 'qhxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['POLAR VOLATILE ORGANICS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 447,\n",
       "  'question': 'Who presented the results on cabin air quality study in commercial aircraft?',\n",
       "  'image': 'documents/qhxj0037_2.png',\n",
       "  'docId': 312,\n",
       "  'ucsf_document_id': 'qhxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['D. J. EATOUGH',\n",
       "   'D. J. Eatough',\n",
       "   'D. J. EATOUGH (BRIGHAM YOUNG UNIVERSITY)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 453,\n",
       "  'question': 'What is the slope mentioned in the first table?',\n",
       "  'image': 'documents/hgbl0037_9.png',\n",
       "  'docId': 313,\n",
       "  'ucsf_document_id': 'hgbl0037',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['0.1088102E+01'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 455,\n",
       "  'question': 'What is the date mentioned in the second table?',\n",
       "  'image': 'documents/hgbl0037_9.png',\n",
       "  'docId': 313,\n",
       "  'ucsf_document_id': 'hgbl0037',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['05-12-92'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 456,\n",
       "  'question': 'What is the S.D. mentioned in the DOSE-ug 0.0000 in the third table?',\n",
       "  'image': 'documents/hgbl0037_9.png',\n",
       "  'docId': 313,\n",
       "  'ucsf_document_id': 'hgbl0037',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['10.6'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 460,\n",
       "  'question': 'Where were the two magnesium containing  papers made at?',\n",
       "  'image': 'documents/nhxj0037_2.png',\n",
       "  'docId': 315,\n",
       "  'ucsf_document_id': 'nhxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['University of Maine'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 465,\n",
       "  'question': 'Which base paper will be coated in-house with various levels of mono potassium phosphate and malonic acid in order to optimize the system?',\n",
       "  'image': 'documents/nhxj0037_2.png',\n",
       "  'docId': 315,\n",
       "  'ucsf_document_id': 'nhxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['091', 'The 091 Base paper'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 466,\n",
       "  'question': 'which cigarette would be better if offered on a thicker cigarette',\n",
       "  'image': 'documents/fxxj0037_5.png',\n",
       "  'docId': 354,\n",
       "  'ucsf_document_id': 'fxxj0037',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['low smoke cigarette',\n",
       "   'These smokers said that a low smoke cigarette would be better if offered on a thicker cigarette',\n",
       "   'low smoke'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 467,\n",
       "  'question': 'Hand sheets were made utilizing a 30% level of which component?',\n",
       "  'image': 'documents/nhxj0037_2.png',\n",
       "  'docId': 315,\n",
       "  'ucsf_document_id': 'nhxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['high surface area magnesium carbonate semihydrate made by the pyrolysis of magnesium ammonium carbonate',\n",
       "   'a high surface area magnesium carbonate semihydrate made by the pyrolysis of magesium ammonium carbonate',\n",
       "   'a high surface area magnesium carbonate semihydrate'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 468,\n",
       "  'question': 'How much percent had not noticed any difference in the odor of VSSS',\n",
       "  'image': 'documents/fxxj0037_5.png',\n",
       "  'docId': 354,\n",
       "  'ucsf_document_id': 'fxxj0037',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Over Fifty percent', 'over fifty percent'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 469,\n",
       "  'question': 'who were bothered by cigarette odors',\n",
       "  'image': 'documents/fxxj0037_5.png',\n",
       "  'docId': 354,\n",
       "  'ucsf_document_id': 'fxxj0037',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Nonsmokers',\n",
       "   'nonsmokers',\n",
       "   'Nonsmokers were bothered by cigarette odors'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 478,\n",
       "  'question': 'What is the heading of first table?',\n",
       "  'image': 'documents/rncj0037_4.png',\n",
       "  'docId': 317,\n",
       "  'ucsf_document_id': 'rncj0037',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Slim Cigarettes', 'SLIM CIGARETTES'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 479,\n",
       "  'question': 'What is RIP-6 value for KOOL KS?',\n",
       "  'image': 'documents/rncj0037_4.png',\n",
       "  'docId': 317,\n",
       "  'ucsf_document_id': 'rncj0037',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['6I/6'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 480,\n",
       "  'question': 'What is the heading of second table',\n",
       "  'image': 'documents/rncj0037_4.png',\n",
       "  'docId': 317,\n",
       "  'ucsf_document_id': 'rncj0037',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['K. C. Cigarettes'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 481,\n",
       "  'question': 'What is the cigarette code of RIP-6(W/O Filter) 21/4SE',\n",
       "  'image': 'documents/rncj0037_4.png',\n",
       "  'docId': 317,\n",
       "  'ucsf_document_id': 'rncj0037',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['P4049-99(5C)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 482,\n",
       "  'question': 'What is the name of the corporation?',\n",
       "  'image': 'documents/qncj0037_1.png',\n",
       "  'docId': 318,\n",
       "  'ucsf_document_id': 'qncj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['brown & Williamson tobacco corporation',\n",
       "   'BROWN & WILLIAMSON TOBACCO corporation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 483,\n",
       "  'question': 'What is the subject?',\n",
       "  'image': 'documents/qncj0037_1.png',\n",
       "  'docId': 318,\n",
       "  'ucsf_document_id': 'qncj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['reduced ignition propensity/498',\n",
       "   'Reduced Ignition Propensity/498'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 484,\n",
       "  'question': 'What is the meeting date?',\n",
       "  'image': 'documents/qncj0037_1.png',\n",
       "  'docId': 318,\n",
       "  'ucsf_document_id': 'qncj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['January 24, 1994', 'January 24 , 1994'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 486,\n",
       "  'question': 'How many one-on-one  interviews were completed during April 10th through the April 12th?',\n",
       "  'image': 'documents/fxxj0037_2.png',\n",
       "  'docId': 319,\n",
       "  'ucsf_document_id': 'fxxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['forty'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 487,\n",
       "  'question': 'According to the listed requirements , what must be the age group of female smokers?',\n",
       "  'image': 'documents/fxxj0037_2.png',\n",
       "  'docId': 319,\n",
       "  'ucsf_document_id': 'fxxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['between the ages of 18 and 55'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 488,\n",
       "  'question': 'According to the requirements what is the minimum required consumption of a regular brand?',\n",
       "  'image': 'documents/fxxj0037_2.png',\n",
       "  'docId': 319,\n",
       "  'ucsf_document_id': 'fxxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['1/2 pack'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 489,\n",
       "  'question': 'How many focus groups were held?',\n",
       "  'image': 'documents/fxxj0037_2.png',\n",
       "  'docId': 319,\n",
       "  'ucsf_document_id': 'fxxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Two'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 490,\n",
       "  'question': 'Which interviews covered the same topics, except packaging, that were discussed in groups?',\n",
       "  'image': 'documents/fxxj0037_2.png',\n",
       "  'docId': 319,\n",
       "  'ucsf_document_id': 'fxxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['The one-on-one',\n",
       "   'The one-on-one interviews',\n",
       "   'one-on-one interviews'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 491,\n",
       "  'question': 'What is the Best Prototype mentioned?',\n",
       "  'image': 'documents/lycj0037_5.png',\n",
       "  'docId': 321,\n",
       "  'ucsf_document_id': 'lycj0037',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['327391'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 492,\n",
       "  'question': 'What is the BLEND mentioned?',\n",
       "  'image': 'documents/lycj0037_5.png',\n",
       "  'docId': 321,\n",
       "  'ucsf_document_id': 'lycj0037',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['bw-6071', 'BW-6071'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 493,\n",
       "  'question': 'What is the LBS AT TARGET of TOTAL STRIPS?',\n",
       "  'image': 'documents/lycj0037_5.png',\n",
       "  'docId': 321,\n",
       "  'ucsf_document_id': 'lycj0037',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['10,000.0 @ 15.0 %'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 494,\n",
       "  'question': 'What is the SOLID LBS of T2F GRADE?',\n",
       "  'image': 'documents/lycj0037_5.png',\n",
       "  'docId': 321,\n",
       "  'ucsf_document_id': 'lycj0037',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['510.0', '510'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 496,\n",
       "  'question': 'What is the title of the letter?',\n",
       "  'image': 'documents/mpcl0037_1.png',\n",
       "  'docId': 322,\n",
       "  'ucsf_document_id': 'mpcl0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['interoffice memorandum', 'INTEROFFICE MEMORANDUM'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 498,\n",
       "  'question': 'To whom is this letter addressed?',\n",
       "  'image': 'documents/mpcl0037_1.png',\n",
       "  'docId': 322,\n",
       "  'ucsf_document_id': 'mpcl0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['mr. roger jennings'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 499,\n",
       "  'question': 'What is the subject of the letter?',\n",
       "  'image': 'documents/mpcl0037_1.png',\n",
       "  'docId': 322,\n",
       "  'ucsf_document_id': 'mpcl0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['effect of chemical stimulation on the perception of draw',\n",
       "   'Effect of Chemical Stimulation on the Perception of Draw'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 500,\n",
       "  'question': 'What is the PROPOSAL NO.?',\n",
       "  'image': 'documents/mpcl0037_1.png',\n",
       "  'docId': 322,\n",
       "  'ucsf_document_id': 'mpcl0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['r9044', 'R9044'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 501,\n",
       "  'question': 'When did the Human Research Committee meet to consider the proposal?',\n",
       "  'image': 'documents/mpcl0037_1.png',\n",
       "  'docId': 322,\n",
       "  'ucsf_document_id': 'mpcl0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['November 27, 1990'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 502,\n",
       "  'question': 'For what does the Bristol tippings have high ink weights for?',\n",
       "  'image': 'documents/xhxj0037_2.png',\n",
       "  'docId': 323,\n",
       "  'ucsf_document_id': 'xhxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Cork-on-white tipping', 'cork-on-white tipping'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 506,\n",
       "  'question': 'When the cigarette was smoked into the filter, what had 5% flare-up while the low silicate ink tipping had 1% flare-up?',\n",
       "  'image': 'documents/xhxj0037_2.png',\n",
       "  'docId': 323,\n",
       "  'ucsf_document_id': 'xhxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['the standard Ink tipping', 'standard ink tipping'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 507,\n",
       "  'question': 'Which inks give significantly lower filter flare-up rates?',\n",
       "  'image': 'documents/xhxj0037_2.png',\n",
       "  'docId': 323,\n",
       "  'ucsf_document_id': 'xhxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['low silicate inks'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 508,\n",
       "  'question': 'What is the 10 digits number written bold on the paper?',\n",
       "  'image': 'documents/xhxj0037_2.png',\n",
       "  'docId': 323,\n",
       "  'ucsf_document_id': 'xhxj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['2022155810'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 510,\n",
       "  'question': 'What is the name of the tobacco company?',\n",
       "  'image': 'documents/qqbl0037_1.png',\n",
       "  'docId': 325,\n",
       "  'ucsf_document_id': 'qqbl0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['RJ Reynolds',\n",
       "   'RJREYNOLDS tobacco company',\n",
       "   'R J Reynolds',\n",
       "   'R J Reynolds tobacco company',\n",
       "   'RJ REYNOLDS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 511,\n",
       "  'question': 'who is this Interoffice Memorandum addressed to?',\n",
       "  'image': 'documents/qqbl0037_1.png',\n",
       "  'docId': 325,\n",
       "  'ucsf_document_id': 'qqbl0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['J. D. Phillips'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 512,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/qqbl0037_1.png',\n",
       "  'docId': 325,\n",
       "  'ucsf_document_id': 'qqbl0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['June 18, 1992'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 513,\n",
       "  'question': 'What is the title of the second paragraph?',\n",
       "  'image': 'documents/qqbl0037_1.png',\n",
       "  'docId': 325,\n",
       "  'ucsf_document_id': 'qqbl0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['even puff-by-puff filter development (eppcat)',\n",
       "   'Even Puff-by-Puff Filter Development (EPPCAT)?'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 516,\n",
       "  'question': 'What is the name of the company?',\n",
       "  'image': 'documents/rzbj0037_4.png',\n",
       "  'docId': 326,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['B&W'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 517,\n",
       "  'question': 'What is the share of the 21-25 segment mentioned?',\n",
       "  'image': 'documents/rzbj0037_4.png',\n",
       "  'docId': 326,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['0%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 518,\n",
       "  'question': 'What is the index value for Retention of Franchise ?',\n",
       "  'image': 'documents/rzbj0037_4.png',\n",
       "  'docId': 326,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['(100)', '100'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 520,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/klcj0037_1.png',\n",
       "  'docId': 327,\n",
       "  'ucsf_document_id': 'klcj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['December 20, 1993', 'DECEMBER 20, 1993'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 522,\n",
       "  'question': 'What is the subject of the email?',\n",
       "  'image': 'documents/klcj0037_1.png',\n",
       "  'docId': 327,\n",
       "  'ucsf_document_id': 'klcj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['TAR/NICOTINE DELIVERIES'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 523,\n",
       "  'question': 'What is the name of the person in the \"FROM\" field?',\n",
       "  'image': 'documents/klcj0037_1.png',\n",
       "  'docId': 327,\n",
       "  'ucsf_document_id': 'klcj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['J. T. WINEBRENNER'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 525,\n",
       "  'question': 'What is the Ecusta of Cig. Code 498062 mentioned in RIP-6?',\n",
       "  'image': 'documents/rncj0037_3.png',\n",
       "  'docId': 341,\n",
       "  'ucsf_document_id': 'rncj0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['6I/6'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 526,\n",
       "  'question': 'What is the 9 digits number mentioned in bold?',\n",
       "  'image': 'documents/rncj0037_3.png',\n",
       "  'docId': 341,\n",
       "  'ucsf_document_id': 'rncj0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['584100575'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 527,\n",
       "  'question': 'Cig. Code 498062 and B&W 6SE  is mentioned in which RIP?',\n",
       "  'image': 'documents/rncj0037_3.png',\n",
       "  'docId': 341,\n",
       "  'ucsf_document_id': 'rncj0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['RIP-4'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 528,\n",
       "  'question': 'What is the title of the document?',\n",
       "  'image': 'documents/hyhk0037_10.png',\n",
       "  'docId': 328,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['KOOL ULTRA KS / 100'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 529,\n",
       "  'question': 'Which is more superior out of Ultra KS Prototype  or Salem Ultra 100 among rep mentol ultra smokers?',\n",
       "  'image': 'documents/hyhk0037_10.png',\n",
       "  'docId': 328,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['Ultra KS Prototype'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 530,\n",
       "  'question': 'KOOL \"C\" With Conventional Filter Will Be Adopted Based On The Acceptability Of The?',\n",
       "  'image': 'documents/hyhk0037_10.png',\n",
       "  'docId': 328,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['The Kool LTS KS CPT results', 'KOOL LTS KS CPT Results'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 531,\n",
       "  'question': 'What is the 9 digits number mentioned on the left margin?',\n",
       "  'image': 'documents/hyhk0037_10.png',\n",
       "  'docId': 328,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['399000387'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 532,\n",
       "  'question': 'What is the first line of the address mentioned at the top?',\n",
       "  'image': 'documents/tynx0037_1.png',\n",
       "  'docId': 329,\n",
       "  'ucsf_document_id': 'tynx0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Reynolds Building'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 533,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/tynx0037_1.png',\n",
       "  'docId': 329,\n",
       "  'ucsf_document_id': 'tynx0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['May 4, 2000'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 536,\n",
       "  'question': 'To whom is this letter addressed?',\n",
       "  'image': 'documents/sxxj0037_1.png',\n",
       "  'docId': 331,\n",
       "  'ucsf_document_id': 'sxxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['W.E.Claflin'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 537,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/sxxj0037_1.png',\n",
       "  'docId': 331,\n",
       "  'ucsf_document_id': 'sxxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['June 19, 1990'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 538,\n",
       "  'question': 'What is the subject of the document?',\n",
       "  'image': 'documents/sxxj0037_1.png',\n",
       "  'docId': 331,\n",
       "  'ucsf_document_id': 'sxxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Modifications to Eight-Port Sidestream Instrument'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 539,\n",
       "  'question': 'What is the date mentioned in the document ?',\n",
       "  'image': 'documents/sxxj0037_1.png',\n",
       "  'docId': 331,\n",
       "  'ucsf_document_id': 'sxxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['June 19, 1990'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 540,\n",
       "  'question': 'Heading of the document?',\n",
       "  'image': 'documents/hyhk0037_3.png',\n",
       "  'docId': 332,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Kool Improvement', 'KOOL IMPROVEMENT'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 541,\n",
       "  'question': 'How many samples were produced?',\n",
       "  'image': 'documents/hyhk0037_3.png',\n",
       "  'docId': 332,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Over 300', '300'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 542,\n",
       "  'question': 'What is the third point mentioned in Project Basis Technologies?',\n",
       "  'image': 'documents/hyhk0037_3.png',\n",
       "  'docId': 332,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Increased Humectants'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 543,\n",
       "  'question': 'What is the 9 digits number mentioned on the left border at the bottom?',\n",
       "  'image': 'documents/hyhk0037_3.png',\n",
       "  'docId': 332,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['399000380'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 544,\n",
       "  'question': 'What is the Objective of the document?',\n",
       "  'image': 'documents/hyhk0037_4.png',\n",
       "  'docId': 333,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Develop a Kool KS Product that is superior to Newport among Kool KS Smokers',\n",
       "   'Develop A KOOL KS Product That Is Superior To Newport Among KOOL KS Smokers'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 545,\n",
       "  'question': 'When was the KOOL \"C\" With 0.51% Menthol Implemented?',\n",
       "  'image': 'documents/hyhk0037_4.png',\n",
       "  'docId': 333,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['1993', 'in 1993'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 546,\n",
       "  'question': 'Heading of the document?',\n",
       "  'image': 'documents/hyhk0037_4.png',\n",
       "  'docId': 333,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Kool KS', 'KOOL KS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 547,\n",
       "  'question': 'What is the 9 digits number mentioned on the left margin?',\n",
       "  'image': 'documents/hyhk0037_4.png',\n",
       "  'docId': 333,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['399000381'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 548,\n",
       "  'question': 'What is the STRAIN TA100,REV/CIG of G7-25 with 1.0% turkish extract?',\n",
       "  'image': 'documents/hgbl0037_2.png',\n",
       "  'docId': 335,\n",
       "  'ucsf_document_id': 'hgbl0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['12621'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 549,\n",
       "  'question': 'What is the sample of the STRAIN TA100, REV/MG TAR 1094?',\n",
       "  'image': 'documents/hgbl0037_2.png',\n",
       "  'docId': 335,\n",
       "  'ucsf_document_id': 'hgbl0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Low extract G7 with 0.5% turkish extract'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 551,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/qhxj0037_1.png',\n",
       "  'docId': 336,\n",
       "  'ucsf_document_id': 'qhxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['May 29, 1990'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 552,\n",
       "  'question': 'To whom is this letter addressed?',\n",
       "  'image': 'documents/qhxj0037_1.png',\n",
       "  'docId': 336,\n",
       "  'ucsf_document_id': 'qhxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['R.Ferguson'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 559,\n",
       "  'question': 'What is the subject of the document?',\n",
       "  'image': 'documents/qhxj0037_1.png',\n",
       "  'docId': 336,\n",
       "  'ucsf_document_id': 'qhxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['EPA/AWMA International Symposium, 1990'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 560,\n",
       "  'question': 'What is the 10 digits number mentioned in bold on the right margin, at the bottom?',\n",
       "  'image': 'documents/qhxj0037_1.png',\n",
       "  'docId': 336,\n",
       "  'ucsf_document_id': 'qhxj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['2022155944'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 561,\n",
       "  'question': 'How many months have the data given here been extracted?',\n",
       "  'image': 'documents/rzbj0037_10.png',\n",
       "  'docId': 337,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['12', '12-month', '12 months', '12-Month Data'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 562,\n",
       "  'question': 'What is the Retention of Franchise?',\n",
       "  'image': 'documents/rzbj0037_10.png',\n",
       "  'docId': 337,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['79.2%', '79.2%    (98)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 563,\n",
       "  'question': 'What is the Index of Single Brand Users in the Franchise?',\n",
       "  'image': 'documents/rzbj0037_10.png',\n",
       "  'docId': 337,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['119', '(119)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 564,\n",
       "  'question': 'What is the share of the 21-25 segment mentioned?',\n",
       "  'image': 'documents/rzbj0037_10.png',\n",
       "  'docId': 337,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['0.5%', '0.5%     (50)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 565,\n",
       "  'question': 'What is the status of the KOOL MILDS KS?',\n",
       "  'image': 'documents/hyhk0037_7.png',\n",
       "  'docId': 339,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Kool \"C\" with 0.63% menthol was implemented in April 1995',\n",
       "   'KOOL \"C\" With 0.63% Menthol Was Implemented In April 1995'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 566,\n",
       "  'question': 'What is the objective of the KOOL MILDS KS?',\n",
       "  'image': 'documents/hyhk0037_7.png',\n",
       "  'docId': 339,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Using Kool \"C\" Technologies, Develop a Kool Milds KS Product which Tests at Parity or Better to Current Kool Milds KS among Kool Milds KS Smokers',\n",
       "   'Using KOOL \"C\" Technologies, Develop A KOOL Milds KS product Which Tests At Parity Or Better To Current KOOL Milds KS AMong KOOL Milds KS Smokers'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 567,\n",
       "  'question': 'What is the name of the company?',\n",
       "  'image': 'documents/hyhk0037_7.png',\n",
       "  'docId': 339,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['B&W', 'Kool Milds KS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 568,\n",
       "  'question': 'When was the KOOL \"C\" With 0.63% Menthol Implemented?',\n",
       "  'image': 'documents/hyhk0037_7.png',\n",
       "  'docId': 339,\n",
       "  'ucsf_document_id': 'hyhk0037',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['April 1995'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 569,\n",
       "  'question': 'Whose assistance will be provided in the manufacture of these tobacco products?',\n",
       "  'image': 'documents/lycj0037_2.png',\n",
       "  'docId': 342,\n",
       "  'ucsf_document_id': 'lycj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['R&D Assistance', 'R&D assistance', 'R&D'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 570,\n",
       "  'question': 'Where is the tobacco being shipped to?',\n",
       "  'image': 'documents/lycj0037_2.png',\n",
       "  'docId': 342,\n",
       "  'ucsf_document_id': 'lycj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['B&W Tobacco Corporation, Development Center, Dock 10F, Lee & McCloskey Streets, Louisville , Kentucky',\n",
       "   'B & W Tobacco Corporation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 571,\n",
       "  'question': 'Where can be the labels used to identify these\\xa0tobaccos obtained?',\n",
       "  'image': 'documents/lycj0037_2.png',\n",
       "  'docId': 342,\n",
       "  'ucsf_document_id': 'lycj0037',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Wayne Sanders, Macon Q.A.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 577,\n",
       "  'question': 'what is the CGR for the age group 21-25?',\n",
       "  'image': 'documents/rzbj0037_1.png',\n",
       "  'docId': 346,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['-0.68%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 578,\n",
       "  'question': 'which age group is having the highest estimated growth rate or CGR?',\n",
       "  'image': 'documents/rzbj0037_1.png',\n",
       "  'docId': 346,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['51+'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 579,\n",
       "  'question': 'which age group is having the lowest estimated growth rate or CGR?',\n",
       "  'image': 'documents/rzbj0037_1.png',\n",
       "  'docId': 346,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['26-35'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 580,\n",
       "  'question': 'Between which years estimated growth rates have been taken?                          ?\\\\',\n",
       "  'image': 'documents/rzbj0037_1.png',\n",
       "  'docId': 346,\n",
       "  'ucsf_document_id': 'rzbj0037',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['1995-2000'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 586,\n",
       "  'question': 'which brands did camel exotic blends compliment?',\n",
       "  'image': 'documents/tynx0037_3.png',\n",
       "  'docId': 351,\n",
       "  'ucsf_document_id': 'tynx0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': [\"the brand's Turkish and Domestic blend with rare tobaccos and flavorful spices\",\n",
       "   'Turkish and domestic blend .'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 588,\n",
       "  'question': 'what does camel crema deliver?',\n",
       "  'image': 'documents/tynx0037_3.png',\n",
       "  'docId': 351,\n",
       "  'ucsf_document_id': 'tynx0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['a creamy indulgent flavor that offers an intriguing and pleasurable smoking experience.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 590,\n",
       "  'question': 'How are speciality blends packed?',\n",
       "  'image': 'documents/tynx0037_3.png',\n",
       "  'docId': 351,\n",
       "  'ucsf_document_id': 'tynx0037',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['stylish tins with graphics', 'In stylish tins with graphics'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 605,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/xjpj0226_1.png',\n",
       "  'docId': 360,\n",
       "  'ucsf_document_id': 'xjpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['September 20, 1985'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 607,\n",
       "  'question': 'To whom is this letter addressed?',\n",
       "  'image': 'documents/xjpj0226_1.png',\n",
       "  'docId': 360,\n",
       "  'ucsf_document_id': 'xjpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Ms. Goldstein', 'Ms. Linda Goldstein'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 608,\n",
       "  'question': 'The amounts of which elements depend on the local water supply?',\n",
       "  'image': 'documents/xjpj0226_1.png',\n",
       "  'docId': 360,\n",
       "  'ucsf_document_id': 'xjpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Sodium, Potassium and Calcium',\n",
       "   'sodium, potassium and calcium'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 609,\n",
       "  'question': 'Where does the complete listing of ingredients in Pepsi products appear?',\n",
       "  'image': 'documents/xjpj0226_1.png',\n",
       "  'docId': 360,\n",
       "  'ucsf_document_id': 'xjpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['on each package.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 614,\n",
       "  'question': 'What is the word written in bold black in the first picture?',\n",
       "  'image': 'documents/mtyj0226_1.png',\n",
       "  'docId': 362,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Coke', 'Coke ®'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 617,\n",
       "  'question': 'What is the name of the beverages company?',\n",
       "  'image': 'documents/ykpj0226_10.png',\n",
       "  'docId': 363,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['Shasta',\n",
       "   'Shasta beverages',\n",
       "   'Shasta BEVERAGES',\n",
       "   'Shasta Beverages'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 618,\n",
       "  'question': 'Which is the new second generation high fructose syrup?',\n",
       "  'image': 'documents/ykpj0226_10.png',\n",
       "  'docId': 363,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['FRUCTOSE 55', 'F R U C T O S E  5 5'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 619,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/ykpj0226_10.png',\n",
       "  'docId': 363,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['July, 1979', 'JULY, 1979'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 621,\n",
       "  'question': 'What is the DEXTROSE (GLUCOSE) level?',\n",
       "  'image': 'documents/ykpj0226_10.png',\n",
       "  'docId': 363,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['42', '42%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 624,\n",
       "  'question': 'What is the date mentioned in the header of the document?',\n",
       "  'image': 'documents/nxpj0226_2.png',\n",
       "  'docId': 365,\n",
       "  'ucsf_document_id': 'nxpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['10/19/2016'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 626,\n",
       "  'question': 'Coca-Cola targeted how many Connecticut legislative proposals for taxes on beverages?',\n",
       "  'image': 'documents/nxpj0226_2.png',\n",
       "  'docId': 365,\n",
       "  'ucsf_document_id': 'nxpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['two'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 627,\n",
       "  'question': 'What is the Commission File No.?',\n",
       "  'image': 'documents/kxpj0226_1.png',\n",
       "  'docId': 367,\n",
       "  'ucsf_document_id': 'kxpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['001-02217', 'Commission File No. 001-02217'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 628,\n",
       "  'question': 'What is the name of the place the UNITED STATES SECURITIES AND EXCHANGE COMMISSION is from?',\n",
       "  'image': 'documents/kxpj0226_1.png',\n",
       "  'docId': 367,\n",
       "  'ucsf_document_id': 'kxpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Washington, d.c.',\n",
       "   'Washington, D.C.',\n",
       "   'Washington',\n",
       "   'Washington, D.C. 20549'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 629,\n",
       "  'question': 'What is the COMMON STOCK PAR VALUE?',\n",
       "  'image': 'documents/kxpj0226_1.png',\n",
       "  'docId': 367,\n",
       "  'ucsf_document_id': 'kxpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['$0.25'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 630,\n",
       "  'question': 'Where is One Coca-Cola Plaza located?',\n",
       "  'image': 'documents/kxpj0226_1.png',\n",
       "  'docId': 367,\n",
       "  'ucsf_document_id': 'kxpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Atlanta, georgia', 'Atlanta, Georgia'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 640,\n",
       "  'question': 'In which year manufacture of carbonated water began ?',\n",
       "  'image': 'documents/mtyj0226_12.png',\n",
       "  'docId': 370,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '12',\n",
       "  'answers': ['1772'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 641,\n",
       "  'question': 'In how many countries coca-cola markets its products?',\n",
       "  'image': 'documents/mtyj0226_12.png',\n",
       "  'docId': 370,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '12',\n",
       "  'answers': ['more than 155 countries'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 642,\n",
       "  'question': 'What does the carbon dioxide  produce in soft drinks ?',\n",
       "  'image': 'documents/mtyj0226_12.png',\n",
       "  'docId': 370,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '12',\n",
       "  'answers': ['produces the distinctive \"sparkling\" quality and that \"bubbling\" effect as the drink is poured from the container.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 643,\n",
       "  'question': 'Who reviewed about the safety of carbon dioxide in food?',\n",
       "  'image': 'documents/mtyj0226_12.png',\n",
       "  'docId': 370,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '12',\n",
       "  'answers': ['by a group of prominent scientists for the food and drug administration'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 644,\n",
       "  'question': \"Which company's consumer information center is given here?\",\n",
       "  'image': 'documents/mtyj0226_12.png',\n",
       "  'docId': 370,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '12',\n",
       "  'answers': ['Coca-Cola USA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 645,\n",
       "  'question': 'what is the average intake of sodium in US ?',\n",
       "  'image': 'documents/mtyj0226_16.png',\n",
       "  'docId': 371,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['3,000-5,000 milligrams per day',\n",
       "   '3000-5000 milligrams per day',\n",
       "   'the average intake of sodium in the U.S. is estimated to be 3,000-5,000 milligrams per day',\n",
       "   'estimated to be3000-5000 milligrams per day'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 646,\n",
       "  'question': 'What is the  average U.S per capita consumption of soft drinks based on national sales estimates?',\n",
       "  'image': 'documents/mtyj0226_16.png',\n",
       "  'docId': 371,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['is approximately two and one-half six-ounce servings.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 647,\n",
       "  'question': 'What is the estimated average intake of sodium per day in the U.S.?',\n",
       "  'image': 'documents/mtyj0226_16.png',\n",
       "  'docId': 371,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['is estimated to be 3,000-5,000 milligrams per day.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 649,\n",
       "  'question': 'what the contact number of  consumer information centre?',\n",
       "  'image': 'documents/mtyj0226_16.png',\n",
       "  'docId': 371,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['1-800-438-2653', '(1-800-438-2653)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 658,\n",
       "  'question': 'what is the gross profit in the year 2009?',\n",
       "  'image': 'documents/mxpj0226_6.png',\n",
       "  'docId': 376,\n",
       "  'ucsf_document_id': 'mxpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['19,902', '19,902 millions'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 659,\n",
       "  'question': 'what is the income before income tax for  the year 2007?',\n",
       "  'image': 'documents/mxpj0226_6.png',\n",
       "  'docId': 376,\n",
       "  'ucsf_document_id': 'mxpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['7,919', '7919', '7,919 millions'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 660,\n",
       "  'question': 'what is the basic net income per share for 2009 vs 2008',\n",
       "  'image': 'documents/mxpj0226_6.png',\n",
       "  'docId': 376,\n",
       "  'ucsf_document_id': 'mxpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['18%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 661,\n",
       "  'question': 'what is the consolidated net income in the year 2008',\n",
       "  'image': 'documents/mxpj0226_6.png',\n",
       "  'docId': 376,\n",
       "  'ucsf_document_id': 'mxpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['5,874', '5,784 millions'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 662,\n",
       "  'question': 'what is the operating margin in the year 2009',\n",
       "  'image': 'documents/mxpj0226_6.png',\n",
       "  'docId': 376,\n",
       "  'ucsf_document_id': 'mxpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['26.6%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 664,\n",
       "  'question': 'To whom, the letter is addressed?',\n",
       "  'image': 'documents/mtyj0226_3.png',\n",
       "  'docId': 378,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Mr. W. Thomas', 'Mr . Thomas:'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 665,\n",
       "  'question': 'Who is the consumer correspondence of coca cola USA?',\n",
       "  'image': 'documents/mtyj0226_3.png',\n",
       "  'docId': 378,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['kimberly boyer'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 667,\n",
       "  'question': 'What is the date mentioned in the letter?',\n",
       "  'image': 'documents/mtyj0226_3.png',\n",
       "  'docId': 378,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['March 4, 1991'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 669,\n",
       "  'question': 'whats the name of company ?',\n",
       "  'image': 'documents/ykpj0226_1.png',\n",
       "  'docId': 381,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Shasta Beverages Inc.', 'Shasta Beverages INC.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 670,\n",
       "  'question': 'Who is this letter sent to ?',\n",
       "  'image': 'documents/ykpj0226_1.png',\n",
       "  'docId': 381,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Ms. Bonnie Liebman', 'Ms. Liebman', 'Ms.Liebman'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 672,\n",
       "  'question': 'who is the vice president of shasta beverages?',\n",
       "  'image': 'documents/ykpj0226_1.png',\n",
       "  'docId': 381,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Cecil B. Lowry'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 673,\n",
       "  'question': 'What is the date mentioned in this letter?',\n",
       "  'image': 'documents/ykpj0226_1.png',\n",
       "  'docId': 381,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['January 14, 1980'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 684,\n",
       "  'question': 'Who has written the comments?',\n",
       "  'image': 'documents/ghpj0226_1.png',\n",
       "  'docId': 384,\n",
       "  'ucsf_document_id': 'ghpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Michael f. brown and richard l. frank',\n",
       "   'Michael F. Brown and Richard L. Frank'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 685,\n",
       "  'question': 'what is the name of the food institute',\n",
       "  'image': 'documents/ghpj0226_1.png',\n",
       "  'docId': 384,\n",
       "  'ucsf_document_id': 'ghpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['the american frozen food institute',\n",
       "   'the American Frozen food institute'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 687,\n",
       "  'question': 'What is the date mentioned in the document?',\n",
       "  'image': 'documents/ghpj0226_1.png',\n",
       "  'docId': 384,\n",
       "  'ucsf_document_id': 'ghpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['July 17 , 1978'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 690,\n",
       "  'question': 'what does the phosphoric acid contain ?',\n",
       "  'image': 'documents/mtyj0226_13.png',\n",
       "  'docId': 385,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['mineral phosphorous'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 691,\n",
       "  'question': 'how many milligrams americans consume phosphorus per day',\n",
       "  'image': 'documents/mtyj0226_13.png',\n",
       "  'docId': 385,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['1200-1600 milligrams'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 692,\n",
       "  'question': 'What happens when a tooth is placed in an acid solution & is left there for a number of days?',\n",
       "  'image': 'documents/mtyj0226_13.png',\n",
       "  'docId': 385,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['erosion will take place.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 693,\n",
       "  'question': 'On which date this statement was passed?',\n",
       "  'image': 'documents/fhpj0226_1.png',\n",
       "  'docId': 386,\n",
       "  'ucsf_document_id': 'fhpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['June 9, 1978'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 694,\n",
       "  'question': 'who is the vice president of the quaker oats company?',\n",
       "  'image': 'documents/fhpj0226_1.png',\n",
       "  'docId': 386,\n",
       "  'ucsf_document_id': 'fhpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['robert o. nesheim',\n",
       "   'ROBERT O. NESHEIM',\n",
       "   'robert o. nesheim, Ph.d.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 695,\n",
       "  'question': 'What was the subcommitteeon?',\n",
       "  'image': 'documents/fhpj0226_1.png',\n",
       "  'docId': 386,\n",
       "  'ucsf_document_id': 'fhpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['health and scientific research',\n",
       "   'HEALTH AND SCIENTIFIC RESEARCH'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 696,\n",
       "  'question': 'What is the date mentioned in the document?',\n",
       "  'image': 'documents/fhpj0226_1.png',\n",
       "  'docId': 386,\n",
       "  'ucsf_document_id': 'fhpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['JUNE 9, 1978'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 698,\n",
       "  'question': 'which country is benefited from the successful integration of jugos de valle?',\n",
       "  'image': 'documents/lxpj0226_8.png',\n",
       "  'docId': 387,\n",
       "  'ucsf_document_id': 'lxpj0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['Latin America'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 700,\n",
       "  'question': 'What is the increase in net operating revenues as part of favorable impact of currency fluctuations?',\n",
       "  'image': 'documents/lxpj0226_8.png',\n",
       "  'docId': 387,\n",
       "  'ucsf_document_id': 'lxpj0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['by approximately 2 percent.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 701,\n",
       "  'question': \"Which financial year's net operating revenues are compared?\",\n",
       "  'image': 'documents/lxpj0226_8.png',\n",
       "  'docId': 387,\n",
       "  'ucsf_document_id': 'lxpj0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['Year ended December 31, 2009, versus Year Ended December 31, 2008'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 702,\n",
       "  'question': 'In which country is the consumer information centre located?',\n",
       "  'image': 'documents/mtyj0226_14.png',\n",
       "  'docId': 388,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '14',\n",
       "  'answers': ['Atlanta, Georgia 30301', 'Georgia'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 703,\n",
       "  'question': 'Which acid do the coca-cola company use to provide a pleasant tartness?',\n",
       "  'image': 'documents/mtyj0226_14.png',\n",
       "  'docId': 388,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '14',\n",
       "  'answers': ['phosphoric acid'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 704,\n",
       "  'question': 'what does soft drinks provide ?',\n",
       "  'image': 'documents/mtyj0226_14.png',\n",
       "  'docId': 388,\n",
       "  'ucsf_document_id': 'mtyj0226',\n",
       "  'ucsf_document_page_no': '14',\n",
       "  'answers': ['refreshing and positive contribution to everyday living',\n",
       "   'a refreshing and positive contribution to everyday living'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 712,\n",
       "  'question': 'what has been playing a significant role in soft drink industry?',\n",
       "  'image': 'documents/ykpj0226_11.png',\n",
       "  'docId': 390,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['High Fructose corn sweeteners',\n",
       "   'high fructose corn sweeteners'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 715,\n",
       "  'question': 'what is the percentage reduction in calories in the fructose sweetened soft drinks?',\n",
       "  'image': 'documents/ykpj0226_11.png',\n",
       "  'docId': 390,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['10-12%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 716,\n",
       "  'question': 'What is the average calories decreased over the past decade in the United States?',\n",
       "  'image': 'documents/jxpj0226_7.png',\n",
       "  'docId': 391,\n",
       "  'ucsf_document_id': 'jxpj0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['11%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 718,\n",
       "  'question': 'In which year diet coke was introduced in United States?',\n",
       "  'image': 'documents/jxpj0226_7.png',\n",
       "  'docId': 391,\n",
       "  'ucsf_document_id': 'jxpj0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['1982'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 721,\n",
       "  'question': 'what is the name of the food institute?',\n",
       "  'image': 'documents/ghpj0226_2.png',\n",
       "  'docId': 392,\n",
       "  'ucsf_document_id': 'ghpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['American Frozen food Institute',\n",
       "   'THE AMERICAN FROZEN FOOD INSTITUTE',\n",
       "   'AFFI'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 722,\n",
       "  'question': 'How many members are included in the frozen food institute?',\n",
       "  'image': 'documents/ghpj0226_2.png',\n",
       "  'docId': 392,\n",
       "  'ucsf_document_id': 'ghpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['more than 400', 'more than 400 members'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 723,\n",
       "  'question': 'AFFI stands for ?',\n",
       "  'image': 'documents/ghpj0226_2.png',\n",
       "  'docId': 392,\n",
       "  'ucsf_document_id': 'ghpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['American Frozen Food Institute',\n",
       "   'American frozen food institute'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 724,\n",
       "  'question': 'This statement or comments is submitted on behalf of?',\n",
       "  'image': 'documents/ghpj0226_2.png',\n",
       "  'docId': 392,\n",
       "  'ucsf_document_id': 'ghpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['The American Frozen food institute',\n",
       "   'The American Frozen food institute (\"AFFI\")',\n",
       "   'AFFI'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 726,\n",
       "  'question': 'where does the high fructose corn will come from ?',\n",
       "  'image': 'documents/ykpj0226_5.png',\n",
       "  'docId': 393,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['major corn refiners in the midwest',\n",
       "   'from major corn refiners in the Midwest',\n",
       "   'major corn refiners in the midwest.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 728,\n",
       "  'question': 'for foreseeable future what will be our only nutritive sweetener?',\n",
       "  'image': 'documents/ykpj0226_5.png',\n",
       "  'docId': 393,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Fructose', 'fructose'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 729,\n",
       "  'question': 'What stops companies like coke and pepsi from using fructose widely?',\n",
       "  'image': 'documents/ykpj0226_5.png',\n",
       "  'docId': 393,\n",
       "  'ucsf_document_id': 'ykpj0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Franchise bottler system', 'franchise bottler system'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 730,\n",
       "  'question': 'this letter was written to whom?',\n",
       "  'image': 'documents/tkpj0226_2.png',\n",
       "  'docId': 395,\n",
       "  'ucsf_document_id': 'tkpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Michael Jacobson', 'Michael jacobson'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 731,\n",
       "  'question': 'On  which date was  this letter was written',\n",
       "  'image': 'documents/tkpj0226_2.png',\n",
       "  'docId': 395,\n",
       "  'ucsf_document_id': 'tkpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['17 March 1975', '17 march 1975'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 732,\n",
       "  'question': 'who is the editor who signed this letter?',\n",
       "  'image': 'documents/tkpj0226_2.png',\n",
       "  'docId': 395,\n",
       "  'ucsf_document_id': 'tkpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Bill Wolf'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 734,\n",
       "  'question': 'under which corporation this letter has been written',\n",
       "  'image': 'documents/tkpj0226_2.png',\n",
       "  'docId': 395,\n",
       "  'ucsf_document_id': 'tkpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['The United Consumer Service Corporation',\n",
       "   'united consumer service corporation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 737,\n",
       "  'question': \"For what price is the film kit plus teacher's guide available?\",\n",
       "  'image': 'documents/tkpj0226_11.png',\n",
       "  'docId': 396,\n",
       "  'ucsf_document_id': 'tkpj0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['is available for $3.50.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 738,\n",
       "  'question': 'The story is designed to interest whom?',\n",
       "  'image': 'documents/tkpj0226_11.png',\n",
       "  'docId': 396,\n",
       "  'ucsf_document_id': 'tkpj0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['middle elementary school level children and older'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 739,\n",
       "  'question': 'Heading of the document?',\n",
       "  'image': 'documents/xfpj0226_2.png',\n",
       "  'docId': 400,\n",
       "  'ucsf_document_id': 'xfpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['The start of a fine home library'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 740,\n",
       "  'question': 'What is the price of the token?',\n",
       "  'image': 'documents/xfpj0226_2.png',\n",
       "  'docId': 400,\n",
       "  'ucsf_document_id': 'xfpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['$1 each', '$1'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 741,\n",
       "  'question': 'How many pages does the volume contain?',\n",
       "  'image': 'documents/xfpj0226_2.png',\n",
       "  'docId': 400,\n",
       "  'ucsf_document_id': 'xfpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['1300-page', '1300'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 742,\n",
       "  'question': 'How many stories are present in The works of Kipling?',\n",
       "  'image': 'documents/xfpj0226_2.png',\n",
       "  'docId': 400,\n",
       "  'ucsf_document_id': 'xfpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['139 stories'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 743,\n",
       "  'question': 'Heading of the document?',\n",
       "  'image': 'documents/xfpj0226_1.png',\n",
       "  'docId': 401,\n",
       "  'ucsf_document_id': 'xfpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Thirst is a pretty good reason for drinking',\n",
       "   'THIRST IS A PRETTY GOOD REASON FOR DRINKING'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 744,\n",
       "  'question': 'What is the name of the company?',\n",
       "  'image': 'documents/xfpj0226_1.png',\n",
       "  'docId': 401,\n",
       "  'ucsf_document_id': 'xfpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['The Coca-Cola company', 'The Coca-Cola Company'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 746,\n",
       "  'question': 'What are critical for well-being of people today?',\n",
       "  'image': 'documents/xfpj0226_1.png',\n",
       "  'docId': 401,\n",
       "  'ucsf_document_id': 'xfpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Nutritious food, balanced diets'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 748,\n",
       "  'question': 'Where was the meeting held?',\n",
       "  'image': 'documents/xfpj0226_5.png',\n",
       "  'docId': 402,\n",
       "  'ucsf_document_id': 'xfpj0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Atlanta'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 750,\n",
       "  'question': 'When will the announcement be held?',\n",
       "  'image': 'documents/xfpj0226_5.png',\n",
       "  'docId': 402,\n",
       "  'ucsf_document_id': 'xfpj0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Tuesday'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 751,\n",
       "  'question': 'Who is the chairman of Coca-Cola company?',\n",
       "  'image': 'documents/xfpj0226_5.png',\n",
       "  'docId': 402,\n",
       "  'ucsf_document_id': 'xfpj0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Roberto C. Goizueta', 'Roberto Goizueta'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 752,\n",
       "  'question': 'What is the DOCKET NO?',\n",
       "  'image': 'documents/szyj0226_1.png',\n",
       "  'docId': 403,\n",
       "  'ucsf_document_id': 'szyj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['8839'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 754,\n",
       "  'question': 'When was this document issued?',\n",
       "  'image': 'documents/szyj0226_1.png',\n",
       "  'docId': 403,\n",
       "  'ucsf_document_id': 'szyj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['October 5, 1973'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 755,\n",
       "  'question': 'Who is the secretary?',\n",
       "  'image': 'documents/szyj0226_1.png',\n",
       "  'docId': 403,\n",
       "  'ucsf_document_id': 'szyj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Charles A. Tobin'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 756,\n",
       "  'question': 'who is the chairman of the council on children, media and merchandising?',\n",
       "  'image': 'documents/mgpj0226_7.png',\n",
       "  'docId': 404,\n",
       "  'ucsf_document_id': 'mgpj0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Robert Choate'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 757,\n",
       "  'question': 'What is the name of the office mentioned in the letter?',\n",
       "  'image': 'documents/mgpj0226_7.png',\n",
       "  'docId': 404,\n",
       "  'ucsf_document_id': 'mgpj0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Freedom of information office'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 758,\n",
       "  'question': 'who has signed the letter?',\n",
       "  'image': 'documents/mgpj0226_7.png',\n",
       "  'docId': 404,\n",
       "  'ucsf_document_id': 'mgpj0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Bonnie Liebman'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 759,\n",
       "  'question': 'what is the heading of the document?',\n",
       "  'image': 'documents/mgpj0226_7.png',\n",
       "  'docId': 404,\n",
       "  'ucsf_document_id': 'mgpj0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Nutrition action', 'Nutrition Action'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 762,\n",
       "  'question': 'By whom  a great deal of advertising is produced locally?',\n",
       "  'image': 'documents/rzyj0226_2.png',\n",
       "  'docId': 406,\n",
       "  'ucsf_document_id': 'rzyj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['bottlers,', 'bottlers'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 765,\n",
       "  'question': 'who began voluntarily listing Yello #5 on its labels well before the FDA required',\n",
       "  'image': 'documents/hjpj0226_9.png',\n",
       "  'docId': 407,\n",
       "  'ucsf_document_id': 'hjpj0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['Pepsi-Cola Company', 'pepsi-cola company'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 766,\n",
       "  'question': 'artificial colour only fulfils whose labelling requirements',\n",
       "  'image': 'documents/hjpj0226_9.png',\n",
       "  'docId': 407,\n",
       "  'ucsf_document_id': 'hjpj0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['federal labeling requirements'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 768,\n",
       "  'question': 'what was removed from the diets of hyperactive children as part of the study?',\n",
       "  'image': 'documents/hjpj0226_9.png',\n",
       "  'docId': 407,\n",
       "  'ucsf_document_id': 'hjpj0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['food coloring'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 770,\n",
       "  'question': 'what sort of certification is this',\n",
       "  'image': 'documents/qpjf0226_4.png',\n",
       "  'docId': 626,\n",
       "  'ucsf_document_id': 'qpjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Certification of Translation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 771,\n",
       "  'question': 'What is the specialization  of international litigation services?',\n",
       "  'image': 'documents/qpjf0226_4.png',\n",
       "  'docId': 626,\n",
       "  'ucsf_document_id': 'qpjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['international cases and foreign language document processing'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 772,\n",
       "  'question': 'when is this executed on',\n",
       "  'image': 'documents/qpjf0226_4.png',\n",
       "  'docId': 626,\n",
       "  'ucsf_document_id': 'qpjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['27th day of August 2013'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 773,\n",
       "  'question': 'who is the managing director of international litigation services',\n",
       "  'image': 'documents/qpjf0226_4.png',\n",
       "  'docId': 626,\n",
       "  'ucsf_document_id': 'qpjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Joseph Thorpe'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 775,\n",
       "  'question': 'who conducted pivotal studies',\n",
       "  'image': 'documents/yljf0226_2.png',\n",
       "  'docId': 634,\n",
       "  'ucsf_document_id': 'yljf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Takeda'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 776,\n",
       "  'question': 'What findings are not duplicated in mouse, monkey, or dog?',\n",
       "  'image': 'documents/yljf0226_2.png',\n",
       "  'docId': 634,\n",
       "  'ucsf_document_id': 'yljf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Rat Findings', 'Rat'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 778,\n",
       "  'question': 'quantity of the product code 15102',\n",
       "  'image': 'documents/szjf0226_1.png',\n",
       "  'docId': 638,\n",
       "  'ucsf_document_id': 'szjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['1'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 796,\n",
       "  'question': 'what are the greatest sources of caffeine?',\n",
       "  'image': 'documents/hjpj0226_6.png',\n",
       "  'docId': 411,\n",
       "  'ucsf_document_id': 'hjpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['coffee, tea and chocolate.', 'coffee, tea and chocolate'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 797,\n",
       "  'question': 'In which year did American Council on Science and Health , published \"the health effects of caffeine\"?',\n",
       "  'image': 'documents/hjpj0226_6.png',\n",
       "  'docId': 411,\n",
       "  'ucsf_document_id': 'hjpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['1983'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 798,\n",
       "  'question': 'What add little to the average total intake of caffeine?',\n",
       "  'image': 'documents/hjpj0226_6.png',\n",
       "  'docId': 411,\n",
       "  'ucsf_document_id': 'hjpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['soft drinks'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 799,\n",
       "  'question': 'what produces a number of caffeine free soft drink for those who prefer no caffeine in their diets?',\n",
       "  'image': 'documents/hjpj0226_6.png',\n",
       "  'docId': 411,\n",
       "  'ucsf_document_id': 'hjpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Pepsi-Cola', 'pepsi-cola'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 807,\n",
       "  'question': 'Where is the Coca-cola company foods division located?',\n",
       "  'image': 'documents/hfpj0226_5.png',\n",
       "  'docId': 412,\n",
       "  'ucsf_document_id': 'hfpj0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Houston, Texas'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 810,\n",
       "  'question': 'From which department the letter is issued?',\n",
       "  'image': 'documents/ggpj0226_1.png',\n",
       "  'docId': 414,\n",
       "  'ucsf_document_id': 'ggpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Department of health, education, and welfare'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 816,\n",
       "  'question': 'whose signature at the bottom of page ?',\n",
       "  'image': 'documents/ggpj0226_1.png',\n",
       "  'docId': 414,\n",
       "  'ucsf_document_id': 'ggpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Alexander Grant', 'alexander grant'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 817,\n",
       "  'question': 'what is the date mentioned at the top of the page?',\n",
       "  'image': 'documents/hjpj0226_1.png',\n",
       "  'docId': 415,\n",
       "  'ucsf_document_id': 'hjpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['November 14, 1986'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 827,\n",
       "  'question': 'who is the consumer correspondent?',\n",
       "  'image': 'documents/hjpj0226_1.png',\n",
       "  'docId': 415,\n",
       "  'ucsf_document_id': 'hjpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Anita Pancotto', 'anita pancotto'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 829,\n",
       "  'question': 'Who is this letter sent to?',\n",
       "  'image': 'documents/sfpj0226_1.png',\n",
       "  'docId': 417,\n",
       "  'ucsf_document_id': 'sfpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Mr. Alm', 'Mr. John R. Alm'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 830,\n",
       "  'question': 'what is the designation of Mr.john r alm?',\n",
       "  'image': 'documents/sfpj0226_1.png',\n",
       "  'docId': 417,\n",
       "  'ucsf_document_id': 'sfpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['President and Chief Operating Officer',\n",
       "   'president and chief operating officer'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 831,\n",
       "  'question': \"what is the president's healthierUS goal ?\",\n",
       "  'image': 'documents/sfpj0226_1.png',\n",
       "  'docId': 417,\n",
       "  'ucsf_document_id': 'sfpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['helping americans live longer, better and healthier lives.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 832,\n",
       "  'question': 'what is the reason to applaud Alm?',\n",
       "  'image': 'documents/sfpj0226_1.png',\n",
       "  'docId': 417,\n",
       "  'ucsf_document_id': 'sfpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['personal commitment to helping the children of los angeles build bright futures through camp paintrock'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 833,\n",
       "  'question': 'what is the title of the page?',\n",
       "  'image': 'documents/rzyj0226_6.png',\n",
       "  'docId': 418,\n",
       "  'ucsf_document_id': 'rzyj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Sing With Me', 'sing with me'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 835,\n",
       "  'question': 'what happens if i sip on my coke while i sing my song according to letter?',\n",
       "  'image': 'documents/rzyj0226_6.png',\n",
       "  'docId': 418,\n",
       "  'ucsf_document_id': 'rzyj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['it cools my throat'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 839,\n",
       "  'question': 'where is the place of coca-cola companyas  mentioned in the letterhead?',\n",
       "  'image': 'documents/phpj0226_1.png',\n",
       "  'docId': 420,\n",
       "  'ucsf_document_id': 'phpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Atlanta, Georgia', 'atlanta,georgia'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 841,\n",
       "  'question': 'What is the letter dated?',\n",
       "  'image': 'documents/phpj0226_3.png',\n",
       "  'docId': 421,\n",
       "  'ucsf_document_id': 'phpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['November 1, 1972', 'November 1 ,  1972'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 842,\n",
       "  'question': 'What is the designation of the sender in this letter?',\n",
       "  'image': 'documents/phpj0226_3.png',\n",
       "  'docId': 421,\n",
       "  'ucsf_document_id': 'phpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['public relations assistant', 'Public Relations Assistant'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 843,\n",
       "  'question': 'Who is this letter addressed to?',\n",
       "  'image': 'documents/phpj0226_1.png',\n",
       "  'docId': 420,\n",
       "  'ucsf_document_id': 'phpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Ms. Catherine Lerza', 'Ms. Lerza'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 844,\n",
       "  'question': \"what was the company's first protein containing beverage?\",\n",
       "  'image': 'documents/phpj0226_1.png',\n",
       "  'docId': 420,\n",
       "  'ucsf_document_id': 'phpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Saci', 'saci'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 845,\n",
       "  'question': 'what is the page number mentioned in this letter?',\n",
       "  'image': 'documents/phpj0226_3.png',\n",
       "  'docId': 421,\n",
       "  'ucsf_document_id': 'phpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['-3-'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 846,\n",
       "  'question': 'who is the senior vice president ?',\n",
       "  'image': 'documents/gjpj0226_1.png',\n",
       "  'docId': 423,\n",
       "  'ucsf_document_id': 'gjpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Alan L. Hoffman'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 847,\n",
       "  'question': 'What kind of study is mentioned in this letter?',\n",
       "  'image': 'documents/mhpj0226_1.png',\n",
       "  'docId': 425,\n",
       "  'ucsf_document_id': 'mhpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Study on soft drinks', 'the study on soft drinks.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 848,\n",
       "  'question': 'what is the date mentioned in the letter?',\n",
       "  'image': 'documents/gjpj0226_1.png',\n",
       "  'docId': 423,\n",
       "  'ucsf_document_id': 'gjpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['April 15,2014', 'April 15, 2014'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 850,\n",
       "  'question': 'who is the executive director?',\n",
       "  'image': 'documents/gjpj0226_1.png',\n",
       "  'docId': 423,\n",
       "  'ucsf_document_id': 'gjpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Mr. Michael jacobson', 'mr. Michael jacobson'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 851,\n",
       "  'question': 'where is Alan L.hoffan working ?',\n",
       "  'image': 'documents/gjpj0226_1.png',\n",
       "  'docId': 423,\n",
       "  'ucsf_document_id': 'gjpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['global public policy and government affairs'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 852,\n",
       "  'question': 'What is the date mentioned on the top of the letter ?',\n",
       "  'image': 'documents/mhpj0226_1.png',\n",
       "  'docId': 425,\n",
       "  'ucsf_document_id': 'mhpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['July 29, 1972'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 853,\n",
       "  'question': 'In how many countries global company is operating ?',\n",
       "  'image': 'documents/gjpj0226_1.png',\n",
       "  'docId': 423,\n",
       "  'ucsf_document_id': 'gjpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['more than 220'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 854,\n",
       "  'question': 'What is the date of this letter?',\n",
       "  'image': 'documents/mhpj0226_1.png',\n",
       "  'docId': 425,\n",
       "  'ucsf_document_id': 'mhpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['July 29, 1972', 'July 29,  1972'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 855,\n",
       "  'question': 'who is the president and chief operating officer?',\n",
       "  'image': 'documents/rfpj0226_1.png',\n",
       "  'docId': 424,\n",
       "  'ucsf_document_id': 'rfpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['John R. Alm', 'John R Alm'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 860,\n",
       "  'question': 'what is the 2nd point inthe letter ?',\n",
       "  'image': 'documents/rfpj0226_1.png',\n",
       "  'docId': 424,\n",
       "  'ucsf_document_id': 'rfpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Reaffirm our decades-old strict policy and guidelines regarding the marketing and advertising of our brands to children.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 862,\n",
       "  'question': 'What sort of document series does it covers ?',\n",
       "  'image': 'documents/pkpj0226_2.png',\n",
       "  'docId': 437,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Soft Drink Ingredient Series', 'Ingredient Series'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 864,\n",
       "  'question': 'What is the title of the series?',\n",
       "  'image': 'documents/pkpj0226_2.png',\n",
       "  'docId': 437,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['SOFT DRINKS AND CAFFEINE'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 865,\n",
       "  'question': 'What is the title of the document?',\n",
       "  'image': 'documents/pkpj0226_2.png',\n",
       "  'docId': 437,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['SOFT DRINKS AND CAFFEINE'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 870,\n",
       "  'question': 'What is the fullform of ils?',\n",
       "  'image': 'documents/tpjf0226_3.png',\n",
       "  'docId': 455,\n",
       "  'ucsf_document_id': 'tpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['international litigation services',\n",
       "   'INTERNATIONAL LITIGATION SERVICES'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 871,\n",
       "  'question': 'What type of certification is mentioned in this document?',\n",
       "  'image': 'documents/tpjf0226_3.png',\n",
       "  'docId': 455,\n",
       "  'ucsf_document_id': 'tpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['CERTIFICATION OF TRANSLATION'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 872,\n",
       "  'question': 'Who is the Managing Director of International Litigation Services, Inc?',\n",
       "  'image': 'documents/tpjf0226_3.png',\n",
       "  'docId': 455,\n",
       "  'ucsf_document_id': 'tpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['joseph thorpe', 'Joseph Thorpe'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 874,\n",
       "  'question': 'what is the heading of the document of the document',\n",
       "  'image': 'documents/kgpj0226_1.png',\n",
       "  'docId': 433,\n",
       "  'ucsf_document_id': 'kgpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['memorandum of meeting', 'Memorandum of Meeting'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 877,\n",
       "  'question': 'What place is mentioned  in document',\n",
       "  'image': 'documents/kgpj0226_1.png',\n",
       "  'docId': 433,\n",
       "  'ucsf_document_id': 'kgpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': [\"commissioner's fb#8 conference room\",\n",
       "   \"commissioner's FB#8 conference Room\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 881,\n",
       "  'question': 'What is the subject of document?',\n",
       "  'image': 'documents/kgpj0226_1.png',\n",
       "  'docId': 433,\n",
       "  'ucsf_document_id': 'kgpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['labeling', 'Labeling'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 885,\n",
       "  'question': \"Who seems to be following America's footsteps?\",\n",
       "  'image': 'documents/gfpj0226_2.png',\n",
       "  'docId': 432,\n",
       "  'ucsf_document_id': 'gfpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Japan'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 898,\n",
       "  'question': 'What is the Telephone Number given?',\n",
       "  'image': 'documents/rxpj0226_3.png',\n",
       "  'docId': 439,\n",
       "  'ucsf_document_id': 'rxpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['301/436-2373'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 899,\n",
       "  'question': 'What is the full form of CFSAN?',\n",
       "  'image': 'documents/rxpj0226_1.png',\n",
       "  'docId': 441,\n",
       "  'ucsf_document_id': 'rxpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Center for Food Safety and Applied Nutrition'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 900,\n",
       "  'question': 'Which department is mentioned in the letter head?',\n",
       "  'image': 'documents/rxpj0226_1.png',\n",
       "  'docId': 441,\n",
       "  'ucsf_document_id': 'rxpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['DEPARTMENT OF HEALTH & HUMAN SERVICES'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 901,\n",
       "  'question': 'Who is the President of Corn Refiners Association?',\n",
       "  'image': 'documents/rxpj0226_1.png',\n",
       "  'docId': 441,\n",
       "  'ucsf_document_id': 'rxpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Audrae Erickson'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 902,\n",
       "  'question': 'When was this letter received?',\n",
       "  'image': 'documents/rxpj0226_1.png',\n",
       "  'docId': 441,\n",
       "  'ucsf_document_id': 'rxpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['07-03-2008'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 903,\n",
       "  'question': 'What is the date mentioned in the letter?',\n",
       "  'image': 'documents/lhpj0226_1.png',\n",
       "  'docId': 426,\n",
       "  'ucsf_document_id': 'lhpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['July 28, 1972'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 904,\n",
       "  'question': 'What is the fulll form of FDA?',\n",
       "  'image': 'documents/rxpj0226_3.png',\n",
       "  'docId': 439,\n",
       "  'ucsf_document_id': 'rxpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Food & Drug Administration', 'FOOD & DRUG ADMINISTRATION'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 905,\n",
       "  'question': 'What are the scheduled public gatherings on?',\n",
       "  'image': 'documents/kgpj0226_2.png',\n",
       "  'docId': 435,\n",
       "  'ucsf_document_id': 'kgpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['food labeling', 'on food labeling'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 907,\n",
       "  'question': 'How much percent of consumers reads labels?',\n",
       "  'image': 'documents/kgpj0226_2.png',\n",
       "  'docId': 435,\n",
       "  'ucsf_document_id': 'kgpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['20%', '20', '20 percent'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 908,\n",
       "  'question': 'What is the heading of the document?',\n",
       "  'image': 'documents/kgpj0226_2.png',\n",
       "  'docId': 435,\n",
       "  'ucsf_document_id': 'kgpj0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['memorandum of meeting', 'Memorandum of Meeting'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 910,\n",
       "  'question': 'what is the main ingredient of soft drink?',\n",
       "  'image': 'documents/pkpj0226_1.png',\n",
       "  'docId': 443,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Carbonated Water', 'Carbonated water'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 912,\n",
       "  'question': 'What is are the words written in bold in second paragraph?',\n",
       "  'image': 'documents/pkpj0226_6.png',\n",
       "  'docId': 438,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Caffeine and Other Alleged Health Related Effects'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 914,\n",
       "  'question': 'What is the heading in right corner ?',\n",
       "  'image': 'documents/pkpj0226_1.png',\n",
       "  'docId': 443,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': [\"What's in Soft Drinks\", \"WHAT'S IN SOFT DRINKS\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 915,\n",
       "  'question': 'What is the second reference mentioned?',\n",
       "  'image': 'documents/pkpj0226_6.png',\n",
       "  'docId': 438,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['PepsiCo, Inc., The Physical or Technical Effect of Caffeine in Cola Beverages, Purchase, N.Y., July 20, 1981'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 917,\n",
       "  'question': 'Which university does the sixth reference mention?',\n",
       "  'image': 'documents/pkpj0226_6.png',\n",
       "  'docId': 438,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['University of Florida'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 918,\n",
       "  'question': 'Which year is mentioned in the first reference?',\n",
       "  'image': 'documents/pkpj0226_6.png',\n",
       "  'docId': 438,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['1983'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 920,\n",
       "  'question': 'who is marketing director?',\n",
       "  'image': 'documents/lhpj0226_1.png',\n",
       "  'docId': 426,\n",
       "  'ucsf_document_id': 'lhpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Robert l. goldsmith', 'Robert L. Goldsmith'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 921,\n",
       "  'question': 'What is the docket No?',\n",
       "  'image': 'documents/xgpj0226_1.png',\n",
       "  'docId': 446,\n",
       "  'ucsf_document_id': 'xgpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['78N-0158'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 922,\n",
       "  'question': 'who published the national magazine for all boys ?',\n",
       "  'image': 'documents/lhpj0226_1.png',\n",
       "  'docId': 426,\n",
       "  'ucsf_document_id': 'lhpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['the boy scouts of america'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 924,\n",
       "  'question': 'What is the date mentioned on the document?',\n",
       "  'image': 'documents/gxpj0226_1.png',\n",
       "  'docId': 442,\n",
       "  'ucsf_document_id': 'gxpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['January 29, 2016'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 925,\n",
       "  'question': 'What is the date in document?',\n",
       "  'image': 'documents/xgpj0226_1.png',\n",
       "  'docId': 446,\n",
       "  'ucsf_document_id': 'xgpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['September 27, 1978'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 926,\n",
       "  'question': 'With whom is the meeting being conducted?',\n",
       "  'image': 'documents/gxpj0226_1.png',\n",
       "  'docId': 442,\n",
       "  'ucsf_document_id': 'gxpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Sandy Douglas', 'Sandy Douglas, Coca-Cola Co.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 927,\n",
       "  'question': 'what is the title of the page?',\n",
       "  'image': 'documents/pkpj0226_3.png',\n",
       "  'docId': 444,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['historical background'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 929,\n",
       "  'question': 'What is the date mentioned in the header of the document?',\n",
       "  'image': 'documents/gxpj0226_1.png',\n",
       "  'docId': 442,\n",
       "  'ucsf_document_id': 'gxpj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['January 29, 2016'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 930,\n",
       "  'question': 'what are the common sources of caffeine consumed by humans?',\n",
       "  'image': 'documents/pkpj0226_3.png',\n",
       "  'docId': 444,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['coffee beans, tea leaves, kola nuts and cocoa beans'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 933,\n",
       "  'question': 'What is the name of the person mentioned to Contact?',\n",
       "  'image': 'documents/lzyj0226_1.png',\n",
       "  'docId': 447,\n",
       "  'ucsf_document_id': 'lzyj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Carlton Curtis', 'Carlton'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 934,\n",
       "  'question': 'Which year is COCA-COLA beginning with a new taste?',\n",
       "  'image': 'documents/lzyj0226_1.png',\n",
       "  'docId': 447,\n",
       "  'ucsf_document_id': 'lzyj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['100th year', 'its 100th year', '100'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 935,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/lzyj0226_1.png',\n",
       "  'docId': 447,\n",
       "  'ucsf_document_id': 'lzyj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['April 23, 1985'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 936,\n",
       "  'question': 'what is widely distributed naturally occuring substance found in more than 60 plant species throughout he world?',\n",
       "  'image': 'documents/pkpj0226_3.png',\n",
       "  'docId': 444,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['caffeine'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 937,\n",
       "  'question': 'Who said, \"The best has been made even better\"?',\n",
       "  'image': 'documents/lzyj0226_1.png',\n",
       "  'docId': 447,\n",
       "  'ucsf_document_id': 'lzyj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Roberto C. Goizueta, chairman of the Board and Chief executive officer of The Coca-Cola Company',\n",
       "   'Roberto C. Goizueta',\n",
       "   'Mr. Goizueta'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 938,\n",
       "  'question': 'H ow many years of advertising is mentioned?',\n",
       "  'image': 'documents/ztyj0226_1.png',\n",
       "  'docId': 448,\n",
       "  'ucsf_document_id': 'ztyj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['95', '95 years'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 939,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/ztyj0226_1.png',\n",
       "  'docId': 448,\n",
       "  'ucsf_document_id': 'ztyj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Feb. 4, 1982', 'Feb 4, 1982'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 940,\n",
       "  'question': 'who is traditionally  attributed to legendary for the first written mention of a coffee containing beverage tea?',\n",
       "  'image': 'documents/pkpj0226_3.png',\n",
       "  'docId': 444,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Chinese emperor Shen nung',\n",
       "   'chinese emperor shen nung',\n",
       "   'Shen nung'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 942,\n",
       "  'question': 'Whose name is mentioned to  Contact?',\n",
       "  'image': 'documents/ztyj0226_1.png',\n",
       "  'docId': 448,\n",
       "  'ucsf_document_id': 'ztyj0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Tony tortorici', 'Tony Tortorici'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 944,\n",
       "  'question': 'who is the managing director of international litigation services ?',\n",
       "  'image': 'documents/zpjf0226_3.png',\n",
       "  'docId': 464,\n",
       "  'ucsf_document_id': 'zpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Joseph Thorpe'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 945,\n",
       "  'question': 'What is the heading of the document?',\n",
       "  'image': 'documents/xsjf0226_5.png',\n",
       "  'docId': 454,\n",
       "  'ucsf_document_id': 'xsjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Response Document'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 946,\n",
       "  'question': 'What are mixed with α, γ?',\n",
       "  'image': 'documents/xsjf0226_5.png',\n",
       "  'docId': 454,\n",
       "  'ucsf_document_id': 'xsjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['α, γ'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 947,\n",
       "  'question': 'What are the renal effects mentioned?',\n",
       "  'image': 'documents/xsjf0226_5.png',\n",
       "  'docId': 454,\n",
       "  'ucsf_document_id': 'xsjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['urine electrolytes, osmolality, pH',\n",
       "   '(urine electrolytes, osmolality, pH)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 948,\n",
       "  'question': 'who were treated to a sweetened chocolate drink by aztec emporer montezuma?',\n",
       "  'image': 'documents/pkpj0226_3.png',\n",
       "  'docId': 444,\n",
       "  'ucsf_document_id': 'pkpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['spanish conquerors', 'the Spanish conquerors'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 953,\n",
       "  'question': 'When it executed?',\n",
       "  'image': 'documents/zpjf0226_3.png',\n",
       "  'docId': 464,\n",
       "  'ucsf_document_id': 'zpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['28th day of August 2013'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 955,\n",
       "  'question': 'Where was the translation executed at?',\n",
       "  'image': 'documents/zpjf0226_3.png',\n",
       "  'docId': 464,\n",
       "  'ucsf_document_id': 'zpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['In aliso Viejo, california', 'Aliso Viejo, California'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 956,\n",
       "  'question': 'From whom has this email been sent?',\n",
       "  'image': 'documents/xtjf0226_1.png',\n",
       "  'docId': 465,\n",
       "  'ucsf_document_id': 'xtjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Kanayama Kiyoshi'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 957,\n",
       "  'question': 'Who are on the CC list?',\n",
       "  'image': 'documents/xtjf0226_1.png',\n",
       "  'docId': 465,\n",
       "  'ucsf_document_id': 'xtjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Shephard, Kirk (TPI); Fuse, Touichirou (TPC)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 958,\n",
       "  'question': 'What is the email ID of Kanayama Kiyoshi?',\n",
       "  'image': 'documents/xtjf0226_1.png',\n",
       "  'docId': 465,\n",
       "  'ucsf_document_id': 'xtjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Kanayama_Kiyoshi@takeda.co.jp'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 959,\n",
       "  'question': 'What is the subject of this email?',\n",
       "  'image': 'documents/xtjf0226_1.png',\n",
       "  'docId': 465,\n",
       "  'ucsf_document_id': 'xtjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Re: Potential Publicaton in Correspondence Section of The Lancet'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 960,\n",
       "  'question': 'What is the level of importance of the email send by Witte, Kimberly?',\n",
       "  'image': 'documents/tsjf0226_1.png',\n",
       "  'docId': 463,\n",
       "  'ucsf_document_id': 'tsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['High'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 961,\n",
       "  'question': 'What is the subject of the document?',\n",
       "  'image': 'documents/tsjf0226_1.png',\n",
       "  'docId': 463,\n",
       "  'ucsf_document_id': 'tsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['fw: skb problems', 'FW: SKB PROBLEMS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 962,\n",
       "  'question': 'What is the EXHIBIT number mentioned?',\n",
       "  'image': 'documents/tsjf0226_1.png',\n",
       "  'docId': 463,\n",
       "  'ucsf_document_id': 'tsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['9'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 963,\n",
       "  'question': 'What is the exhibit no given in the document?',\n",
       "  'image': 'documents/tsjf0226_1.png',\n",
       "  'docId': 463,\n",
       "  'ucsf_document_id': 'tsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['9'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 964,\n",
       "  'question': 'Who is this Memo to?',\n",
       "  'image': 'documents/sqjf0226_2.png',\n",
       "  'docId': 476,\n",
       "  'ucsf_document_id': 'sqjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['distribution', 'Distribution'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 965,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/sqjf0226_2.png',\n",
       "  'docId': 476,\n",
       "  'ucsf_document_id': 'sqjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['JULY 19, 2002', 'July 19, 2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 966,\n",
       "  'question': 'Whose signature is present at the bottom?',\n",
       "  'image': 'documents/sqjf0226_2.png',\n",
       "  'docId': 476,\n",
       "  'ucsf_document_id': 'sqjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['MARLENE C. DUBAS', 'Marlene C. Dubas'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 971,\n",
       "  'question': 'who are in the cc?',\n",
       "  'image': 'documents/tzjf0226_1.png',\n",
       "  'docId': 461,\n",
       "  'ucsf_document_id': 'tzjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['johnston,Kendra; precurato-grubb, marti'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 972,\n",
       "  'question': 'Who is the 23rd Addressee mentioned in the list?',\n",
       "  'image': 'documents/srjf0226_17.png',\n",
       "  'docId': 470,\n",
       "  'ucsf_document_id': 'srjf0226',\n",
       "  'ucsf_document_page_no': '17',\n",
       "  'answers': ['Senior Vice President, Accounting Center'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 973,\n",
       "  'question': 'Heading of the document?',\n",
       "  'image': 'documents/xsjf0226_3.png',\n",
       "  'docId': 471,\n",
       "  'ucsf_document_id': 'xsjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Draft Agenda', 'Draft Agenda?'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 975,\n",
       "  'question': 'What are the timings for Continental Breakfast?',\n",
       "  'image': 'documents/xsjf0226_3.png',\n",
       "  'docId': 471,\n",
       "  'ucsf_document_id': 'xsjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['8:00-9:00'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 976,\n",
       "  'question': 'what is the \"subject\" of this letter?',\n",
       "  'image': 'documents/tzjf0226_1.png',\n",
       "  'docId': 461,\n",
       "  'ucsf_document_id': 'tzjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': [\"article in today's USA Today regarding Avandia hearing\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 978,\n",
       "  'question': 'who is writing this letter?',\n",
       "  'image': 'documents/tzjf0226_1.png',\n",
       "  'docId': 461,\n",
       "  'ucsf_document_id': 'tzjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['CHEN, GIGI', 'chen, gigi', 'gigi m. chen, MBA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 979,\n",
       "  'question': 'when was this letter sent?',\n",
       "  'image': 'documents/tzjf0226_1.png',\n",
       "  'docId': 461,\n",
       "  'ucsf_document_id': 'tzjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['7/31/2007 11:48:09 AM', '7/31/2007 11:48:09 am'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 980,\n",
       "  'question': 'who is the premier sales representative ?',\n",
       "  'image': 'documents/tzjf0226_1.png',\n",
       "  'docId': 461,\n",
       "  'ucsf_document_id': 'tzjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['gigi m. chen, MBA', 'gigi m.chen'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 981,\n",
       "  'question': 'what is the title of this page?',\n",
       "  'image': 'documents/xsjf0226_6.png',\n",
       "  'docId': 480,\n",
       "  'ucsf_document_id': 'xsjf0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Executive Summary, cont.', 'executive summary, cont.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 982,\n",
       "  'question': 'Heading of the document?',\n",
       "  'image': 'documents/xsjf0226_4.png',\n",
       "  'docId': 481,\n",
       "  'ucsf_document_id': 'xsjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['response document', 'Response Document'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 983,\n",
       "  'question': 'what is the first point under the title-executive summary, cont.',\n",
       "  'image': 'documents/xsjf0226_6.png',\n",
       "  'docId': 480,\n",
       "  'ucsf_document_id': 'xsjf0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Proposed experiments', 'proposed experiments'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 987,\n",
       "  'question': 'What is the full form of FDA?',\n",
       "  'image': 'documents/hsjf0226_1.png',\n",
       "  'docId': 484,\n",
       "  'ucsf_document_id': 'hsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Food and Drug Administration'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 989,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/hsjf0226_1.png',\n",
       "  'docId': 484,\n",
       "  'ucsf_document_id': 'hsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['January 3, 2003'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 990,\n",
       "  'question': 'who is writing this letter?',\n",
       "  'image': 'documents/sqjf0226_1.png',\n",
       "  'docId': 483,\n",
       "  'ucsf_document_id': 'sqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Marlene Dubas', 'marlene dubas'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 992,\n",
       "  'question': 'who is in the cc?',\n",
       "  'image': 'documents/sqjf0226_1.png',\n",
       "  'docId': 483,\n",
       "  'ucsf_document_id': 'sqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Tom Muldoon', 'tom muldoon'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 993,\n",
       "  'question': 'Who is the sender of this fax?',\n",
       "  'image': 'documents/hsjf0226_1.png',\n",
       "  'docId': 484,\n",
       "  'ucsf_document_id': 'hsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Jena Weber'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 994,\n",
       "  'question': 'What is the total no of pages in the fax including cover?',\n",
       "  'image': 'documents/hsjf0226_1.png',\n",
       "  'docId': 484,\n",
       "  'ucsf_document_id': 'hsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['1'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 998,\n",
       "  'question': 'Which all  compaies are added as defendants in a lawsuit?',\n",
       "  'image': 'documents/sqjf0226_1.png',\n",
       "  'docId': 483,\n",
       "  'ucsf_document_id': 'sqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Takeda Pharmaceuticals North America, Inc. and Takeda Pharmaceuticals America, Inc.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1001,\n",
       "  'question': \"what is 'RE' in the letter?\",\n",
       "  'image': 'documents/sqjf0226_1.png',\n",
       "  'docId': 483,\n",
       "  'ucsf_document_id': 'sqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Preservation of Documents and Electronic Data relating to Actos',\n",
       "   'preservation of documents and electronic data relating to actos'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1002,\n",
       "  'question': 'Heading of the first paragraph?',\n",
       "  'image': 'documents/lzjf0226_4.png',\n",
       "  'docId': 487,\n",
       "  'ucsf_document_id': 'lzjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['SIXTH OBJECTION'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1003,\n",
       "  'question': 'Name of the judge?',\n",
       "  'image': 'documents/lzjf0226_4.png',\n",
       "  'docId': 487,\n",
       "  'ucsf_document_id': 'lzjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Patrick Hanna'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1004,\n",
       "  'question': 'What is the page no mentioned in this document?',\n",
       "  'image': 'documents/lzjf0226_4.png',\n",
       "  'docId': 487,\n",
       "  'ucsf_document_id': 'lzjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['3'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1005,\n",
       "  'question': 'When was the hearing before Judge?',\n",
       "  'image': 'documents/lzjf0226_4.png',\n",
       "  'docId': 487,\n",
       "  'ucsf_document_id': 'lzjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['July 25, 2013'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1037,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/ttjf0226_5.png',\n",
       "  'docId': 501,\n",
       "  'ucsf_document_id': 'ttjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['January 14, 1999'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1040,\n",
       "  'question': 'What is the name of the company mentioned in the letterhead?',\n",
       "  'image': 'documents/kmjf0226_1.png',\n",
       "  'docId': 503,\n",
       "  'ucsf_document_id': 'kmjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['DEPARTMENT OF HEALTH & HUMAN SERVICES'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1041,\n",
       "  'question': 'What is the company name ?',\n",
       "  'image': 'documents/ttjf0226_5.png',\n",
       "  'docId': 501,\n",
       "  'ucsf_document_id': 'ttjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['ELI LILLY AND COMPANY'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1042,\n",
       "  'question': 'What is the fullform of NDA?',\n",
       "  'image': 'documents/kmjf0226_1.png',\n",
       "  'docId': 503,\n",
       "  'ucsf_document_id': 'kmjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['new drug application', 'New drug application.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1043,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/gnjf0226_1.png',\n",
       "  'docId': 502,\n",
       "  'ucsf_document_id': 'gnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['August 16, 1999'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1044,\n",
       "  'question': 'What is the name of the addressee?',\n",
       "  'image': 'documents/kmjf0226_1.png',\n",
       "  'docId': 503,\n",
       "  'ucsf_document_id': 'kmjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Ms. Pritza', 'Mary Jo Pritza, MPH, PharmD'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1045,\n",
       "  'question': 'To whom is this letter addressed?',\n",
       "  'image': 'documents/gnjf0226_1.png',\n",
       "  'docId': 502,\n",
       "  'ucsf_document_id': 'gnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Alan D. Mackenzie', 'Alan'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1046,\n",
       "  'question': 'What is the full form of TPA?',\n",
       "  'image': 'documents/gnjf0226_1.png',\n",
       "  'docId': 502,\n",
       "  'ucsf_document_id': 'gnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Takeda Pharmaceuticals America, Inc.',\n",
       "   'Takeda Pharmaceuticals America Inc.',\n",
       "   'Takeda Pharmaceuticals America'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1047,\n",
       "  'question': 'What kind of a letter is  this ?',\n",
       "  'image': 'documents/kmjf0226_1.png',\n",
       "  'docId': 503,\n",
       "  'ucsf_document_id': 'kmjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['DISCIPLINE REVIEW LETTER'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1048,\n",
       "  'question': 'Which two companies have agreed to amend the Co-Promotion Agreement?',\n",
       "  'image': 'documents/gnjf0226_1.png',\n",
       "  'docId': 502,\n",
       "  'ucsf_document_id': 'gnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Takeda Pharmaceuticals America, Inc. (\"TPA\") and Eli Lilly and Company (\"Lilly\")'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1049,\n",
       "  'question': 'What is the name of the company?',\n",
       "  'image': 'documents/lljf0226_1.png',\n",
       "  'docId': 504,\n",
       "  'ucsf_document_id': 'lljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['THE UPJOHN COMPANY'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1051,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/lljf0226_1.png',\n",
       "  'docId': 504,\n",
       "  'ucsf_document_id': 'lljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['September 21, 1993'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1052,\n",
       "  'question': 'To whom is this letter addressed?',\n",
       "  'image': 'documents/lljf0226_1.png',\n",
       "  'docId': 504,\n",
       "  'ucsf_document_id': 'lljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Tai Matsuzawa, Ph.D.',\n",
       "   'Doctor Matsuzawa',\n",
       "   'Tai Matsuzawa, Ph.D',\n",
       "   'Matsuzawa'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1053,\n",
       "  'question': 'As a consequence of the decision Upjohn must decline participation with which company?',\n",
       "  'image': 'documents/lljf0226_1.png',\n",
       "  'docId': 504,\n",
       "  'ucsf_document_id': 'lljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Takeda'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1055,\n",
       "  'question': 'A 79-year-old female was enrolled in the study for how many days?',\n",
       "  'image': 'documents/gyjf0226_2.png',\n",
       "  'docId': 507,\n",
       "  'ucsf_document_id': 'gyjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['200 days'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1056,\n",
       "  'question': 'The patient had a history of bladder cancer since when?',\n",
       "  'image': 'documents/gyjf0226_2.png',\n",
       "  'docId': 507,\n",
       "  'ucsf_document_id': 'gyjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['1996', 'since 1996'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1057,\n",
       "  'question': 'Who is the general manager of International development Dept. of Takeda Chemical Industires, Ltd.?',\n",
       "  'image': 'documents/mljf0226_2.png',\n",
       "  'docId': 509,\n",
       "  'ucsf_document_id': 'mljf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['K. Kitazawa, Ph. D.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1058,\n",
       "  'question': 'Who is the writer of the document?',\n",
       "  'image': 'documents/gyjf0226_2.png',\n",
       "  'docId': 507,\n",
       "  'ucsf_document_id': 'gyjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Janet L. Haskins'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1059,\n",
       "  'question': 'The woman had a positive history of what?',\n",
       "  'image': 'documents/gyjf0226_2.png',\n",
       "  'docId': 507,\n",
       "  'ucsf_document_id': 'gyjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['tobacco use'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1061,\n",
       "  'question': 'what is the name of the industry ?',\n",
       "  'image': 'documents/mljf0226_2.png',\n",
       "  'docId': 509,\n",
       "  'ucsf_document_id': 'mljf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['TAKEDA CHEMICAL INDUSTRIES, LTD.',\n",
       "   'TAKEDA CHEMICAL INDUSTRIES , LTD .'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1063,\n",
       "  'question': 'How many pages are there in total?',\n",
       "  'image': 'documents/mljf0226_2.png',\n",
       "  'docId': 509,\n",
       "  'ucsf_document_id': 'mljf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['2', 'Page 2 of 2'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1065,\n",
       "  'question': 'what is the month and date mentioned in this letter, at the top ?',\n",
       "  'image': 'documents/mljf0226_2.png',\n",
       "  'docId': 509,\n",
       "  'ucsf_document_id': 'mljf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['October 25', 'october 25'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1066,\n",
       "  'question': 'By whom is this document written?',\n",
       "  'image': 'documents/ksjf0226_4.png',\n",
       "  'docId': 511,\n",
       "  'ucsf_document_id': 'ksjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Stacey Dixon Calahan'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1068,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/nljf0226_1.png',\n",
       "  'docId': 514,\n",
       "  'ucsf_document_id': 'nljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['January 21, 1999'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1069,\n",
       "  'question': 'To whom is this document addressed?',\n",
       "  'image': 'documents/nljf0226_1.png',\n",
       "  'docId': 514,\n",
       "  'ucsf_document_id': 'nljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Mr. Larry Ellingson', 'Mr. Ellingson'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1070,\n",
       "  'question': 'to which department it belongs to ?',\n",
       "  'image': 'documents/gyjf0226_3.png',\n",
       "  'docId': 513,\n",
       "  'ucsf_document_id': 'gyjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['DEPARTMENT OF HEALTH AND HUMAN SERVICES',\n",
       "   'department of health and human services.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1071,\n",
       "  'question': 'By whom is this document written?',\n",
       "  'image': 'documents/nljf0226_1.png',\n",
       "  'docId': 514,\n",
       "  'ucsf_document_id': 'nljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Kunio Iwatani'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1073,\n",
       "  'question': 'what is the date of submission?',\n",
       "  'image': 'documents/gyjf0226_3.png',\n",
       "  'docId': 513,\n",
       "  'ucsf_document_id': 'gyjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['11/18/2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1074,\n",
       "  'question': 'what is the telephone number (include area code)?',\n",
       "  'image': 'documents/gyjf0226_3.png',\n",
       "  'docId': 513,\n",
       "  'ucsf_document_id': 'gyjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['847-383-3739'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1076,\n",
       "  'question': 'What is the serial number mentioned in the form?',\n",
       "  'image': 'documents/gyjf0226_3.png',\n",
       "  'docId': 513,\n",
       "  'ucsf_document_id': 'gyjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['5 0 1'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1077,\n",
       "  'question': 'what is the expiration date ?',\n",
       "  'image': 'documents/gyjf0226_3.png',\n",
       "  'docId': 513,\n",
       "  'ucsf_document_id': 'gyjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['November 30, 2002', 'november 30, 2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1078,\n",
       "  'question': 'what is  the name of the sponsor ?',\n",
       "  'image': 'documents/gyjf0226_3.png',\n",
       "  'docId': 513,\n",
       "  'ucsf_document_id': 'gyjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Takeda Pharmaceuticals North America, Inc.',\n",
       "   'Takeda Pharmaceuticals North america , Inc.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1079,\n",
       "  'question': 'what has to be investigated before starting pioglitazone therapy?',\n",
       "  'image': 'documents/psjf0226_5.png',\n",
       "  'docId': 515,\n",
       "  'ucsf_document_id': 'psjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['any macroscopic haematuria'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1080,\n",
       "  'question': 'what has been experienced commonly in patients taking actos in combination with insulin?',\n",
       "  'image': 'documents/psjf0226_5.png',\n",
       "  'docId': 515,\n",
       "  'ucsf_document_id': 'psjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Heart failure', 'heart failure'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1081,\n",
       "  'question': 'Which foundation is mentioned in this document?',\n",
       "  'image': 'documents/zfkf0226_2.png',\n",
       "  'docId': 517,\n",
       "  'ucsf_document_id': 'zfkf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Cleveland Clinic Foundation',\n",
       "   'The Cleveland Clinic Foundation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1082,\n",
       "  'question': 'Under which department , The Cleveland Clinic Foundation operates?',\n",
       "  'image': 'documents/zfkf0226_2.png',\n",
       "  'docId': 517,\n",
       "  'ucsf_document_id': 'zfkf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Department of Cardiovascular Medicine',\n",
       "   'Department of Cardiovascular Medicine.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1083,\n",
       "  'question': 'What is written in big bold letters at the bottom?',\n",
       "  'image': 'documents/nljf0226_1.png',\n",
       "  'docId': 514,\n",
       "  'ucsf_document_id': 'nljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['DALY 19'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1084,\n",
       "  'question': 'Which medicine is used to treat type 2 diabetes mellitus?',\n",
       "  'image': 'documents/psjf0226_5.png',\n",
       "  'docId': 515,\n",
       "  'ucsf_document_id': 'psjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Actos/Competact'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1087,\n",
       "  'question': 'How many cases of bladder cancer from 12506 patients were reported?',\n",
       "  'image': 'documents/psjf0226_5.png',\n",
       "  'docId': 515,\n",
       "  'ucsf_document_id': 'psjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['19 cases'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1088,\n",
       "  'question': 'What is the PO Box number?',\n",
       "  'image': 'documents/zfkf0226_2.png',\n",
       "  'docId': 517,\n",
       "  'ucsf_document_id': 'zfkf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['931535'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1090,\n",
       "  'question': 'what is the IND mumber (if previously assigned ) ?',\n",
       "  'image': 'documents/tyjf0226_3.png',\n",
       "  'docId': 518,\n",
       "  'ucsf_document_id': 'tyjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['33,729'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1091,\n",
       "  'question': 'What is the serial number mentioned in the form?',\n",
       "  'image': 'documents/tyjf0226_3.png',\n",
       "  'docId': 518,\n",
       "  'ucsf_document_id': 'tyjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['4 9 7'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1092,\n",
       "  'question': 'what is the date of submission ?',\n",
       "  'image': 'documents/tyjf0226_3.png',\n",
       "  'docId': 518,\n",
       "  'ucsf_document_id': 'tyjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['11/1/02'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1093,\n",
       "  'question': 'what is the Name(s) of drug (include all available names: Trade , Generic, Chemical, Code)?',\n",
       "  'image': 'documents/tyjf0226_3.png',\n",
       "  'docId': 518,\n",
       "  'ucsf_document_id': 'tyjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['ACTOS (pioglitazone HCI)', 'ACTOS  (Pioglitazone HCI)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1094,\n",
       "  'question': 'What is the Tax ID mentioned in this document?',\n",
       "  'image': 'documents/zfkf0226_2.png',\n",
       "  'docId': 517,\n",
       "  'ucsf_document_id': 'zfkf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['34-0714585'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1096,\n",
       "  'question': 'what is the form approved : OMB No',\n",
       "  'image': 'documents/tyjf0226_3.png',\n",
       "  'docId': 518,\n",
       "  'ucsf_document_id': 'tyjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['0910-0014', '0910-0014.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1097,\n",
       "  'question': 'What is the word written in bold on the top of the document?',\n",
       "  'image': 'documents/psjf0226_1.png',\n",
       "  'docId': 505,\n",
       "  'ucsf_document_id': 'psjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Takeda'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1098,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/psjf0226_1.png',\n",
       "  'docId': 505,\n",
       "  'ucsf_document_id': 'psjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['19th January 2012'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1099,\n",
       "  'question': 'what is the name of pharmaceuticals ?',\n",
       "  'image': 'documents/xyjf0226_1.png',\n",
       "  'docId': 519,\n",
       "  'ucsf_document_id': 'xyjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Takeda Pharmaceuticals North America, Inc.',\n",
       "   'TAkeda pharmaceuticals North America ,INc.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1101,\n",
       "  'question': 'to whom this letter is written ?',\n",
       "  'image': 'documents/xyjf0226_1.png',\n",
       "  'docId': 519,\n",
       "  'ucsf_document_id': 'xyjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Janet L. Haskins', 'janet L. haskins', 'Ms. Haskins'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1102,\n",
       "  'question': 'When did Regulatory affairs department receive this letter?',\n",
       "  'image': 'documents/xyjf0226_1.png',\n",
       "  'docId': 519,\n",
       "  'ucsf_document_id': 'xyjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['JUN 16 2003'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1105,\n",
       "  'question': 'To whom was this letter written?',\n",
       "  'image': 'documents/psjf0226_1.png',\n",
       "  'docId': 505,\n",
       "  'ucsf_document_id': 'psjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Healthcare Professional'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1107,\n",
       "  'question': 'What is the fifth point?',\n",
       "  'image': 'documents/frjf0226_3.png',\n",
       "  'docId': 510,\n",
       "  'ucsf_document_id': 'frjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['WAC and AWP generally;', 'WAC AND AWP generally;'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1108,\n",
       "  'question': 'Education grants regarding which products?',\n",
       "  'image': 'documents/frjf0226_3.png',\n",
       "  'docId': 510,\n",
       "  'ucsf_document_id': 'frjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['TPNA', 'TPNA products'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1109,\n",
       "  'question': 'What is the date this document was last printed?',\n",
       "  'image': 'documents/frjf0226_3.png',\n",
       "  'docId': 510,\n",
       "  'ucsf_document_id': 'frjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['11/30/2012', '11/30/2012 4:28:00 AM'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1110,\n",
       "  'question': 'To whom a copy of cover letter has to be sent ?',\n",
       "  'image': 'documents/xyjf0226_1.png',\n",
       "  'docId': 519,\n",
       "  'ucsf_document_id': 'xyjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Ms. Jens Weber'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1111,\n",
       "  'question': 'Which reimbursement for TPNA pharmaceutical products is generally given?',\n",
       "  'image': 'documents/frjf0226_3.png',\n",
       "  'docId': 510,\n",
       "  'ucsf_document_id': 'frjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Medicare and Medicaid'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1113,\n",
       "  'question': 'What is the designation of Alfonso T. Perez, M.D.?',\n",
       "  'image': 'documents/zfkf0226_5.png',\n",
       "  'docId': 512,\n",
       "  'ucsf_document_id': 'zfkf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Vice President, Clinical Research'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1114,\n",
       "  'question': 'By whom was this agreement Agreed and Accepted?',\n",
       "  'image': 'documents/zfkf0226_5.png',\n",
       "  'docId': 512,\n",
       "  'ucsf_document_id': 'zfkf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Richard A. Rudick, M.D.',\n",
       "   'Richard A. Rudick, M.D. Chairman, Division of Clinical Research',\n",
       "   'Richard A. Rudick'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1115,\n",
       "  'question': 'What is the full form of FAR?',\n",
       "  'image': 'documents/zfkf0226_5.png',\n",
       "  'docId': 512,\n",
       "  'ucsf_document_id': 'zfkf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Federal Acquisitions Regulation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1116,\n",
       "  'question': 'What is the number written above TAK-INDNDA-01577086?',\n",
       "  'image': 'documents/xyjf0226_2.png',\n",
       "  'docId': 520,\n",
       "  'ucsf_document_id': 'xyjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['425'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1117,\n",
       "  'question': 'What is the contact number of Ms. Jena Weber, Regulatory Project Manager?',\n",
       "  'image': 'documents/xyjf0226_2.png',\n",
       "  'docId': 520,\n",
       "  'ucsf_document_id': 'xyjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['301-827-6422'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1118,\n",
       "  'question': 'What is the full form of ODE?',\n",
       "  'image': 'documents/xyjf0226_2.png',\n",
       "  'docId': 520,\n",
       "  'ucsf_document_id': 'xyjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Office of Drug Evaluation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1119,\n",
       "  'question': 'What is written above Page 2 on the top?',\n",
       "  'image': 'documents/xyjf0226_2.png',\n",
       "  'docId': 520,\n",
       "  'ucsf_document_id': 'xyjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['IND 33, 729'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1120,\n",
       "  'question': 'what is the unit mentioned in the letter ?',\n",
       "  'image': 'documents/zsjf0226_1.png',\n",
       "  'docId': 521,\n",
       "  'ucsf_document_id': 'zsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['7200'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1121,\n",
       "  'question': 'what is the date mentioned',\n",
       "  'image': 'documents/zsjf0226_1.png',\n",
       "  'docId': 521,\n",
       "  'ucsf_document_id': 'zsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['9/23/93'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1122,\n",
       "  'question': 'What is the date of the signature of the chairman of the Division of clinical research?',\n",
       "  'image': 'documents/zfkf0226_5.png',\n",
       "  'docId': 512,\n",
       "  'ucsf_document_id': 'zfkf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['5/8/07'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1123,\n",
       "  'question': 'Name of the first person in the To list?',\n",
       "  'image': 'documents/zsjf0226_1.png',\n",
       "  'docId': 521,\n",
       "  'ucsf_document_id': 'zsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['PJ Daniels', 'pj Daniels'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1124,\n",
       "  'question': 'When did Regulatory affairs department receive this letter?',\n",
       "  'image': 'documents/kmjf0226_1.png',\n",
       "  'docId': 503,\n",
       "  'ucsf_document_id': 'kmjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Feb 19 2007', 'FEB 19 2007'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1125,\n",
       "  'question': 'from whose desk this letter is  written ?',\n",
       "  'image': 'documents/zsjf0226_1.png',\n",
       "  'docId': 521,\n",
       "  'ucsf_document_id': 'zsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Timothy J. Gumbleton', 'timothy J Gumbleton'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1126,\n",
       "  'question': \"Whose letter's copy is attached?\",\n",
       "  'image': 'documents/zsjf0226_1.png',\n",
       "  'docId': 521,\n",
       "  'ucsf_document_id': 'zsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['DR. Mitchell', 'Dr. Mitchell'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1128,\n",
       "  'question': 'what is the date mentioned ?',\n",
       "  'image': 'documents/hmjf0226_1.png',\n",
       "  'docId': 522,\n",
       "  'ucsf_document_id': 'hmjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['February 6, 1996', 'february 6 , 1996'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1129,\n",
       "  'question': 'to whom this letter is written  ?',\n",
       "  'image': 'documents/hmjf0226_1.png',\n",
       "  'docId': 522,\n",
       "  'ucsf_document_id': 'hmjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Dr. K. KItazawa', 'Dr . k. Kitazawa'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1130,\n",
       "  'question': 'this letter is written by whom ?',\n",
       "  'image': 'documents/hmjf0226_1.png',\n",
       "  'docId': 522,\n",
       "  'ucsf_document_id': 'hmjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['T. Suzuki', 'Tsuyoshi Suzuki , M S .'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1131,\n",
       "  'question': 'Which laboratory is T. Suzuki associated with ?',\n",
       "  'image': 'documents/hmjf0226_1.png',\n",
       "  'docId': 522,\n",
       "  'ucsf_document_id': 'hmjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Drug Safety Research Laboratories',\n",
       "   'drug safety research laboratories .'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1132,\n",
       "  'question': 'what is the date mentioned in  the letter',\n",
       "  'image': 'documents/pljf0226_1.png',\n",
       "  'docId': 524,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['August 8, 2002', 'august 8 , 2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1133,\n",
       "  'question': 'What is the name of the industry given here?',\n",
       "  'image': 'documents/pljf0226_1.png',\n",
       "  'docId': 524,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Takeda chemical industries, LTD .',\n",
       "   'TAKEDA CHEMICAL INDUSTRIES, LTD.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1134,\n",
       "  'question': 'to whom this letter is written ?',\n",
       "  'image': 'documents/pljf0226_1.png',\n",
       "  'docId': 524,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Dr. Claire Thom', 'Dr. Thom'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1135,\n",
       "  'question': 'what is the name mentioned in CC',\n",
       "  'image': 'documents/pljf0226_1.png',\n",
       "  'docId': 524,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Mr. S. Hamanaka', 'Mr . S . Hamanaka'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1136,\n",
       "  'question': 'Who sent this letter?',\n",
       "  'image': 'documents/pljf0226_1.png',\n",
       "  'docId': 524,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Katsuhisa Saito', 'katsuhisa saito'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1137,\n",
       "  'question': 'what is Ref: code  mentioned ?',\n",
       "  'image': 'documents/pljf0226_1.png',\n",
       "  'docId': 524,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['TPNA-TS-020808'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1138,\n",
       "  'question': 'What is the venue mentioned in the document?',\n",
       "  'image': 'documents/pljf0226_6.png',\n",
       "  'docId': 526,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['TPNA, Chicago'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1139,\n",
       "  'question': 'What is the date mentioned in the document?',\n",
       "  'image': 'documents/pljf0226_6.png',\n",
       "  'docId': 526,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Monday, 12 and Tuesday, 13 August 2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1140,\n",
       "  'question': 'what is the fax number  mentioned in the letter at the top?',\n",
       "  'image': 'documents/pljf0226_6.png',\n",
       "  'docId': 526,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['06 6204 2244'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1141,\n",
       "  'question': 'what is the date and time mentioned ?',\n",
       "  'image': 'documents/sljf0226_1.png',\n",
       "  'docId': 527,\n",
       "  'ucsf_document_id': 'sljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['10/27/93 09:36:07'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1142,\n",
       "  'question': 'what is mentioned in the subject ?',\n",
       "  'image': 'documents/sljf0226_1.png',\n",
       "  'docId': 527,\n",
       "  'ucsf_document_id': 'sljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Pioglitazone statement', 'pioglitazone statement'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1143,\n",
       "  'question': 'To whom this email was send?',\n",
       "  'image': 'documents/sljf0226_1.png',\n",
       "  'docId': 527,\n",
       "  'ucsf_document_id': 'sljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['PETER J. DANIELS', 'PJ DANIEL--PW17PO PETER J. DANIELS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1144,\n",
       "  'question': 'what is the date mentioned in the forwarding note ?',\n",
       "  'image': 'documents/sljf0226_1.png',\n",
       "  'docId': 527,\n",
       "  'ucsf_document_id': 'sljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['10/26/93', '10/26/93 15:44'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1145,\n",
       "  'question': 'what is the time mentioned in the forwarding note ?',\n",
       "  'image': 'documents/sljf0226_1.png',\n",
       "  'docId': 527,\n",
       "  'ucsf_document_id': 'sljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['15:44'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1146,\n",
       "  'question': 'To whom this email was forwaded?',\n",
       "  'image': 'documents/sljf0226_1.png',\n",
       "  'docId': 527,\n",
       "  'ucsf_document_id': 'sljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['RUPPEL, PATRICIA', 'PLRUPPEL--RCC1 RUPPEL, PATRICIA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1147,\n",
       "  'question': 'what is the name of the company',\n",
       "  'image': 'documents/zsjf0226_2.png',\n",
       "  'docId': 528,\n",
       "  'ucsf_document_id': 'zsjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['THE UPJOHN COMPANY'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1148,\n",
       "  'question': 'what is the date and year mentioned ?',\n",
       "  'image': 'documents/zsjf0226_2.png',\n",
       "  'docId': 528,\n",
       "  'ucsf_document_id': 'zsjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['September 21, 1993', 'september 21 , 1993'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1150,\n",
       "  'question': 'Which company is mentioned in the letterhead?',\n",
       "  'image': 'documents/zsjf0226_2.png',\n",
       "  'docId': 528,\n",
       "  'ucsf_document_id': 'zsjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['THE UPJOHN COMPANY'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1151,\n",
       "  'question': 'in which country the upjohn company is located ?',\n",
       "  'image': 'documents/zsjf0226_2.png',\n",
       "  'docId': 528,\n",
       "  'ucsf_document_id': 'zsjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['U.S.A', 'USA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1152,\n",
       "  'question': 'what is the fax mentioned ?',\n",
       "  'image': 'documents/pljf0226_3.png',\n",
       "  'docId': 530,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['06 6204 2244'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1153,\n",
       "  'question': 'what is year date and time mentioned?',\n",
       "  'image': 'documents/pljf0226_3.png',\n",
       "  'docId': 530,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['2002 08/08 21:49'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1154,\n",
       "  'question': 'what is the name of the division ?',\n",
       "  'image': 'documents/pljf0226_3.png',\n",
       "  'docId': 530,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['TAKEDA DEVELOP DIVISION', 'Takeda Develop division'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1155,\n",
       "  'question': 'to whom they can ask directly to disclose the details of \"promotion study\"?',\n",
       "  'image': 'documents/pljf0226_3.png',\n",
       "  'docId': 530,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['FDA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1157,\n",
       "  'question': 'what is the date mentioned in the  letter',\n",
       "  'image': 'documents/syjf0226_1.png',\n",
       "  'docId': 531,\n",
       "  'ucsf_document_id': 'syjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['8 January 2003', '8 january 2003'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1158,\n",
       "  'question': 'To whom this letter is addressed?',\n",
       "  'image': 'documents/syjf0226_1.png',\n",
       "  'docId': 531,\n",
       "  'ucsf_document_id': 'syjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['MPDRAP I Leader'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1159,\n",
       "  'question': 'what is mentioned in the CC?',\n",
       "  'image': 'documents/syjf0226_1.png',\n",
       "  'docId': 531,\n",
       "  'ucsf_document_id': 'syjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['CEOs and General Managers of Pharmaceutical Units',\n",
       "   'CEOs and general managers of pharmaceutical units'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1160,\n",
       "  'question': 'combination therapy in the us market accounts for how much % of total actos sales .',\n",
       "  'image': 'documents/syjf0226_1.png',\n",
       "  'docId': 531,\n",
       "  'ucsf_document_id': 'syjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['64', '64%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1177,\n",
       "  'question': 'What is the due date to evaluate data from actos 507?',\n",
       "  'image': 'documents/qtjf0226_4.png',\n",
       "  'docId': 535,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['August 5'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1178,\n",
       "  'question': 'who is the lead responsibility for developing additional monitoring plan for actos 508',\n",
       "  'image': 'documents/qtjf0226_4.png',\n",
       "  'docId': 535,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Amy Hagaman', 'Amy hagaman'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1179,\n",
       "  'question': 'what is the due date for \"draft  justification for actos 508\" ?',\n",
       "  'image': 'documents/qtjf0226_4.png',\n",
       "  'docId': 535,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['August 12', 'august 12'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1180,\n",
       "  'question': 'when was this  last updated ?',\n",
       "  'image': 'documents/qtjf0226_4.png',\n",
       "  'docId': 535,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['August 1, 2002', 'august 1, 2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1181,\n",
       "  'question': 'Who is the lead responsible person for draft justification for actos 508?',\n",
       "  'image': 'documents/qtjf0226_4.png',\n",
       "  'docId': 535,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Amy Hagaman/Alfonso Perez'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1195,\n",
       "  'question': 'Which is the core organization of Takeda pharmaceutical Company?',\n",
       "  'image': 'documents/lmjf0226_2.png',\n",
       "  'docId': 543,\n",
       "  'ucsf_document_id': 'lmjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Pharmaceutical development Division',\n",
       "   'Pharmaceutical Development Division'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1196,\n",
       "  'question': 'Who made the opening remarks ?',\n",
       "  'image': 'documents/lmjf0226_2.png',\n",
       "  'docId': 543,\n",
       "  'ucsf_document_id': 'lmjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Dr. Kitazawa'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1197,\n",
       "  'question': 'When is the clinical expert meeting scheduled?',\n",
       "  'image': 'documents/lmjf0226_2.png',\n",
       "  'docId': 543,\n",
       "  'ucsf_document_id': 'lmjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['for October 1 and 2.', 'October 1 and 2'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1198,\n",
       "  'question': 'what is the date mentioned in the given information ?',\n",
       "  'image': 'documents/nqjf0226_1.png',\n",
       "  'docId': 539,\n",
       "  'ucsf_document_id': 'nqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['20 April 2006', '20 april 2006'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1199,\n",
       "  'question': 'What is the meeting time mentioned here?',\n",
       "  'image': 'documents/nqjf0226_1.png',\n",
       "  'docId': 539,\n",
       "  'ucsf_document_id': 'nqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['4:00pm - 5:00pm'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1200,\n",
       "  'question': 'what is the place mentioned ?',\n",
       "  'image': 'documents/nqjf0226_1.png',\n",
       "  'docId': 539,\n",
       "  'ucsf_document_id': 'nqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Meeting Room 403', 'meeting room 403'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1201,\n",
       "  'question': 'Why was it suggested to prepare non-clinical \"White paper\"?',\n",
       "  'image': 'documents/lmjf0226_2.png',\n",
       "  'docId': 543,\n",
       "  'ucsf_document_id': 'lmjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['to address the bladder issue', 'to address the bladder issue.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1202,\n",
       "  'question': 'who will forward the article regarding rosiglitazone and non clinical bladder data to andy ?',\n",
       "  'image': 'documents/nqjf0226_1.png',\n",
       "  'docId': 539,\n",
       "  'ucsf_document_id': 'nqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Mondira'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1203,\n",
       "  'question': 'What date is the meeting scheduled to develop the overall structure of the document?',\n",
       "  'image': 'documents/nqjf0226_1.png',\n",
       "  'docId': 539,\n",
       "  'ucsf_document_id': 'nqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['in early May'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1204,\n",
       "  'question': 'Who presented an outline of the Cohen hypothesis?',\n",
       "  'image': 'documents/myjf0226_4.png',\n",
       "  'docId': 540,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Philip Collett'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1205,\n",
       "  'question': 'What is significant in the development of calculi?',\n",
       "  'image': 'documents/myjf0226_4.png',\n",
       "  'docId': 540,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Raising the pH of male rat urine above 6.5'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1206,\n",
       "  'question': \"What is the correlation observed in cohen's paper?\",\n",
       "  'image': 'documents/myjf0226_4.png',\n",
       "  'docId': 540,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['0.61'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1207,\n",
       "  'question': \"Why didn't rats eliminate calculi as humans do?\",\n",
       "  'image': 'documents/myjf0226_4.png',\n",
       "  'docId': 540,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Because rats are quadropeds', 'Because rats are quadropeds.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1208,\n",
       "  'question': 'What is the fullform of MAA?',\n",
       "  'image': 'documents/gmjf0226_1.png',\n",
       "  'docId': 547,\n",
       "  'ucsf_document_id': 'gmjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Marketing Authorization Application'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1209,\n",
       "  'question': 'Which forum is mentioned in this document?',\n",
       "  'image': 'documents/gmjf0226_1.png',\n",
       "  'docId': 547,\n",
       "  'ucsf_document_id': 'gmjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Takeda Global Risk Management Forum',\n",
       "   'Takeda Global Risk Management Forum/March 22, 2004'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1211,\n",
       "  'question': 'What is the issued date of this document?',\n",
       "  'image': 'documents/jsjf0226_1.png',\n",
       "  'docId': 542,\n",
       "  'ucsf_document_id': 'jsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['august 13, 2002', 'August 13, 2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1212,\n",
       "  'question': 'Who is the Director of Nonclinical Safety and Efficacy?',\n",
       "  'image': 'documents/jsjf0226_1.png',\n",
       "  'docId': 542,\n",
       "  'ucsf_document_id': 'jsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['David baron', 'David Baron'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1213,\n",
       "  'question': 'Who described tumor promoter-model study?',\n",
       "  'image': 'documents/jsjf0226_1.png',\n",
       "  'docId': 542,\n",
       "  'ucsf_document_id': 'jsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['dr. el-hage', 'Dr.  El-Hage'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1214,\n",
       "  'question': 'What is the duration of daily dosing?',\n",
       "  'image': 'documents/jsjf0226_1.png',\n",
       "  'docId': 542,\n",
       "  'ucsf_document_id': 'jsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['32-weeks', '32-weeks after BBN.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1215,\n",
       "  'question': 'Who updated the CEO on August 6?',\n",
       "  'image': 'documents/myjf0226_2.png',\n",
       "  'docId': 541,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Mr. Saito'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1216,\n",
       "  'question': 'By when should TPNA send outline of response to TCI ?',\n",
       "  'image': 'documents/myjf0226_2.png',\n",
       "  'docId': 541,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['August 19', 'by August 19'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1217,\n",
       "  'question': 'When will Mr. Saito present outline to CEO?',\n",
       "  'image': 'documents/myjf0226_2.png',\n",
       "  'docId': 541,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['August 20', 'on August 20'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1218,\n",
       "  'question': 'By when will the document be finalized?',\n",
       "  'image': 'documents/myjf0226_2.png',\n",
       "  'docId': 541,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['August 26', 'by August 26'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1219,\n",
       "  'question': 'When will the FDA Conference Call be held?',\n",
       "  'image': 'documents/fsjf0226_1.png',\n",
       "  'docId': 545,\n",
       "  'ucsf_document_id': 'fsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['July 31, 2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1220,\n",
       "  'question': 'What is the heading of the document?',\n",
       "  'image': 'documents/qtjf0226_1.png',\n",
       "  'docId': 546,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['ACTOS FDA RESPONSE TASK FORCE-TPNA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1221,\n",
       "  'question': 'How many key issues does the FDA have with respect to the non-clinical data related to bladder tumors?',\n",
       "  'image': 'documents/qtjf0226_1.png',\n",
       "  'docId': 546,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['The FDA has 3 key issues with respect to the non-clinical data related to bladder tumors.',\n",
       "   '3'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1222,\n",
       "  'question': 'What plan is developed by TPNA?',\n",
       "  'image': 'documents/qtjf0226_1.png',\n",
       "  'docId': 546,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['TPNA will develop monitoring plan.', 'monitoring plan'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1223,\n",
       "  'question': \"What is TPNA's goal?\",\n",
       "  'image': 'documents/qtjf0226_1.png',\n",
       "  'docId': 546,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['is to supply justification to support maintaining current labeling.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1224,\n",
       "  'question': 'When was this document last updated?',\n",
       "  'image': 'documents/qtjf0226_8.png',\n",
       "  'docId': 548,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['August 1, 2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1225,\n",
       "  'question': 'What is the last point in the table?',\n",
       "  'image': 'documents/qtjf0226_8.png',\n",
       "  'docId': 548,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['Evaluate Impact on Tak-559', 'EVALUATE IMPACT ON TAK-559'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1227,\n",
       "  'question': \"What is the Draft's Due Date?\",\n",
       "  'image': 'documents/qtjf0226_8.png',\n",
       "  'docId': 548,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['August 5'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1228,\n",
       "  'question': 'Which benefit start after 1 year of service?',\n",
       "  'image': 'documents/ttjf0226_5.png',\n",
       "  'docId': 501,\n",
       "  'ucsf_document_id': 'ttjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Extended Disability', 'extended disability'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1229,\n",
       "  'question': \"What is Ms Wakamatsu's role in Dept. Strategic Development?\",\n",
       "  'image': 'documents/lmjf0226_2.png',\n",
       "  'docId': 543,\n",
       "  'ucsf_document_id': 'lmjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Assistant manager', 'Assistant Manager'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1230,\n",
       "  'question': \"Which drug's toxicity study results will be discussed ?\",\n",
       "  'image': 'documents/pljf0226_6.png',\n",
       "  'docId': 526,\n",
       "  'ucsf_document_id': 'pljf0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['pioglitazone'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1231,\n",
       "  'question': 'How many pages are there in total as part of this document?',\n",
       "  'image': 'documents/qtjf0226_4.png',\n",
       "  'docId': 535,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['7'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1233,\n",
       "  'question': 'Who challenged authorities regrading implementing monitoring plan?',\n",
       "  'image': 'documents/myjf0226_4.png',\n",
       "  'docId': 540,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Takeda Europe'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1234,\n",
       "  'question': 'What content is high in male rat urine?',\n",
       "  'image': 'documents/myjf0226_4.png',\n",
       "  'docId': 540,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['protein', 'protien content'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1235,\n",
       "  'question': 'What kind of meeting is mentioned in this letter?',\n",
       "  'image': 'documents/myjf0226_1.png',\n",
       "  'docId': 550,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['ACTOS FDA RESPONSE MEETING'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1239,\n",
       "  'question': 'what kind of drug is used to treat the group of rats?',\n",
       "  'image': 'documents/myjf0226_1.png',\n",
       "  'docId': 550,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Pioglitazone', 'pioglitazone'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1240,\n",
       "  'question': 'In the rat oncogenicity study, what was observed in male rats?',\n",
       "  'image': 'documents/myjf0226_3.png',\n",
       "  'docId': 552,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['thickening of the bladder and hypertrophy of the urothelium'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1241,\n",
       "  'question': 'What is the due date to conduct review meeting for FDA package?',\n",
       "  'image': 'documents/qtjf0226_7.png',\n",
       "  'docId': 551,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['August 22'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1242,\n",
       "  'question': 'What is the time span where no tumors are seen?',\n",
       "  'image': 'documents/myjf0226_3.png',\n",
       "  'docId': 552,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['shorter term (12 month)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1243,\n",
       "  'question': 'Who is the lead responsible person for the  compilation of FDA package?',\n",
       "  'image': 'documents/qtjf0226_7.png',\n",
       "  'docId': 551,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Larry Hancock'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1244,\n",
       "  'question': 'According to mouse oncogenicity study, what was seen male mice only?',\n",
       "  'image': 'documents/myjf0226_3.png',\n",
       "  'docId': 552,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['hyperplasia'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1245,\n",
       "  'question': 'what kind of cell tumours experienced the same frequency when group of rats treated with pioglitazone?',\n",
       "  'image': 'documents/myjf0226_1.png',\n",
       "  'docId': 550,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['transitional', 'transitional cell tumors'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1246,\n",
       "  'question': 'who conducted robust program?',\n",
       "  'image': 'documents/myjf0226_3.png',\n",
       "  'docId': 552,\n",
       "  'ucsf_document_id': 'myjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['TCI'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1247,\n",
       "  'question': 'What is the task assigned to David Baron?',\n",
       "  'image': 'documents/qtjf0226_7.png',\n",
       "  'docId': 551,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Send nonclinical rationale/justification section to medical writing for compilation',\n",
       "   'Send nonclinical rationale/justification section to medical writing for compilation.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1248,\n",
       "  'question': 'Who is responsible for sending  package to TCI/EU for review?',\n",
       "  'image': 'documents/qtjf0226_7.png',\n",
       "  'docId': 551,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Mary Ramstack'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1249,\n",
       "  'question': 'What is the due date for sending FDA Document to Regulatory Affairs?',\n",
       "  'image': 'documents/qtjf0226_7.png',\n",
       "  'docId': 551,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['August 26'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1251,\n",
       "  'question': 'What is the last updated date mentioned in this document?',\n",
       "  'image': 'documents/qtjf0226_7.png',\n",
       "  'docId': 551,\n",
       "  'ucsf_document_id': 'qtjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['August 1, 2002', 'August 1,  2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1253,\n",
       "  'question': \"Which product's liability claims are described here?\",\n",
       "  'image': 'documents/hrjf0226_1.png',\n",
       "  'docId': 554,\n",
       "  'ucsf_document_id': 'hrjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['ACTOS PRODUCTS', 'ACTOS PRODUCTS LIABILITY CLAIMS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1254,\n",
       "  'question': 'What is the date mentioned in this document at the bottom?',\n",
       "  'image': 'documents/hrjf0226_1.png',\n",
       "  'docId': 554,\n",
       "  'ucsf_document_id': 'hrjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['1/11/2007'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1255,\n",
       "  'question': 'Mention the first name listed in the \"apologies\"?',\n",
       "  'image': 'documents/ltjf0226_1.png',\n",
       "  'docId': 553,\n",
       "  'ucsf_document_id': 'ltjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Professor Ele Ferrannini'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1256,\n",
       "  'question': 'What is the exhibit number?',\n",
       "  'image': 'documents/hrjf0226_1.png',\n",
       "  'docId': 554,\n",
       "  'ucsf_document_id': 'hrjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['52'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1259,\n",
       "  'question': 'when was  the last meeting/conference call held on ?',\n",
       "  'image': 'documents/ltjf0226_1.png',\n",
       "  'docId': 553,\n",
       "  'ucsf_document_id': 'ltjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['15th October 2005', '15 October 2005'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1260,\n",
       "  'question': 'What is the exhibit number?',\n",
       "  'image': 'documents/jsjf0226_1.png',\n",
       "  'docId': 542,\n",
       "  'ucsf_document_id': 'jsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['107'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1262,\n",
       "  'question': 'what is the date mentioned under the title - \" minutes of conference call\"?',\n",
       "  'image': 'documents/ltjf0226_1.png',\n",
       "  'docId': 553,\n",
       "  'ucsf_document_id': 'ltjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Monday 28th November 2005',\n",
       "   'monday 28th november 2005',\n",
       "   '28th November 2005'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1264,\n",
       "  'question': 'What is the heading of this document?',\n",
       "  'image': 'documents/xqjf0226_2.png',\n",
       "  'docId': 558,\n",
       "  'ucsf_document_id': 'xqjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Rationale for 3 segments', 'Rationale for 3 Segments'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1265,\n",
       "  'question': 'what is the title of chapter 3?',\n",
       "  'image': 'documents/jpjf0226_3.png',\n",
       "  'docId': 556,\n",
       "  'ucsf_document_id': 'jpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Document Storage Period', 'document storage period'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1266,\n",
       "  'question': 'What is the graphical representation about?',\n",
       "  'image': 'documents/xqjf0226_2.png',\n",
       "  'docId': 558,\n",
       "  'ucsf_document_id': 'xqjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Summary of Segment Attractiveness'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1267,\n",
       "  'question': 'On what basis, the Summary of Segment Attractiveness is carried out?',\n",
       "  'image': 'documents/xqjf0226_2.png',\n",
       "  'docId': 558,\n",
       "  'ucsf_document_id': 'xqjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['based on current situation & future trends',\n",
       "   'Based on current situation & future trends.',\n",
       "   'current situation & future trends'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1268,\n",
       "  'question': 'What are the three segments indicated in the graph?',\n",
       "  'image': 'documents/xqjf0226_2.png',\n",
       "  'docId': 558,\n",
       "  'ucsf_document_id': 'xqjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Treatment Machines, Life Negotiators, Struggle for Control'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1269,\n",
       "  'question': 'what is the \"document storage period \" article number?',\n",
       "  'image': 'documents/jpjf0226_3.png',\n",
       "  'docId': 556,\n",
       "  'ucsf_document_id': 'jpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['7', 'Article 7'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1270,\n",
       "  'question': 'What is the conclusion obtained from the graph?',\n",
       "  'image': 'documents/xqjf0226_2.png',\n",
       "  'docId': 558,\n",
       "  'ucsf_document_id': 'xqjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['All 3 segments have consistent needs',\n",
       "   'All 3 Segments Have Consistent Needs.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1271,\n",
       "  'question': 'mention the second point listed under the article 7(document storage period)?',\n",
       "  'image': 'documents/jpjf0226_3.png',\n",
       "  'docId': 556,\n",
       "  'ucsf_document_id': 'jpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['To be stored for ten years', 'to be stored for ten years'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1272,\n",
       "  'question': 'what is article 4?',\n",
       "  'image': 'documents/jpjf0226_2.png',\n",
       "  'docId': 557,\n",
       "  'ucsf_document_id': 'jpjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['(PRINCIPLES OF CREATING DOCUMENTS)',\n",
       "   'principles of creating documents',\n",
       "   'PRINCIPLES OF CREATING DOCUMENTS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1273,\n",
       "  'question': 'Semi exclusive rights in how many countries?',\n",
       "  'image': 'documents/trjf0226_2.png',\n",
       "  'docId': 580,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['20', '20 countries'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1274,\n",
       "  'question': 'what is the title of chapter 2?',\n",
       "  'image': 'documents/jpjf0226_2.png',\n",
       "  'docId': 557,\n",
       "  'ucsf_document_id': 'jpjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['DOCUMENT STORAGE FUNCTIONS', 'document storage functions'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1276,\n",
       "  'question': 'What percent is the Supply Price / Royalty Rate?',\n",
       "  'image': 'documents/trjf0226_2.png',\n",
       "  'docId': 580,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['30% SUPPLY PRICE', '30% supply price'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1277,\n",
       "  'question': 'What does article 5 in this document describes?',\n",
       "  'image': 'documents/jpjf0226_2.png',\n",
       "  'docId': 557,\n",
       "  'ucsf_document_id': 'jpjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['(principles concerning document storage functions)',\n",
       "   'principles concerning document storage functions'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1278,\n",
       "  'question': 'what is article 6?',\n",
       "  'image': 'documents/jpjf0226_2.png',\n",
       "  'docId': 557,\n",
       "  'ucsf_document_id': 'jpjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['DUTIES OF RESPONSIBLE PERSON IN CHARGE OF STORAGE AND PERSON IN CHARGE OF STORAGE',\n",
       "   'duties of responsible person in charge of storage and person in charge of storage',\n",
       "   '(DUTIES OF RESPONSIBLE PERSON IN CHARGE OF STORAGE AND PERSON IN CHARGE OF STORAGE)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1279,\n",
       "  'question': 'In how many countires, license to Exclusive rights are provided?',\n",
       "  'image': 'documents/trjf0226_2.png',\n",
       "  'docId': 580,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['in approximately 60 countries', '60 COUNTRIES', '60'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1280,\n",
       "  'question': 'what is the name of pediatric program?',\n",
       "  'image': 'documents/jfkf0226_1.png',\n",
       "  'docId': 560,\n",
       "  'ucsf_document_id': 'jfkf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['ACTOS', 'ACTOS PEDIATRIC PROGRAM'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1282,\n",
       "  'question': 'What is the date mentioned in this page?',\n",
       "  'image': 'documents/jfkf0226_1.png',\n",
       "  'docId': 560,\n",
       "  'ucsf_document_id': 'jfkf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['5 October 2006'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1283,\n",
       "  'question': 'What is the title of this document?',\n",
       "  'image': 'documents/xqjf0226_8.png',\n",
       "  'docId': 573,\n",
       "  'ucsf_document_id': 'xqjf0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['CRITICAL SUCCESS FACTORS', 'Critical Success Factors'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1287,\n",
       "  'question': 'What is the title of this document?',\n",
       "  'image': 'documents/ynjf0226_6.png',\n",
       "  'docId': 570,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Consequences of IR'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1294,\n",
       "  'question': 'What is the title of this page?',\n",
       "  'image': 'documents/ynjf0226_17.png',\n",
       "  'docId': 565,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '17',\n",
       "  'answers': ['ACTOS PLAN OVERVIEW', 'Actos plan overview'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1295,\n",
       "  'question': 'which are prescibed eariler in the treatment of type 2 diabetes under the title of \"critical success factors\"?',\n",
       "  'image': 'documents/ynjf0226_17.png',\n",
       "  'docId': 565,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '17',\n",
       "  'answers': [\"TZD'S\", \"TZD's\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1296,\n",
       "  'question': 'What does the graph describes in this document?',\n",
       "  'image': 'documents/ynjf0226_3.png',\n",
       "  'docId': 586,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['TZD SHARE OF ORAL MARKET', 'TZD Share of Oral Market'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1301,\n",
       "  'question': 'What is the Plan TZD Share for the year 2003?',\n",
       "  'image': 'documents/ynjf0226_3.png',\n",
       "  'docId': 586,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['19.7%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1303,\n",
       "  'question': 'Which year has 13.3% Oral share (TZD)?',\n",
       "  'image': 'documents/ynjf0226_3.png',\n",
       "  'docId': 586,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['2000'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1304,\n",
       "  'question': 'which has a superior lipid profile(v. avandia and others) under the title of \"strength/opportunities?',\n",
       "  'image': 'documents/ynjf0226_17.png',\n",
       "  'docId': 565,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '17',\n",
       "  'answers': ['ACTOS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1309,\n",
       "  'question': \"Which study's synopsis is this?\",\n",
       "  'image': 'documents/jfkf0226_4.png',\n",
       "  'docId': 571,\n",
       "  'ucsf_document_id': 'jfkf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Clinical Study', 'clinical'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1310,\n",
       "  'question': 'what is the code mentioned under the title of clinical study synopsis?',\n",
       "  'image': 'documents/jfkf0226_4.png',\n",
       "  'docId': 571,\n",
       "  'ucsf_document_id': 'jfkf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['01-06-TL-OPI-527'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1311,\n",
       "  'question': 'When was expert advisory meeting ?',\n",
       "  'image': 'documents/jfkf0226_4.png',\n",
       "  'docId': 571,\n",
       "  'ucsf_document_id': 'jfkf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['4 OCTOBER 2006', '4 october 2006'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1312,\n",
       "  'question': 'What is the title of this document?',\n",
       "  'image': 'documents/jfkf0226_3.png',\n",
       "  'docId': 599,\n",
       "  'ucsf_document_id': 'jfkf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['OVERVIEW OF NOVEMBER 2006 SUBMISSION',\n",
       "   'Overview of November 2006 Submission'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1313,\n",
       "  'question': 'What is the full form of PPSR?',\n",
       "  'image': 'documents/jfkf0226_3.png',\n",
       "  'docId': 599,\n",
       "  'ucsf_document_id': 'jfkf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['PROPOSED PEDIATRIC STUDY REQUEST',\n",
       "   'Proposed Pediatric Study Request'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1316,\n",
       "  'question': 'What study is described in the table given?',\n",
       "  'image': 'documents/hfkf0226_7.png',\n",
       "  'docId': 605,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Glycemic Parameters in a 26-Week Placebo-Controlled Dose-Ranging Study.',\n",
       "   'PLACEBO- CONTROLLED DOSE RANGING STUDY'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1317,\n",
       "  'question': 'Which parameters are considered for the study(see heading of table 2)?',\n",
       "  'image': 'documents/hfkf0226_7.png',\n",
       "  'docId': 605,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Glycemic Parameters', 'GLYCEMIC'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1318,\n",
       "  'question': 'Prior to what, the patients entered an 8 week washout/run-in-period?',\n",
       "  'image': 'documents/hfkf0226_7.png',\n",
       "  'docId': 605,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['double-blind treatment'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1320,\n",
       "  'question': 'What is the floor supply price?',\n",
       "  'image': 'documents/trjf0226_5.png',\n",
       "  'docId': 579,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': [\"$0.17 / 30 mg or Takeda's cost from site of lowest cost\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1321,\n",
       "  'question': 'What is the royalty adjustment if generic enters the market ?',\n",
       "  'image': 'documents/trjf0226_5.png',\n",
       "  'docId': 579,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['50%', '50% royalty adjustment'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1322,\n",
       "  'question': 'what is the promotional trails data usage  for( Lilly in exclusive) ?',\n",
       "  'image': 'documents/trjf0226_5.png',\n",
       "  'docId': 579,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Split of 70/30 (Lilly in Exclusive)',\n",
       "   'split of 70/30 (Lilly in exclusive)',\n",
       "   'Split of 70/30'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1323,\n",
       "  'question': 'What is the title mentioned in this document?',\n",
       "  'image': 'documents/xqjf0226_9.png',\n",
       "  'docId': 582,\n",
       "  'ucsf_document_id': 'xqjf0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': [\"CSF'S AND MARKETING OBJECTIVES\",\n",
       "   \"CSF's and Marketing Objectives\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1324,\n",
       "  'question': 'What is the promotional trials data usage for (semi exclusive)?',\n",
       "  'image': 'documents/trjf0226_5.png',\n",
       "  'docId': 579,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['50/50 in Semi-exclusive'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1325,\n",
       "  'question': 'what is the name of the plan review ?',\n",
       "  'image': 'documents/ynjf0226_1.png',\n",
       "  'docId': 583,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['MARKETING PLAN REVIEW',\n",
       "   'Marketing plan review.',\n",
       "   'MARKETING PLAN'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1326,\n",
       "  'question': 'What is the heading of this document?',\n",
       "  'image': 'documents/yljf0226_1.png',\n",
       "  'docId': 620,\n",
       "  'ucsf_document_id': 'yljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['ACTOS FDA RESPONSE STRATEGY', 'ACTOS FDA Response Strategy'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1327,\n",
       "  'question': 'What is the last revision date mentioned in this document?',\n",
       "  'image': 'documents/yljf0226_1.png',\n",
       "  'docId': 620,\n",
       "  'ucsf_document_id': 'yljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['August 7, 2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1328,\n",
       "  'question': 'What is the goal of TPNA?',\n",
       "  'image': 'documents/yljf0226_1.png',\n",
       "  'docId': 620,\n",
       "  'ucsf_document_id': 'yljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['to supply justification to support maintaining current labeling.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1329,\n",
       "  'question': 'what is the first point given in table for bladder cancer alongside of  clinical findings ?',\n",
       "  'image': 'documents/trjf0226_4.png',\n",
       "  'docId': 575,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['OBSERVED DURING PRECLINICAL STUDIES IN RATS',\n",
       "   'observed during preclinical studies in rats'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1331,\n",
       "  'question': 'Mention the year given for Actos?',\n",
       "  'image': 'documents/ynjf0226_1.png',\n",
       "  'docId': 583,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['2004', 'Actos  2004'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1333,\n",
       "  'question': 'what is the percentage of  TZD share in the year 2000 ?',\n",
       "  'image': 'documents/ynjf0226_4.png',\n",
       "  'docId': 584,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['40.3%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1335,\n",
       "  'question': 'what is Actos TRx (000s) in the year 2003 ?',\n",
       "  'image': 'documents/ynjf0226_4.png',\n",
       "  'docId': 584,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['9,497'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1337,\n",
       "  'question': \"how much percent of  drug quantity present in rezulin under the title of 'clinical findings'?\",\n",
       "  'image': 'documents/trjf0226_4.png',\n",
       "  'docId': 575,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['1.7%', '1.7'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1339,\n",
       "  'question': 'what is the percentage of plan TZD share in the year 2004 ?',\n",
       "  'image': 'documents/ynjf0226_4.png',\n",
       "  'docId': 584,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['42.9%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1340,\n",
       "  'question': 'how much percent of placebo present in avandia alongside of the clinical findings?',\n",
       "  'image': 'documents/trjf0226_4.png',\n",
       "  'docId': 575,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['0.20%', '0.20'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1341,\n",
       "  'question': \"in which month and the year the launch of Merck's PPAR's took place?\",\n",
       "  'image': 'documents/ynjf0226_4.png',\n",
       "  'docId': 584,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['FEB 2005', 'feb 2005'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1342,\n",
       "  'question': \"what is the TZD's TRx (000s) in the year 2005 ?\",\n",
       "  'image': 'documents/ynjf0226_4.png',\n",
       "  'docId': 584,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['22,902'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1343,\n",
       "  'question': 'what is the total number of all claims under the title of \"summary of litigation risk in the ous territories\"?',\n",
       "  'image': 'documents/trjf0226_4.png',\n",
       "  'docId': 575,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['10'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1344,\n",
       "  'question': 'what is the first TZD used for type 2 patients ?',\n",
       "  'image': 'documents/ynjf0226_13.png',\n",
       "  'docId': 585,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['ACTOS', 'Actos'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1345,\n",
       "  'question': \"For which type of diabetes the TZD's prescribed earlier in treatment?\",\n",
       "  'image': 'documents/ynjf0226_13.png',\n",
       "  'docId': 585,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['Type 2 diabetes'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1346,\n",
       "  'question': 'what has to be establish as the the best OAD medication by treating insulin resistance ?',\n",
       "  'image': 'documents/ynjf0226_13.png',\n",
       "  'docId': 585,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['ACTOS', 'Actos'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1347,\n",
       "  'question': 'What is the Specific example given?',\n",
       "  'image': 'documents/gmjf0226_2.png',\n",
       "  'docId': 544,\n",
       "  'ucsf_document_id': 'gmjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['pioglitazone: need to commit to studies to investigate certain signals',\n",
       "   'Pioglitazone: Need to commit to studies to investigate certain signals'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1348,\n",
       "  'question': 'what is the month and year of overview of submission ?',\n",
       "  'image': 'documents/jfkf0226_2.png',\n",
       "  'docId': 588,\n",
       "  'ucsf_document_id': 'jfkf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['NOVEMBER 2006', 'November 2006'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1349,\n",
       "  'question': 'Which country would have similar interest as in Europe?',\n",
       "  'image': 'documents/gmjf0226_2.png',\n",
       "  'docId': 544,\n",
       "  'ucsf_document_id': 'gmjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['usa', 'USA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1350,\n",
       "  'question': 'what is included in the summary document ?',\n",
       "  'image': 'documents/jfkf0226_2.png',\n",
       "  'docId': 588,\n",
       "  'ucsf_document_id': 'jfkf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['includes benefit-risk assessment',\n",
       "   'benefit risk assessment',\n",
       "   '(includes benefit-risk assessment)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1351,\n",
       "  'question': 'What is the Suggestion from Glyn?',\n",
       "  'image': 'documents/gmjf0226_2.png',\n",
       "  'docId': 544,\n",
       "  'ucsf_document_id': 'gmjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': [\"tgrd would formulate direct risk management plan and obtain japan's input\",\n",
       "   \"TGRD would formulate direct Risk Management plan and obtain Japan's input\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1352,\n",
       "  'question': 'what is the executive summary of bladder cancer cases ?',\n",
       "  'image': 'documents/jfkf0226_2.png',\n",
       "  'docId': 588,\n",
       "  'ucsf_document_id': 'jfkf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['CONFIRM'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1353,\n",
       "  'question': 'Full form of PEM?',\n",
       "  'image': 'documents/gmjf0226_2.png',\n",
       "  'docId': 544,\n",
       "  'ucsf_document_id': 'gmjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['prescription event monitoring'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1354,\n",
       "  'question': 'what is the name of the request document ?',\n",
       "  'image': 'documents/jfkf0226_2.png',\n",
       "  'docId': 588,\n",
       "  'ucsf_document_id': 'jfkf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['PARTIAL CLINICAL HOLD REMOVAL REQUEST DOCUMENT',\n",
       "   'Partial clinical hold removal request document',\n",
       "   'PARTIAL CLINICAL HOLD REMOVAL'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1356,\n",
       "  'question': 'who appointed as the responsible person on this issue ?',\n",
       "  'image': 'documents/ymjf0226_1.png',\n",
       "  'docId': 594,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['MR. SAITO', 'Mr. Saito'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1357,\n",
       "  'question': 'On the purpose of teleconference, how many topics were to be discussed?',\n",
       "  'image': 'documents/fsjf0226_1.png',\n",
       "  'docId': 545,\n",
       "  'ucsf_document_id': 'fsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['3', '3 topics'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1358,\n",
       "  'question': 'basically by whom the current action plan was approved ?',\n",
       "  'image': 'documents/ymjf0226_1.png',\n",
       "  'docId': 594,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['CEO'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1359,\n",
       "  'question': 'What is the date mentioned at the bottom?',\n",
       "  'image': 'documents/fsjf0226_1.png',\n",
       "  'docId': 545,\n",
       "  'ucsf_document_id': 'fsjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['09/18/12'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1360,\n",
       "  'question': 'in which month and date it was reported to CEO ?',\n",
       "  'image': 'documents/ymjf0226_1.png',\n",
       "  'docId': 594,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['AUGUST 6', 'August 6'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1361,\n",
       "  'question': 'What is the heading of this document, given at the top?',\n",
       "  'image': 'documents/ynjf0226_5.png',\n",
       "  'docId': 596,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Avandamet Uptake'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1362,\n",
       "  'question': 'What are shown on the x-axis?',\n",
       "  'image': 'documents/ynjf0226_5.png',\n",
       "  'docId': 596,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['FULL MONTHS POST LAUNCH', 'Full Months Post Launch'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1363,\n",
       "  'question': 'what has to be reported to CEO on August 20 (japan time) ?',\n",
       "  'image': 'documents/ymjf0226_1.png',\n",
       "  'docId': 594,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['AN OUTLINE OF THE FDA RESPONSE',\n",
       "   'an outline of the FDA response'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1364,\n",
       "  'question': 'What is the percentage of Avandamet scripts from Actos mentioned?',\n",
       "  'image': 'documents/ynjf0226_5.png',\n",
       "  'docId': 596,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['36%', '36'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1365,\n",
       "  'question': 'what is the name of the policy on Actos issue ?',\n",
       "  'image': 'documents/ymjf0226_1.png',\n",
       "  'docId': 594,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['TAKEDA BASIC POLICY', 'Takeda basic policy'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1366,\n",
       "  'question': 'What is on the horizonal axis of the graph?',\n",
       "  'image': 'documents/ynjf0226_5.png',\n",
       "  'docId': 596,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Full Months Post Launch'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1367,\n",
       "  'question': 'Heading of the document?',\n",
       "  'image': 'documents/ynjf0226_7.png',\n",
       "  'docId': 597,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['LINK BETWEEN IR AND CVD', 'Link between IR and CVD'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1369,\n",
       "  'question': 'who is the chief leader ?',\n",
       "  'image': 'documents/ymjf0226_2.png',\n",
       "  'docId': 598,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['MR. K SAITO', 'Mr.K Saito'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1370,\n",
       "  'question': 'What is the percentage of Nondiabetic patients with prior MI?',\n",
       "  'image': 'documents/ynjf0226_7.png',\n",
       "  'docId': 597,\n",
       "  'ucsf_document_id': 'ynjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['18.8%', '18.8'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1371,\n",
       "  'question': 'who is the responsible person for TPNA ?',\n",
       "  'image': 'documents/ymjf0226_2.png',\n",
       "  'docId': 598,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Dr. C Thom'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1373,\n",
       "  'question': 'what is the name of the organization ?',\n",
       "  'image': 'documents/ymjf0226_2.png',\n",
       "  'docId': 598,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['ACTOS ISSUE ORGANIZATION', 'Actos issue organization'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1374,\n",
       "  'question': 'who is the responsible person of TCI ?',\n",
       "  'image': 'documents/ymjf0226_2.png',\n",
       "  'docId': 598,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['MR. K SAITO'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1375,\n",
       "  'question': 'What is the Handwritten sentence on the top?',\n",
       "  'image': 'documents/trjf0226_1.png',\n",
       "  'docId': 600,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Row-Contract (as of 7/19/99)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1376,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/trjf0226_1.png',\n",
       "  'docId': 600,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['JULY 19, 1999', 'July 19, 1999'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1377,\n",
       "  'question': 'who is the first contact person of EuR&D ?',\n",
       "  'image': 'documents/ymjf0226_2.png',\n",
       "  'docId': 598,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['DR. P COLLETT', 'Dr. P Collett'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1378,\n",
       "  'question': 'With whom is the discussion being held?',\n",
       "  'image': 'documents/trjf0226_1.png',\n",
       "  'docId': 600,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['JIM HARPER', 'Jim Harper'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1380,\n",
       "  'question': 'who is the responsible person for EuR&D ?',\n",
       "  'image': 'documents/ymjf0226_2.png',\n",
       "  'docId': 598,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['DR. D ECKLAND', 'Dr. D Eckland'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1381,\n",
       "  'question': 'What is the date of randomisation?',\n",
       "  'image': 'documents/rljf0226_3.png',\n",
       "  'docId': 602,\n",
       "  'ucsf_document_id': 'rljf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['05-11-01', '05/11/01'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1382,\n",
       "  'question': 'who is the first contact person of TPNA ?',\n",
       "  'image': 'documents/ymjf0226_2.png',\n",
       "  'docId': 598,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['MS. M RAMSTACK, MS. J HASKINS',\n",
       "   'Ms. M Ramstack ,Ms. J Haskins'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1383,\n",
       "  'question': 'What is the patient number?',\n",
       "  'image': 'documents/rljf0226_3.png',\n",
       "  'docId': 602,\n",
       "  'ucsf_document_id': 'rljf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['014'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1384,\n",
       "  'question': 'What is the Centre number?',\n",
       "  'image': 'documents/rljf0226_3.png',\n",
       "  'docId': 602,\n",
       "  'ucsf_document_id': 'rljf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['49013'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1385,\n",
       "  'question': 'who is the first contact person of TCI ?',\n",
       "  'image': 'documents/ymjf0226_2.png',\n",
       "  'docId': 598,\n",
       "  'ucsf_document_id': 'ymjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['MR. M MIYAZAKI', 'Mr. M Miyazaki'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1386,\n",
       "  'question': 'What is the Reference mentioned here?',\n",
       "  'image': 'documents/rljf0226_3.png',\n",
       "  'docId': 602,\n",
       "  'ucsf_document_id': 'rljf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['135037-HRT-11', '135037-hrt-11'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1387,\n",
       "  'question': 'What is the heading of the table?',\n",
       "  'image': 'documents/hfkf0226_13.png',\n",
       "  'docId': 604,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['Weight Changes (kg) from Baseline during Double-Blind Clinical Trials with ACTOS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1388,\n",
       "  'question': 'what is the total number of drug claims under the title of \"summary  of litigation risk in the ous territories\"?',\n",
       "  'image': 'documents/trjf0226_4.png',\n",
       "  'docId': 575,\n",
       "  'ucsf_document_id': 'trjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['5'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1389,\n",
       "  'question': 'what are secondary endpoints ?',\n",
       "  'image': 'documents/fzjf0226_7.png',\n",
       "  'docId': 606,\n",
       "  'ucsf_document_id': 'fzjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['CARDIOVASCULAR MORTALITY', 'cardiovascular mortality'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1390,\n",
       "  'question': 'what is the title of this page?',\n",
       "  'image': 'documents/rnjf0226_4.png',\n",
       "  'docId': 608,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['OBJECTIVES AND METHODOLOGY', 'objectives and methodology'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1391,\n",
       "  'question': 'What is  the number of patients ?',\n",
       "  'image': 'documents/fzjf0226_7.png',\n",
       "  'docId': 606,\n",
       "  'ucsf_document_id': 'fzjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['5,000'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1392,\n",
       "  'question': 'What is  \"FPV\" ?',\n",
       "  'image': 'documents/fzjf0226_7.png',\n",
       "  'docId': 606,\n",
       "  'ucsf_document_id': 'fzjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['JUNE 2001', 'June 2001'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1393,\n",
       "  'question': 'What is the ACTOS 15 mg of Monotherapy?',\n",
       "  'image': 'documents/hfkf0226_13.png',\n",
       "  'docId': 604,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['0.9(-0.5/3.4) N=79', '0.9(-0.5/3.4) n=79'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1395,\n",
       "  'question': 'What is the trial duration mentioned?',\n",
       "  'image': 'documents/hfkf0226_13.png',\n",
       "  'docId': 604,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['16 TO 26 WEEKS', '16 to 26 weeks'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1396,\n",
       "  'question': 'what is the name of the form ?',\n",
       "  'image': 'documents/rljf0226_2.png',\n",
       "  'docId': 610,\n",
       "  'ucsf_document_id': 'rljf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['URGENT DATA ENQUIRY FORM',\n",
       "   'urgent data enquiry form',\n",
       "   'URGENT DATA ENQUIRY'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1397,\n",
       "  'question': 'what is the centre number ?',\n",
       "  'image': 'documents/rljf0226_2.png',\n",
       "  'docId': 610,\n",
       "  'ucsf_document_id': 'rljf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['49013'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1398,\n",
       "  'question': 'What is the ACTOS 45 mg of Combination Therapy of Insulin?',\n",
       "  'image': 'documents/hfkf0226_13.png',\n",
       "  'docId': 604,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['4.1 (1.4/6.8)  N=338', '4.1 (1.4/6.8) N=338'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1399,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/mnjf0226_2.png',\n",
       "  'docId': 611,\n",
       "  'ucsf_document_id': 'mnjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['August 12-13, 2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1401,\n",
       "  'question': 'what is the date issued mentioned in the form ?',\n",
       "  'image': 'documents/rljf0226_2.png',\n",
       "  'docId': 610,\n",
       "  'ucsf_document_id': 'rljf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['22-04-04'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1402,\n",
       "  'question': 'what is the patient number ?',\n",
       "  'image': 'documents/rljf0226_2.png',\n",
       "  'docId': 610,\n",
       "  'ucsf_document_id': 'rljf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['014'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1404,\n",
       "  'question': 'What is the Item that shows Person Responsible Bob Ahlbrandt will send to John?',\n",
       "  'image': 'documents/mnjf0226_2.png',\n",
       "  'docId': 611,\n",
       "  'ucsf_document_id': 'mnjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Add renal colic to clinical AE search'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1405,\n",
       "  'question': 'What is the heading of the document?',\n",
       "  'image': 'documents/mnjf0226_2.png',\n",
       "  'docId': 611,\n",
       "  'ucsf_document_id': 'mnjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['TPNA/TEUR&D/TCI ACTOS RESPONSE MEETING'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1406,\n",
       "  'question': 'What is written just below the date?',\n",
       "  'image': 'documents/mnjf0226_2.png',\n",
       "  'docId': 611,\n",
       "  'ucsf_document_id': 'mnjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Action Item List/Document Timelines'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1407,\n",
       "  'question': 'What is the EXHIBIT number mentioned?',\n",
       "  'image': 'documents/gpjf0226_1.png',\n",
       "  'docId': 613,\n",
       "  'ucsf_document_id': 'gpjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['R-12'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1408,\n",
       "  'question': 'What is the BOP Number?',\n",
       "  'image': 'documents/gpjf0226_1.png',\n",
       "  'docId': 613,\n",
       "  'ucsf_document_id': 'gpjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['CORP-B-019'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1409,\n",
       "  'question': 'What is the Effective Date?',\n",
       "  'image': 'documents/gpjf0226_1.png',\n",
       "  'docId': 613,\n",
       "  'ucsf_document_id': 'gpjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['05/01/2006'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1411,\n",
       "  'question': 'What is the heading of the document?',\n",
       "  'image': 'documents/mnjf0226_1.png',\n",
       "  'docId': 614,\n",
       "  'ucsf_document_id': 'mnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['TPNA/TEUR&D/TCI ACTOS RESPONSE MEETING'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1412,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/mnjf0226_1.png',\n",
       "  'docId': 614,\n",
       "  'ucsf_document_id': 'mnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['August 12-13, 2002'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1415,\n",
       "  'question': 'What is the heading of the handwritten words in Pediatric Indication?',\n",
       "  'image': 'documents/mnjf0226_1.png',\n",
       "  'docId': 614,\n",
       "  'ucsf_document_id': 'mnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Appendix', 'appendix'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1419,\n",
       "  'question': 'what is the patient number?',\n",
       "  'image': 'documents/rljf0226_1.png',\n",
       "  'docId': 615,\n",
       "  'ucsf_document_id': 'rljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['014'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1420,\n",
       "  'question': 'Which Procedures No is being decribed here?',\n",
       "  'image': 'documents/xpjf0226_1.png',\n",
       "  'docId': 617,\n",
       "  'ucsf_document_id': 'xpjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Procedures No. 19'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1421,\n",
       "  'question': 'how many targeted primary care physicians are included in these meetings ?',\n",
       "  'image': 'documents/rnjf0226_3.png',\n",
       "  'docId': 612,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['350'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1422,\n",
       "  'question': 'What is Article 4 in this document referred to?',\n",
       "  'image': 'documents/xpjf0226_1.png',\n",
       "  'docId': 617,\n",
       "  'ucsf_document_id': 'xpjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Disposal Record Ledger'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1425,\n",
       "  'question': 'in which month and year eight regional market research consultants meetings were held ?',\n",
       "  'image': 'documents/rnjf0226_3.png',\n",
       "  'docId': 612,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['October and November 2001', 'october and november 2001'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1427,\n",
       "  'question': 'In which Article, Persons In Charge of Retention is described?',\n",
       "  'image': 'documents/xpjf0226_1.png',\n",
       "  'docId': 617,\n",
       "  'ucsf_document_id': 'xpjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Article 2'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1428,\n",
       "  'question': 'what is diagnosis?',\n",
       "  'image': 'documents/rljf0226_1.png',\n",
       "  'docId': 615,\n",
       "  'ucsf_document_id': 'rljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['benign tumor of the urinary bladder'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1429,\n",
       "  'question': 'what are the challenges of ACTOS positive data?',\n",
       "  'image': 'documents/rnjf0226_11.png',\n",
       "  'docId': 618,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['small numbers in the studies, non-randomized, company-sponsored.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1430,\n",
       "  'question': 'In U.S. clinical trials, how many patients have received ACTOS?',\n",
       "  'image': 'documents/hfkf0226_17.png',\n",
       "  'docId': 631,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '17',\n",
       "  'answers': ['over 4700 patients', 'OVER 4700'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1431,\n",
       "  'question': 'What does alternate terms include?',\n",
       "  'image': 'documents/rnjf0226_11.png',\n",
       "  'docId': 618,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['core therapy; cornerstone therapy; first-line.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1433,\n",
       "  'question': 'which is an effective and liver-safe agent accepted by the participants ?',\n",
       "  'image': 'documents/rnjf0226_3.png',\n",
       "  'docId': 612,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['ACTOS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1434,\n",
       "  'question': 'what is an effective and trusted agent ?',\n",
       "  'image': 'documents/rnjf0226_3.png',\n",
       "  'docId': 612,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Metformin', 'metformin'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1435,\n",
       "  'question': 'Which medicine is used for treating type 2 diabetes in over 5900 patients?',\n",
       "  'image': 'documents/hfkf0226_17.png',\n",
       "  'docId': 631,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '17',\n",
       "  'answers': ['ACTOS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1436,\n",
       "  'question': \"what are the most commonly mentioned reasons not to prescribe TZD's ?\",\n",
       "  'image': 'documents/rnjf0226_3.png',\n",
       "  'docId': 612,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['1) Cost, 2) Edema/weight gain, and 3) Reimbursement.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1439,\n",
       "  'question': 'in one ACTOS treatment group how much amount of initial dose is given to the patients daily ?',\n",
       "  'image': 'documents/hfkf0226_8.png',\n",
       "  'docId': 621,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['7.5 mg', '7.5 mg once daily'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1440,\n",
       "  'question': 'in a 24 week placebo controlled study how many patients with type 2 diabetes were randomized ?',\n",
       "  'image': 'documents/hfkf0226_8.png',\n",
       "  'docId': 621,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['260 patients', '260'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1441,\n",
       "  'question': 'What is the retention time period of monthly reports?',\n",
       "  'image': 'documents/xpjf0226_3.png',\n",
       "  'docId': 625,\n",
       "  'ucsf_document_id': 'xpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['30 years'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1442,\n",
       "  'question': 'in the second ACTOS treatment group,how much amount of initial dose patients should receive daily ?',\n",
       "  'image': 'documents/hfkf0226_8.png',\n",
       "  'docId': 621,\n",
       "  'ucsf_document_id': 'hfkf0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['15 mg', '15 mg once daily'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1443,\n",
       "  'question': 'What does Attachment 1 describes?',\n",
       "  'image': 'documents/xpjf0226_3.png',\n",
       "  'docId': 625,\n",
       "  'ucsf_document_id': 'xpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['List of Retention Periods of Time, Retention Locations'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1444,\n",
       "  'question': 'What is the retention time period of contracts?',\n",
       "  'image': 'documents/xpjf0226_3.png',\n",
       "  'docId': 625,\n",
       "  'ucsf_document_id': 'xpjf0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Permanently'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1446,\n",
       "  'question': 'where participants seemed more cautious more resistant to the entire message?',\n",
       "  'image': 'documents/rnjf0226_7.png',\n",
       "  'docId': 623,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['In Boston', 'in Boston'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1447,\n",
       "  'question': 'What is the fullform of ARA?',\n",
       "  'image': 'documents/kqbn0226_16.png',\n",
       "  'docId': 644,\n",
       "  'ucsf_document_id': 'kqbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Alliance for Risk Assessment'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1448,\n",
       "  'question': 'What is the date mentioned in this document?',\n",
       "  'image': 'documents/ffcn0226_5.png',\n",
       "  'docId': 667,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['March 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1449,\n",
       "  'question': 'where were responses more strongly positive than in other cities?',\n",
       "  'image': 'documents/rnjf0226_7.png',\n",
       "  'docId': 623,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['In Philadelphia', 'in philadelphia (home of glaxosmithkline)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1450,\n",
       "  'question': 'Who is the President of The Fertilizer Institute?',\n",
       "  'image': 'documents/ffcn0226_5.png',\n",
       "  'docId': 667,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Chris Jahn'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1451,\n",
       "  'question': 'What is the exhibit number?',\n",
       "  'image': 'documents/rljf0226_1.png',\n",
       "  'docId': 615,\n",
       "  'ucsf_document_id': 'rljf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['39'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1452,\n",
       "  'question': 'Roger Johnson is associated with which union?',\n",
       "  'image': 'documents/ffcn0226_5.png',\n",
       "  'docId': 667,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['National Farmers Union'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1453,\n",
       "  'question': 'What is the title of this document?',\n",
       "  'image': 'documents/ffcn0226_5.png',\n",
       "  'docId': 667,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['CEO Council Members'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1456,\n",
       "  'question': 'What is accepted as an effective glucose control agent?',\n",
       "  'image': 'documents/rnjf0226_9.png',\n",
       "  'docId': 630,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['ACTOS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1457,\n",
       "  'question': 'what are reasons not to prescribe TZDs ?',\n",
       "  'image': 'documents/rnjf0226_9.png',\n",
       "  'docId': 630,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['1)cost,2)edema/weight gain, and 3) reimbursement',\n",
       "   '1) Cost, 2) Edema/Weight gain, and 3) Reimbursement.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1458,\n",
       "  'question': 'what is the subheading under the title of \"specific findings\"?',\n",
       "  'image': 'documents/rnjf0226_9.png',\n",
       "  'docId': 630,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['A. Reaction to IR Information',\n",
       "   'reaction to IR information',\n",
       "   'Reaction to IR Information'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1459,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/rnjf0226_1.png',\n",
       "  'docId': 635,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['December, 2001'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1463,\n",
       "  'question': 'By whom was this document prepared?',\n",
       "  'image': 'documents/rnjf0226_1.png',\n",
       "  'docId': 635,\n",
       "  'ucsf_document_id': 'rnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['C. Beck, LLC', 'C. Beck'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1465,\n",
       "  'question': 'What is the name of the Article 6?',\n",
       "  'image': 'documents/xpjf0226_2.png',\n",
       "  'docId': 637,\n",
       "  'ucsf_document_id': 'xpjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Self Inspection'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1467,\n",
       "  'question': 'When was this document Enacted?',\n",
       "  'image': 'documents/xpjf0226_2.png',\n",
       "  'docId': 637,\n",
       "  'ucsf_document_id': 'xpjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['2006 May 31'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1468,\n",
       "  'question': 'When was the second revision?',\n",
       "  'image': 'documents/xpjf0226_2.png',\n",
       "  'docId': 637,\n",
       "  'ucsf_document_id': 'xpjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['2011 April 26'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1469,\n",
       "  'question': 'When was this document Revised first?',\n",
       "  'image': 'documents/xpjf0226_2.png',\n",
       "  'docId': 637,\n",
       "  'ucsf_document_id': 'xpjf0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['2006 October 20'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1473,\n",
       "  'question': 'When was the rule PROPOSED?',\n",
       "  'image': 'documents/mmcn0226_1.png',\n",
       "  'docId': 639,\n",
       "  'ucsf_document_id': 'mmcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Jan. 19, 2017', 'JAN. 19, 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1475,\n",
       "  'question': 'What is the name of the FOUNDATION this PROPOSAL belongs to?',\n",
       "  'image': 'documents/nfcn0226_6.png',\n",
       "  'docId': 645,\n",
       "  'ucsf_document_id': 'nfcn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Toxicology Education Foundation',\n",
       "   'TOXICOLOGY EDUCATION FOUNDATION'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1476,\n",
       "  'question': 'Who is the vice president of this FOUNDATION?',\n",
       "  'image': 'documents/nfcn0226_6.png',\n",
       "  'docId': 645,\n",
       "  'ucsf_document_id': 'nfcn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['William Farland, PhD, ATS', 'William Farland'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1477,\n",
       "  'question': 'What is the date mentioned at the bottom?',\n",
       "  'image': 'documents/nfcn0226_6.png',\n",
       "  'docId': 645,\n",
       "  'ucsf_document_id': 'nfcn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['July 20th 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1479,\n",
       "  'question': 'Whose biography is this?',\n",
       "  'image': 'documents/ffcn0226_14.png',\n",
       "  'docId': 643,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '14',\n",
       "  'answers': ['Christopher Jahn', 'CHRISTOPHER JAHN'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1480,\n",
       "  'question': 'What is the full form of TFI?',\n",
       "  'image': 'documents/ffcn0226_14.png',\n",
       "  'docId': 643,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '14',\n",
       "  'answers': ['The Fertilizer Institute'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1481,\n",
       "  'question': 'For how many years did Christopher Jahn work for U.S. Senator Craig Thomas?',\n",
       "  'image': 'documents/ffcn0226_14.png',\n",
       "  'docId': 643,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '14',\n",
       "  'answers': ['10', 'nearly 10 years', '10 years'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1483,\n",
       "  'question': 'What is the full form CSA?',\n",
       "  'image': 'documents/ffcn0226_14.png',\n",
       "  'docId': 643,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '14',\n",
       "  'answers': ['Contract Services Association'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1488,\n",
       "  'question': 'Which number is lightly printed lower-right side of the document?',\n",
       "  'image': 'documents/kqbn0226_24.png',\n",
       "  'docId': 641,\n",
       "  'ucsf_document_id': 'kqbn0226',\n",
       "  'ucsf_document_page_no': '24',\n",
       "  'answers': ['22'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1489,\n",
       "  'question': 'what is in the appendix A?',\n",
       "  'image': 'documents/fsbn0226_23.png',\n",
       "  'docId': 640,\n",
       "  'ucsf_document_id': 'fsbn0226',\n",
       "  'ucsf_document_page_no': '23',\n",
       "  'answers': ['mode of action analysis for liver tumors based on NCI slide reread and Rfd derivation (Dourson et al. 2014)',\n",
       "   'Mode of Action Analysis for Liver Tumors Based on NCI Slide Reread and RfD Derivation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1491,\n",
       "  'question': 'What is the name of the President of BOARD OF TRUSTEES?',\n",
       "  'image': 'documents/jgcn0226_9.png',\n",
       "  'docId': 646,\n",
       "  'ucsf_document_id': 'jgcn0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['Michael Leonard Dourson',\n",
       "   'Michael Leonard Dourson, PhD, DABT, ATS'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1494,\n",
       "  'question': 'To which university did William H. Farland belong to?',\n",
       "  'image': 'documents/jgcn0226_9.png',\n",
       "  'docId': 646,\n",
       "  'ucsf_document_id': 'jgcn0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['Colorado State University'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1495,\n",
       "  'question': 'What is the timing mentioned?',\n",
       "  'image': 'documents/mxcn0226_15.png',\n",
       "  'docId': 642,\n",
       "  'ucsf_document_id': 'mxcn0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['a one week turnaround, depending upon availability',\n",
       "   'Toxys offers a one week turnaround, depending upon availability'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1497,\n",
       "  'question': 'What is the Total Project Cost?',\n",
       "  'image': 'documents/mxcn0226_15.png',\n",
       "  'docId': 642,\n",
       "  'ucsf_document_id': 'mxcn0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['56,400'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1499,\n",
       "  'question': 'What is the heading of the budget table?',\n",
       "  'image': 'documents/mxcn0226_15.png',\n",
       "  'docId': 642,\n",
       "  'ucsf_document_id': 'mxcn0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['For 5 Test Articles - Phase IB (definitive)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1502,\n",
       "  'question': 'What is the heading of the document?',\n",
       "  'image': 'documents/kqbn0226_34.png',\n",
       "  'docId': 647,\n",
       "  'ucsf_document_id': 'kqbn0226',\n",
       "  'ucsf_document_page_no': '34',\n",
       "  'answers': ['Thank You'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1504,\n",
       "  'question': 'Who are the Publication co-authors?',\n",
       "  'image': 'documents/kqbn0226_34.png',\n",
       "  'docId': 647,\n",
       "  'ucsf_document_id': 'kqbn0226',\n",
       "  'ucsf_document_page_no': '34',\n",
       "  'answers': ['Michael Dourson, Bernard Gadagbui, John Lowe and Rod Thompson'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1506,\n",
       "  'question': 'what is the full form of ppe?',\n",
       "  'image': 'documents/hlcn0226_6.png',\n",
       "  'docId': 650,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Personal Protective Equipment',\n",
       "   'personal protective equipment'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1508,\n",
       "  'question': 'what is the subtitle for research foundation?',\n",
       "  'image': 'documents/hlcn0226_6.png',\n",
       "  'docId': 650,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Research for the NFPA Mission',\n",
       "   'research for the NFPA mission'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1509,\n",
       "  'question': 'what is the phone number for david bernzweig under the list of \"project technical panel\"?',\n",
       "  'image': 'documents/hlcn0226_6.png',\n",
       "  'docId': 650,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['614-774-7446'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1510,\n",
       "  'question': \"what is the email id for bryan ormand under the list of 'project technical panel'?\",\n",
       "  'image': 'documents/hlcn0226_6.png',\n",
       "  'docId': 650,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['rbormond@ncsu.edu'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1511,\n",
       "  'question': 'What is the fullform of TCE?',\n",
       "  'image': 'documents/kqbn0226_15.png',\n",
       "  'docId': 652,\n",
       "  'ucsf_document_id': 'kqbn0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['Trichloroethylene'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1512,\n",
       "  'question': 'How many scientists from multiple international organizations are invited?',\n",
       "  'image': 'documents/kqbn0226_15.png',\n",
       "  'docId': 652,\n",
       "  'ucsf_document_id': 'kqbn0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['over 300 scientists'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1513,\n",
       "  'question': 'When was ARA TCE Workgroup formed?',\n",
       "  'image': 'documents/kqbn0226_15.png',\n",
       "  'docId': 652,\n",
       "  'ucsf_document_id': 'kqbn0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['in the fall of 2012',\n",
       "   'ARA TCE Workgroup formed in the Fall of 2012'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1514,\n",
       "  'question': 'What is the abbreviation of Alliance for Risk Assessment?',\n",
       "  'image': 'documents/kqbn0226_15.png',\n",
       "  'docId': 652,\n",
       "  'ucsf_document_id': 'kqbn0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['ARA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1515,\n",
       "  'question': 'What does Figure 2 represents?',\n",
       "  'image': 'documents/mxcn0226_13.png',\n",
       "  'docId': 655,\n",
       "  'ucsf_document_id': 'mxcn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['Ah Receptor Activation - HIPS with and without FR'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1516,\n",
       "  'question': 'What is the page no mentioned in this document?',\n",
       "  'image': 'documents/mxcn0226_13.png',\n",
       "  'docId': 655,\n",
       "  'ucsf_document_id': 'mxcn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['10'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1518,\n",
       "  'question': 'What is the handwritten  date  above the signature?',\n",
       "  'image': 'documents/jhcn0226_46.png',\n",
       "  'docId': 661,\n",
       "  'ucsf_document_id': 'jhcn0226',\n",
       "  'ucsf_document_page_no': '46',\n",
       "  'answers': ['3/29/2017', '3 / 29 / 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1519,\n",
       "  'question': 'Who has signed the document?',\n",
       "  'image': 'documents/jhcn0226_46.png',\n",
       "  'docId': 661,\n",
       "  'ucsf_document_id': 'jhcn0226',\n",
       "  'ucsf_document_page_no': '46',\n",
       "  'answers': ['E. Scott Pruitt'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1520,\n",
       "  'question': 'What is the designation of E. Scott Pruitt?',\n",
       "  'image': 'documents/jhcn0226_46.png',\n",
       "  'docId': 661,\n",
       "  'ucsf_document_id': 'jhcn0226',\n",
       "  'ucsf_document_page_no': '46',\n",
       "  'answers': ['Administrator'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1521,\n",
       "  'question': 'What does Figure 1 represents?',\n",
       "  'image': 'documents/hlcn0226_9.png',\n",
       "  'docId': 658,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['Project Conceptual Approach'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1522,\n",
       "  'question': 'What is the fullform of PPE?',\n",
       "  'image': 'documents/hlcn0226_9.png',\n",
       "  'docId': 658,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['Personal Protective Equipment'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1523,\n",
       "  'question': 'On which date is the senior steering committee meeting conducted?',\n",
       "  'image': 'documents/prbn0226_5.png',\n",
       "  'docId': 654,\n",
       "  'ucsf_document_id': 'prbn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Thursday August 17, 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1524,\n",
       "  'question': 'At what time is the senior steering committee meeting scheduled ?',\n",
       "  'image': 'documents/prbn0226_5.png',\n",
       "  'docId': 654,\n",
       "  'ucsf_document_id': 'prbn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['1:00pm - 3:00pm EST'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1525,\n",
       "  'question': 'between what timings the welcome is sheduled ?',\n",
       "  'image': 'documents/prbn0226_5.png',\n",
       "  'docId': 654,\n",
       "  'ucsf_document_id': 'prbn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['1:00PM-1:03PM', '1:00pm-1:03pm'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1526,\n",
       "  'question': 'What is the last updated date mentioned in this document?',\n",
       "  'image': 'documents/hlcn0226_9.png',\n",
       "  'docId': 658,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['5 February 2016'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1528,\n",
       "  'question': 'What is the agenda between 1:03pm-1:05pm?',\n",
       "  'image': 'documents/prbn0226_5.png',\n",
       "  'docId': 654,\n",
       "  'ucsf_document_id': 'prbn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Roll Call'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1529,\n",
       "  'question': 'What time is the subcommittee updates discussed?',\n",
       "  'image': 'documents/prbn0226_5.png',\n",
       "  'docId': 654,\n",
       "  'ucsf_document_id': 'prbn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['1:10PM - 1:20PM'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1531,\n",
       "  'question': 'what is the agenda between 1:40 pm-2:00 pm ?',\n",
       "  'image': 'documents/prbn0226_5.png',\n",
       "  'docId': 654,\n",
       "  'ucsf_document_id': 'prbn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Summary of Action Items', 'summary of action items'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1532,\n",
       "  'question': 'what is the passcode number ?',\n",
       "  'image': 'documents/prbn0226_5.png',\n",
       "  'docId': 654,\n",
       "  'ucsf_document_id': 'prbn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['202-564-2754'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1533,\n",
       "  'question': 'Where is the senior steering committee meeting held?',\n",
       "  'image': 'documents/prbn0226_5.png',\n",
       "  'docId': 654,\n",
       "  'ucsf_document_id': 'prbn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['HHS Hubert Humphery building -Room 325A'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1534,\n",
       "  'question': 'What is the fullform of NASDA?',\n",
       "  'image': 'documents/fgcn0226_7.png',\n",
       "  'docId': 662,\n",
       "  'ucsf_document_id': 'fgcn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['National Association of State Departments of Agriculture',\n",
       "   'The National Association of State Departments of Agriculture'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1535,\n",
       "  'question': 'what is the given dail-in number ?',\n",
       "  'image': 'documents/prbn0226_5.png',\n",
       "  'docId': 654,\n",
       "  'ucsf_document_id': 'prbn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['1-866-299-3188'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1539,\n",
       "  'question': 'what is the given location ?',\n",
       "  'image': 'documents/gybn0226_12.png',\n",
       "  'docId': 659,\n",
       "  'ucsf_document_id': 'gybn0226',\n",
       "  'ucsf_document_page_no': '12',\n",
       "  'answers': ['New York, NY'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1543,\n",
       "  'question': 'who reviewed the overall objectives for the meeting ?',\n",
       "  'image': 'documents/gybn0226_12.png',\n",
       "  'docId': 659,\n",
       "  'ucsf_document_id': 'gybn0226',\n",
       "  'ucsf_document_page_no': '12',\n",
       "  'answers': ['K. White'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1544,\n",
       "  'question': 'what are the units of BW ?',\n",
       "  'image': 'documents/fsbn0226_16.png',\n",
       "  'docId': 664,\n",
       "  'ucsf_document_id': 'fsbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['kg'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1545,\n",
       "  'question': 'what is the value CSF ?',\n",
       "  'image': 'documents/fsbn0226_16.png',\n",
       "  'docId': 664,\n",
       "  'ucsf_document_id': 'fsbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['0.1'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1546,\n",
       "  'question': 'what is NFSD?',\n",
       "  'image': 'documents/gybn0226_11.png',\n",
       "  'docId': 665,\n",
       "  'ucsf_document_id': 'gybn0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['Nordic Fire & Safety Days', 'nordic fire & safety days'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1548,\n",
       "  'question': 'what is kg mentioned as ?',\n",
       "  'image': 'documents/fsbn0226_16.png',\n",
       "  'docId': 664,\n",
       "  'ucsf_document_id': 'fsbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['kilograms'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1549,\n",
       "  'question': 'what is L/d mentioned as ?',\n",
       "  'image': 'documents/fsbn0226_16.png',\n",
       "  'docId': 664,\n",
       "  'ucsf_document_id': 'fsbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Liters per day', 'liters per day'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1550,\n",
       "  'question': 'when does the session end?',\n",
       "  'image': 'documents/gybn0226_11.png',\n",
       "  'docId': 665,\n",
       "  'ucsf_document_id': 'gybn0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['16:45'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1551,\n",
       "  'question': 'what is the value of conversion factor ?',\n",
       "  'image': 'documents/fsbn0226_16.png',\n",
       "  'docId': 664,\n",
       "  'ucsf_document_id': 'fsbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['1,000'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1552,\n",
       "  'question': 'what is RSC stands for ?',\n",
       "  'image': 'documents/fsbn0226_16.png',\n",
       "  'docId': 664,\n",
       "  'ucsf_document_id': 'fsbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Relative Source Contribution', 'relative source contribution'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1554,\n",
       "  'question': 'what is the P&B score for persistent and bioaccumulative',\n",
       "  'image': 'documents/jzbn0226_34.png',\n",
       "  'docId': 719,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '34',\n",
       "  'answers': ['5'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1555,\n",
       "  'question': 'what is TR stands for ?',\n",
       "  'image': 'documents/fsbn0226_16.png',\n",
       "  'docId': 664,\n",
       "  'ucsf_document_id': 'fsbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Target Risk', 'target risk'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1556,\n",
       "  'question': 'what is the p&B ranking for not persistent and not bioaccumulative',\n",
       "  'image': 'documents/jzbn0226_34.png',\n",
       "  'docId': 719,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '34',\n",
       "  'answers': ['Low', 'low'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1557,\n",
       "  'question': 'what is the unit of uncertainty factor ?',\n",
       "  'image': 'documents/fsbn0226_16.png',\n",
       "  'docId': 664,\n",
       "  'ucsf_document_id': 'fsbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Unitless', 'unitless'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1558,\n",
       "  'question': 'what is the date mentioned in this invoice?',\n",
       "  'image': 'documents/hrbn0226_6.png',\n",
       "  'docId': 670,\n",
       "  'ucsf_document_id': 'hrbn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['June 24, 2016'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1559,\n",
       "  'question': 'what is the total amount of the invoice?',\n",
       "  'image': 'documents/hrbn0226_6.png',\n",
       "  'docId': 670,\n",
       "  'ucsf_document_id': 'hrbn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['$27,600.00'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1560,\n",
       "  'question': 'what is the exposure rank for the combined score-All 3 elements 11-13',\n",
       "  'image': 'documents/jzbn0226_34.png',\n",
       "  'docId': 719,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '34',\n",
       "  'answers': ['High', 'high'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1561,\n",
       "  'question': 'When did NASDA submitted comments to EPA?',\n",
       "  'image': 'documents/fgcn0226_7.png',\n",
       "  'docId': 662,\n",
       "  'ucsf_document_id': 'fgcn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['January 2016'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1564,\n",
       "  'question': 'which priority groups are deemed as  high priority groups?',\n",
       "  'image': 'documents/jzbn0226_34.png',\n",
       "  'docId': 719,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '34',\n",
       "  'answers': ['priority groups 7,8, and 9'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1565,\n",
       "  'question': 'What does FR stand for?',\n",
       "  'image': 'documents/qrbn0226_3.png',\n",
       "  'docId': 675,\n",
       "  'ucsf_document_id': 'qrbn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['fire retardant'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1566,\n",
       "  'question': 'What is the invoice# given?',\n",
       "  'image': 'documents/hrbn0226_6.png',\n",
       "  'docId': 670,\n",
       "  'ucsf_document_id': 'hrbn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['ACCTCESystemJul16'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1567,\n",
       "  'question': 'which priority groups are deemed as medium priority groups?',\n",
       "  'image': 'documents/jzbn0226_34.png',\n",
       "  'docId': 719,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '34',\n",
       "  'answers': ['priority groups 4,5, and 6'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1568,\n",
       "  'question': 'what is the use of fire retardant plastics?',\n",
       "  'image': 'documents/qrbn0226_3.png',\n",
       "  'docId': 675,\n",
       "  'ucsf_document_id': 'qrbn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Fire Retardant (FR) plastics are used in many products(toys, chairs, electronics, etc.) to reduce the risk of fire and burn hazards.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1569,\n",
       "  'question': 'which priority groups are deemed as low priority groups ?',\n",
       "  'image': 'documents/jzbn0226_34.png',\n",
       "  'docId': 719,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '34',\n",
       "  'answers': ['Priority groups 2 and 3'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1570,\n",
       "  'question': 'What is the issued date of this document?',\n",
       "  'image': 'documents/fgcn0226_7.png',\n",
       "  'docId': 662,\n",
       "  'ucsf_document_id': 'fgcn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['March 29 2017', 'March 29 , 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1571,\n",
       "  'question': 'in which year this data was published ?',\n",
       "  'image': 'documents/jzbn0226_34.png',\n",
       "  'docId': 719,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '34',\n",
       "  'answers': ['2011'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1572,\n",
       "  'question': 'Who is the Louisiana Commissioner of Agriculture & Forestry?',\n",
       "  'image': 'documents/fgcn0226_7.png',\n",
       "  'docId': 662,\n",
       "  'ucsf_document_id': 'fgcn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Dr. Mike Strain'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1573,\n",
       "  'question': 'Who is mentioned in the CC:?',\n",
       "  'image': 'documents/pfcn0226_2.png',\n",
       "  'docId': 726,\n",
       "  'ucsf_document_id': 'pfcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['OCSPP senior staff Justina Fugh, Senior Counsel for Ethics'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1574,\n",
       "  'question': 'who is the CEO of National Association of Wheat Growers?',\n",
       "  'image': 'documents/ffcn0226_13.png',\n",
       "  'docId': 672,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['Chandler Goule'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1575,\n",
       "  'question': 'When did Chandler Goule assume his responsibilities as CEO?',\n",
       "  'image': 'documents/ffcn0226_13.png',\n",
       "  'docId': 672,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['on July 5, 2016.', 'July 5, 2016'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1576,\n",
       "  'question': 'What happens if enough flammable gas is produced ?',\n",
       "  'image': 'documents/qrbn0226_3.png',\n",
       "  'docId': 675,\n",
       "  'ucsf_document_id': 'qrbn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['the battery casing can fail releasing the gas, which can potentially ignited surrounding materials and cause a fire.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1577,\n",
       "  'question': \"What was Chandler Goule's position in national wheat foundation?\",\n",
       "  'image': 'documents/ffcn0226_13.png',\n",
       "  'docId': 672,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['CEO', 'Executive Director'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1578,\n",
       "  'question': 'under which  safety act this is performed ?',\n",
       "  'image': 'documents/ylcn0226_3.png',\n",
       "  'docId': 730,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Launtenberg Chemical Safety Act'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1579,\n",
       "  'question': 'what is the date mentioned in the given invoice ?',\n",
       "  'image': 'documents/hpbn0226_2.png',\n",
       "  'docId': 677,\n",
       "  'ucsf_document_id': 'hpbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['may 12,2017', 'May 12, 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1580,\n",
       "  'question': 'what is the name of the foundation?',\n",
       "  'image': 'documents/hpbn0226_2.png',\n",
       "  'docId': 677,\n",
       "  'ucsf_document_id': 'hpbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['University Environmental Health Foundation',\n",
       "   'university environmental health foundation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1581,\n",
       "  'question': 'what is the name of the university ?',\n",
       "  'image': 'documents/hpbn0226_2.png',\n",
       "  'docId': 677,\n",
       "  'ucsf_document_id': 'hpbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['University of Cincinnati', 'university of cincinnati'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1582,\n",
       "  'question': 'Earlier where did Goule worked as senior vice president of programs?',\n",
       "  'image': 'documents/ffcn0226_13.png',\n",
       "  'docId': 672,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['National Farmers Union', 'NFU', 'At National Farmers Union.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1584,\n",
       "  'question': 'What is NFU?',\n",
       "  'image': 'documents/ffcn0226_13.png',\n",
       "  'docId': 672,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['National Farmers Union', 'National Farmers Union.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1586,\n",
       "  'question': 'under which country  initial input to environmental protection agency is performed ?',\n",
       "  'image': 'documents/ylcn0226_3.png',\n",
       "  'docId': 730,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['U.S.', 'U.S'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1587,\n",
       "  'question': 'to whom the payment of checks to be done ?',\n",
       "  'image': 'documents/hpbn0226_2.png',\n",
       "  'docId': 677,\n",
       "  'ucsf_document_id': 'hpbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['university environmental health foundation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1588,\n",
       "  'question': 'what is mentioned in the table content 1 ?',\n",
       "  'image': 'documents/ylcn0226_3.png',\n",
       "  'docId': 730,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Introduction and Executive Summary'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1589,\n",
       "  'question': 'Where does Goule hail from?',\n",
       "  'image': 'documents/ffcn0226_13.png',\n",
       "  'docId': 672,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['Texas'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1590,\n",
       "  'question': 'when was this information published ?',\n",
       "  'image': 'documents/jzbn0226_37.png',\n",
       "  'docId': 728,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '37',\n",
       "  'answers': ['August 29, 2011', 'august 29, 2011'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1591,\n",
       "  'question': 'Where does Goule holds degree from?',\n",
       "  'image': 'documents/ffcn0226_13.png',\n",
       "  'docId': 672,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['Texas A&M and George Washington University'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1592,\n",
       "  'question': 'what is an example for  risk -based screening prioritization process?',\n",
       "  'image': 'documents/jzbn0226_37.png',\n",
       "  'docId': 728,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '37',\n",
       "  'answers': [\"ACC's prioritization approach\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1593,\n",
       "  'question': 'When was he appointed as senior vice president of NFU programs?',\n",
       "  'image': 'documents/ffcn0226_13.png',\n",
       "  'docId': 672,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['2014'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1594,\n",
       "  'question': 'what is the total amount in the given invoice ?',\n",
       "  'image': 'documents/hpbn0226_2.png',\n",
       "  'docId': 677,\n",
       "  'ucsf_document_id': 'hpbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['$5,476.50'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1595,\n",
       "  'question': 'when conducting screening for thousands of chemicals, EPA may not have access to what ?',\n",
       "  'image': 'documents/jzbn0226_37.png',\n",
       "  'docId': 728,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '37',\n",
       "  'answers': ['all available information', 'to all available information'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1596,\n",
       "  'question': 'what is mentioned in phase 1 task 1.2 ?',\n",
       "  'image': 'documents/hlcn0226_10.png',\n",
       "  'docId': 678,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['review prior studies/literature'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1597,\n",
       "  'question': 'ICR Stands for ?',\n",
       "  'image': 'documents/kzbn0226_46.png',\n",
       "  'docId': 709,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '46',\n",
       "  'answers': ['Information Collection Request',\n",
       "   'information collection request'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1598,\n",
       "  'question': 'EPA is taking comment on ICR No ?',\n",
       "  'image': 'documents/kzbn0226_46.png',\n",
       "  'docId': 709,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '46',\n",
       "  'answers': ['2559.01', '2559.01.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1599,\n",
       "  'question': 'what is IPP stands for ?',\n",
       "  'image': 'documents/hlcn0226_10.png',\n",
       "  'docId': 678,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['International Personal Protection',\n",
       "   'international personal protection'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1600,\n",
       "  'question': 'what is NIOSH stands for ?',\n",
       "  'image': 'documents/hlcn0226_10.png',\n",
       "  'docId': 678,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['National Institute for Occupational Safety and Health',\n",
       "   'national institute for occupational safety and health'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1601,\n",
       "  'question': 'for each manufacture request , EPA estimates that the burden on public will be how many hours ?',\n",
       "  'image': 'documents/kzbn0226_46.png',\n",
       "  'docId': 709,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '46',\n",
       "  'answers': ['96 hours'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1602,\n",
       "  'question': 'what is mentioned in phase 3 task 3.3 ?',\n",
       "  'image': 'documents/hlcn0226_10.png',\n",
       "  'docId': 678,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['Put together test plan (biological)',\n",
       "   'put together test plan (biological)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1604,\n",
       "  'question': 'Who is currently the President and CEO of the American Seed Trade Association?',\n",
       "  'image': 'documents/ffcn0226_16.png',\n",
       "  'docId': 683,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Andrew W. \"Andy\" LaVigne',\n",
       "   'Andrew W. LaVigne',\n",
       "   'Andrew W.LaVigne'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1605,\n",
       "  'question': 'When Andrew W.LaVigne joined ASTA',\n",
       "  'image': 'documents/ffcn0226_16.png',\n",
       "  'docId': 683,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['February, 2006'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1607,\n",
       "  'question': 'What core areas of expertise include ?',\n",
       "  'image': 'documents/ffcn0226_16.png',\n",
       "  'docId': 683,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['agriculture, food policy and international trade',\n",
       "   'Agriculture, food policy and international trade'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1608,\n",
       "  'question': 'What does FFAA stands for ?',\n",
       "  'image': 'documents/ffcn0226_16.png',\n",
       "  'docId': 683,\n",
       "  'ucsf_document_id': 'ffcn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Florida Fertilizer and Agrichemical Association',\n",
       "   \"Florida Fertilizer and Agrichemical Association's\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1610,\n",
       "  'question': 'What is the Urgent/Immediate Action Commercial of Connecticut?',\n",
       "  'image': 'documents/kqbn0226_7.png',\n",
       "  'docId': 685,\n",
       "  'ucsf_document_id': 'kqbn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['8'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1611,\n",
       "  'question': 'What is the Imminent Action Residential of Massachusetts ?',\n",
       "  'image': 'documents/kqbn0226_7.png',\n",
       "  'docId': 685,\n",
       "  'ucsf_document_id': 'kqbn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['20'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1612,\n",
       "  'question': 'What is the Imminent Action Commercial of Ohio?',\n",
       "  'image': 'documents/kqbn0226_7.png',\n",
       "  'docId': 685,\n",
       "  'ucsf_document_id': 'kqbn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['60'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1613,\n",
       "  'question': 'What is the p-Value of Gamma?',\n",
       "  'image': 'documents/kxcn0226_25.png',\n",
       "  'docId': 689,\n",
       "  'ucsf_document_id': 'kxcn0226',\n",
       "  'ucsf_document_page_no': '25',\n",
       "  'answers': ['0.75'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1614,\n",
       "  'question': 'What is the Scaled Residual at Dose of LogLogistic?',\n",
       "  'image': 'documents/kxcn0226_25.png',\n",
       "  'docId': 689,\n",
       "  'ucsf_document_id': 'kxcn0226',\n",
       "  'ucsf_document_page_no': '25',\n",
       "  'answers': ['0.042'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1615,\n",
       "  'question': 'What is the Visual Fit of Logistic?',\n",
       "  'image': 'documents/kxcn0226_25.png',\n",
       "  'docId': 689,\n",
       "  'ucsf_document_id': 'kxcn0226',\n",
       "  'ucsf_document_page_no': '25',\n",
       "  'answers': ['acceptable', 'Acceptable'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1616,\n",
       "  'question': 'What is the Ratio BMD/BMDL of Multistage(1*)?',\n",
       "  'image': 'documents/kxcn0226_25.png',\n",
       "  'docId': 689,\n",
       "  'ucsf_document_id': 'kxcn0226',\n",
       "  'ucsf_document_page_no': '25',\n",
       "  'answers': ['1.5'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1617,\n",
       "  'question': 'What is AIC of Weibull?',\n",
       "  'image': 'documents/kxcn0226_25.png',\n",
       "  'docId': 689,\n",
       "  'ucsf_document_id': 'kxcn0226',\n",
       "  'ucsf_document_page_no': '25',\n",
       "  'answers': ['223.1'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1618,\n",
       "  'question': 'What is the Goal of this Workshop?',\n",
       "  'image': 'documents/hlcn0226_3.png',\n",
       "  'docId': 691,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['is to identify concepts and materials that are or can be useful to control the spread of harmful fire ground contaminants, ultimately in support of improved fire fighter long-term health.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1620,\n",
       "  'question': 'What is the limit of Workshop attendance?',\n",
       "  'image': 'documents/hlcn0226_3.png',\n",
       "  'docId': 691,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['is limited to the first 50 attendees,'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1621,\n",
       "  'question': 'When is the Workshop?',\n",
       "  'image': 'documents/hlcn0226_3.png',\n",
       "  'docId': 691,\n",
       "  'ucsf_document_id': 'hlcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['19-20 July 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1622,\n",
       "  'question': 'What does ICMJE stand for?',\n",
       "  'image': 'documents/lzbn0226_3.png',\n",
       "  'docId': 694,\n",
       "  'ucsf_document_id': 'lzbn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['International Committee of Medical Journal Editors'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1624,\n",
       "  'question': 'What is Section 5 ?',\n",
       "  'image': 'documents/lzbn0226_3.png',\n",
       "  'docId': 694,\n",
       "  'ucsf_document_id': 'lzbn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Relationships not covered above'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1626,\n",
       "  'question': 'What is Section 6?',\n",
       "  'image': 'documents/lzbn0226_3.png',\n",
       "  'docId': 694,\n",
       "  'ucsf_document_id': 'lzbn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Disclosure statement', 'Disclosure Statement'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1629,\n",
       "  'question': 'How many days are the people granted to submit relevant information about that chemical?',\n",
       "  'image': 'documents/jzbn0226_9.png',\n",
       "  'docId': 699,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['90 days'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1630,\n",
       "  'question': 'Who must propose a designation of a chemical as a high or low priority?',\n",
       "  'image': 'documents/jzbn0226_9.png',\n",
       "  'docId': 699,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['EPA', 'The EPA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1631,\n",
       "  'question': 'Who initiates priority designation?',\n",
       "  'image': 'documents/jzbn0226_9.png',\n",
       "  'docId': 699,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['EPA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1632,\n",
       "  'question': 'How long is the public comment period?',\n",
       "  'image': 'documents/jzbn0226_9.png',\n",
       "  'docId': 699,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['90 day', '90 day public comment period'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1633,\n",
       "  'question': 'What email is provided at the bottom?',\n",
       "  'image': 'documents/jzbn0226_2.png',\n",
       "  'docId': 701,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Sarah_Brozena@americanchemistry.com',\n",
       "   'Sarah_brozena@americanchemistry.com'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1634,\n",
       "  'question': 'What is the date on the document?',\n",
       "  'image': 'documents/jzbn0226_2.png',\n",
       "  'docId': 701,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['March 20, 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1635,\n",
       "  'question': \"What is Sarah Brozena's designation in american chemistry council?\",\n",
       "  'image': 'documents/jzbn0226_2.png',\n",
       "  'docId': 701,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Senior director, regulatory and technical affairs'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1636,\n",
       "  'question': 'Who is the Senior director, regulatory and technical affairs at American chemistry council?',\n",
       "  'image': 'documents/jzbn0226_2.png',\n",
       "  'docId': 701,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Sarah Brozena'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1642,\n",
       "  'question': 'Post marketing surveillance(PMS) affiliates to which region?',\n",
       "  'image': 'documents/fzjf0226_15.png',\n",
       "  'docId': 628,\n",
       "  'ucsf_document_id': 'fzjf0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['Spain'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1643,\n",
       "  'question': 'The study based on collection of data from patient charts',\n",
       "  'image': 'documents/fzjf0226_15.png',\n",
       "  'docId': 628,\n",
       "  'ucsf_document_id': 'fzjf0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['Observational Studies'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1644,\n",
       "  'question': 'IITs stands for?',\n",
       "  'image': 'documents/fzjf0226_15.png',\n",
       "  'docId': 628,\n",
       "  'ucsf_document_id': 'fzjf0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['Investigator Initiated Trials'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1645,\n",
       "  'question': 'What is the fullform of ICR?',\n",
       "  'image': 'documents/kzbn0226_5.png',\n",
       "  'docId': 702,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Information Collection Request'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1646,\n",
       "  'question': 'The program which provides free products for specified time frames to physicians to gain experience',\n",
       "  'image': 'documents/fzjf0226_15.png',\n",
       "  'docId': 628,\n",
       "  'ucsf_document_id': 'fzjf0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['Physician Experience Programs (PEPs)',\n",
       "   'Physician Experience Programs'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1647,\n",
       "  'question': 'A study based on collection of AE data from patient charts',\n",
       "  'image': 'documents/fzjf0226_15.png',\n",
       "  'docId': 628,\n",
       "  'ucsf_document_id': 'fzjf0226',\n",
       "  'ucsf_document_page_no': '15',\n",
       "  'answers': ['Post Marketing Surveillance',\n",
       "   'Post marketing surveillance',\n",
       "   'Post Marketing Surveillance (PMS)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1649,\n",
       "  'question': 'What does QSAR stands for?',\n",
       "  'image': 'documents/jzbn0226_8.png',\n",
       "  'docId': 706,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['Quantitative Structure Activity relationship',\n",
       "   'Quantitative structure activity relationship'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1650,\n",
       "  'question': 'what is page 3 heading',\n",
       "  'image': 'documents/kgpj0226_3.png',\n",
       "  'docId': 436,\n",
       "  'ucsf_document_id': 'kgpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Memorandum of Meeting'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1651,\n",
       "  'question': 'Who gave a short discussion as to what her office is doing with respect to labeling?',\n",
       "  'image': 'documents/kgpj0226_3.png',\n",
       "  'docId': 436,\n",
       "  'ucsf_document_id': 'kgpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Ms. Williams'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1652,\n",
       "  'question': 'It is hoped that each hearing will be in what length',\n",
       "  'image': 'documents/kgpj0226_3.png',\n",
       "  'docId': 436,\n",
       "  'ucsf_document_id': 'kgpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['one day', 'one day in length'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1654,\n",
       "  'question': 'who announced the schedule of hearings',\n",
       "  'image': 'documents/kgpj0226_3.png',\n",
       "  'docId': 436,\n",
       "  'ucsf_document_id': 'kgpj0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Ms. Williams', 'Ms williams'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1655,\n",
       "  'question': 'What is the heading',\n",
       "  'image': 'documents/tljf0226_7.png',\n",
       "  'docId': 450,\n",
       "  'ucsf_document_id': 'tljf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Research & Development Organization Chart'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1656,\n",
       "  'question': 'who is VP, Research & Development',\n",
       "  'image': 'documents/tljf0226_7.png',\n",
       "  'docId': 450,\n",
       "  'ucsf_document_id': 'tljf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Dr. Claire Thom & Masatake Kashiyae',\n",
       "   'Dr Claire Thom & Masatake Kashiyae'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1657,\n",
       "  'question': 'who is Director,Safety',\n",
       "  'image': 'documents/tljf0226_7.png',\n",
       "  'docId': 450,\n",
       "  'ucsf_document_id': 'tljf0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Dr. John Page', 'Dr John Page'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1659,\n",
       "  'question': 'From whom is this document',\n",
       "  'image': 'documents/tqjf0226_1.png',\n",
       "  'docId': 453,\n",
       "  'ucsf_document_id': 'tqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['tpna news on behalf of tpna news',\n",
       "   'TPNA News on behalf of tpna news'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1660,\n",
       "  'question': 'Who is the sender of this email?',\n",
       "  'image': 'documents/tqjf0226_1.png',\n",
       "  'docId': 453,\n",
       "  'ucsf_document_id': 'tqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['TPNA News on behalf of tpna news'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1661,\n",
       "  'question': 'What is the subject of this email?',\n",
       "  'image': 'documents/tqjf0226_1.png',\n",
       "  'docId': 453,\n",
       "  'ucsf_document_id': 'tqjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Important Takeda Legal Information Relating to Actos - 1st of 2'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1665,\n",
       "  'question': 'who is the sender of this email',\n",
       "  'image': 'documents/ptjf0226_1.png',\n",
       "  'docId': 456,\n",
       "  'ucsf_document_id': 'ptjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Jose f caro/am/lly', 'Jose F Caro/AM/LLY', 'Jose f caro'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1667,\n",
       "  'question': 'what algorithm is mentioned in Table 1 heading',\n",
       "  'image': 'documents/qnjf0226_10.png',\n",
       "  'docId': 467,\n",
       "  'ucsf_document_id': 'qnjf0226',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['MGPS** data mining algorithm'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1668,\n",
       "  'question': 'when will I be available for telecon if deemed necessary',\n",
       "  'image': 'documents/qnjf0226_1.png',\n",
       "  'docId': 469,\n",
       "  'ucsf_document_id': 'qnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['tomorrow'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1669,\n",
       "  'question': 'which version of disproportionality report was attached',\n",
       "  'image': 'documents/qnjf0226_1.png',\n",
       "  'docId': 469,\n",
       "  'ucsf_document_id': 'qnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['updated', 'an updated version'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1670,\n",
       "  'question': 'which report is mentioned in the subject',\n",
       "  'image': 'documents/qnjf0226_1.png',\n",
       "  'docId': 469,\n",
       "  'ucsf_document_id': 'qnjf0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['disproportionality report'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1671,\n",
       "  'question': 'who retained a professional translator',\n",
       "  'image': 'documents/tfkf0226_9.png',\n",
       "  'docId': 478,\n",
       "  'ucsf_document_id': 'tfkf0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['International Litigation Services'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1673,\n",
       "  'question': 'who is the managing director of international litigation services,Inc.',\n",
       "  'image': 'documents/tfkf0226_9.png',\n",
       "  'docId': 478,\n",
       "  'ucsf_document_id': 'tfkf0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['Joseph Thorpe'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1674,\n",
       "  'question': 'What is the fullform of ILS?',\n",
       "  'image': 'documents/tfkf0226_9.png',\n",
       "  'docId': 478,\n",
       "  'ucsf_document_id': 'tfkf0226',\n",
       "  'ucsf_document_page_no': '9',\n",
       "  'answers': ['INTERNATIONAL LITIGATION SERVICES'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1686,\n",
       "  'question': 'What is the issued date of this letter?',\n",
       "  'image': 'documents/klcn0226_1.png',\n",
       "  'docId': 722,\n",
       "  'ucsf_document_id': 'klcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['June 15, 2006'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1687,\n",
       "  'question': 'What is the subject of the letter?',\n",
       "  'image': 'documents/klcn0226_1.png',\n",
       "  'docId': 722,\n",
       "  'ucsf_document_id': 'klcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['comments on proposed risk assessment bulletin',\n",
       "   'Comments on proposed risk assessment bulletin'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1688,\n",
       "  'question': 'What is ACC stands for?',\n",
       "  'image': 'documents/klcn0226_1.png',\n",
       "  'docId': 722,\n",
       "  'ucsf_document_id': 'klcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['American Chemistry council', 'American Chemistry Council'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1689,\n",
       "  'question': 'What is Task A?',\n",
       "  'image': 'documents/qrbn0226_4.png',\n",
       "  'docId': 648,\n",
       "  'ucsf_document_id': 'qrbn0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Fabricate Replica Baby Monitors'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1690,\n",
       "  'question': 'What does the Figure 3 show?',\n",
       "  'image': 'documents/qrbn0226_4.png',\n",
       "  'docId': 648,\n",
       "  'ucsf_document_id': 'qrbn0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Makerbot Flammability warning video',\n",
       "   'Makerbot flammability warning video'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1692,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/qrbn0226_4.png',\n",
       "  'docId': 648,\n",
       "  'ucsf_document_id': 'qrbn0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['August 3, 2016'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1697,\n",
       "  'question': 'How many steps Prioritization Process is shown?',\n",
       "  'image': 'documents/jzbn0226_40.png',\n",
       "  'docId': 715,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '40',\n",
       "  'answers': ['Two-step', 'Two-Step'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1698,\n",
       "  'question': 'In the Second Tier the Ranking Ordering are within which groups?',\n",
       "  'image': 'documents/jzbn0226_40.png',\n",
       "  'docId': 715,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '40',\n",
       "  'answers': ['Priority groups', 'Priority Groups', 'Priority'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1699,\n",
       "  'question': 'What is the heading of the picture shown?',\n",
       "  'image': 'documents/jzbn0226_40.png',\n",
       "  'docId': 715,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '40',\n",
       "  'answers': ['Risk-Based Prioritization Matrix'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1700,\n",
       "  'question': 'What is the alternative given for Biomonitoring?',\n",
       "  'image': 'documents/jzbn0226_40.png',\n",
       "  'docId': 715,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '40',\n",
       "  'answers': ['Environmental Monitoring'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1701,\n",
       "  'question': 'What is the heading of the document?',\n",
       "  'image': 'documents/ngcn0226_1.png',\n",
       "  'docId': 725,\n",
       "  'ucsf_document_id': 'ngcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['American Chemistry council', 'American Chemistry Council'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1702,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/ngcn0226_1.png',\n",
       "  'docId': 725,\n",
       "  'ucsf_document_id': 'ngcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['january 28, 2013', 'January 28, 2013'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1703,\n",
       "  'question': 'To whom is this email addressed?',\n",
       "  'image': 'documents/ngcn0226_1.png',\n",
       "  'docId': 725,\n",
       "  'ucsf_document_id': 'ngcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Drs. Cowden and Lee',\n",
       "   'John Cowden, Ph.D.',\n",
       "   'Docket_ORD@epa.gov; cowden.john@epa.gov; lee.janices@epagov'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1704,\n",
       "  'question': 'What is the full form ACC?',\n",
       "  'image': 'documents/ngcn0226_1.png',\n",
       "  'docId': 725,\n",
       "  'ucsf_document_id': 'ngcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['American Chemistry council', 'American Chemistry Council'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1705,\n",
       "  'question': 'By whom is this ethics agreement written?',\n",
       "  'image': 'documents/llcn0226_2.png',\n",
       "  'docId': 731,\n",
       "  'ucsf_document_id': 'llcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Michael L. Dourson'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1706,\n",
       "  'question': 'From which Publishing Platform did the author receive royalties for sales of his three books?',\n",
       "  'image': 'documents/llcn0226_2.png',\n",
       "  'docId': 731,\n",
       "  'ucsf_document_id': 'llcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['CreateSpace Independent Publishing Platform'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1707,\n",
       "  'question': 'The authors wife is a sole proprietor of which firm?',\n",
       "  'image': 'documents/llcn0226_2.png',\n",
       "  'docId': 731,\n",
       "  'ucsf_document_id': 'llcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['her law firm', 'law firm', 'Martha C. Dourson, LLC.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1708,\n",
       "  'question': 'Name the first book written by the author among the three?',\n",
       "  'image': 'documents/llcn0226_2.png',\n",
       "  'docId': 731,\n",
       "  'ucsf_document_id': 'llcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': [\"Messiah's Star (Evidence for Faith) (Volume 1)\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1709,\n",
       "  'question': 'What two are the degree of independent verification and peer review?',\n",
       "  'image': 'documents/kzbn0226_20.png',\n",
       "  'docId': 723,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '20',\n",
       "  'answers': ['variability, uncertainty'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1710,\n",
       "  'question': 'Who agrees that the term WoE has meant different things to different groups?',\n",
       "  'image': 'documents/kzbn0226_20.png',\n",
       "  'docId': 723,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '20',\n",
       "  'answers': ['ACC'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1711,\n",
       "  'question': 'Who does not provide information regarding the quality of the individual?',\n",
       "  'image': 'documents/kzbn0226_20.png',\n",
       "  'docId': 723,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '20',\n",
       "  'answers': ['EPA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1712,\n",
       "  'question': 'What is the name of the second point?',\n",
       "  'image': 'documents/kzbn0226_20.png',\n",
       "  'docId': 723,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '20',\n",
       "  'answers': ['Weight of the Evidence (WoE)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1713,\n",
       "  'question': 'What is the date mentioned in the bottom?',\n",
       "  'image': 'documents/jzbn0226_31.png',\n",
       "  'docId': 718,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '31',\n",
       "  'answers': ['August 29, 2011'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1714,\n",
       "  'question': 'What is the heading of the point B?',\n",
       "  'image': 'documents/jzbn0226_31.png',\n",
       "  'docId': 718,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '31',\n",
       "  'answers': ['Exposure Potential Ranking'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1715,\n",
       "  'question': 'Together how many elements are used to make rank exposure potential?',\n",
       "  'image': 'documents/jzbn0226_31.png',\n",
       "  'docId': 718,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '31',\n",
       "  'answers': ['3 elements', '3'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1716,\n",
       "  'question': \"The proposed approach applies the most to which year's TSCA Inventory Update Reporting rule?\",\n",
       "  'image': 'documents/jzbn0226_31.png',\n",
       "  'docId': 718,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '31',\n",
       "  'answers': ['2006'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1717,\n",
       "  'question': 'What is the fullform of ACC?',\n",
       "  'image': 'documents/jzbn0226_6.png',\n",
       "  'docId': 724,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['American Chemistry Council', 'The American Chemistry Council'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1718,\n",
       "  'question': 'what does acc stands for?',\n",
       "  'image': 'documents/kzbn0226_1.png',\n",
       "  'docId': 720,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['The American Chemistry Council',\n",
       "   'american chemistry council',\n",
       "   'American Chemistry Council'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1719,\n",
       "  'question': 'In which year, EPA held a Stakeholder Dialogue on prioritization?',\n",
       "  'image': 'documents/jzbn0226_6.png',\n",
       "  'docId': 724,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['2011'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1720,\n",
       "  'question': 'By whom is this document written?',\n",
       "  'image': 'documents/pfcn0226_1.png',\n",
       "  'docId': 751,\n",
       "  'ucsf_document_id': 'pfcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Nancy B. Beck', 'Nancy B. Beck, Ph.D., DABT'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1721,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/pfcn0226_1.png',\n",
       "  'docId': 751,\n",
       "  'ucsf_document_id': 'pfcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['June 9, 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1722,\n",
       "  'question': 'To whom is this document addressed?',\n",
       "  'image': 'documents/pfcn0226_1.png',\n",
       "  'docId': 751,\n",
       "  'ucsf_document_id': 'pfcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Wendy Cleland-Hamnett'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1723,\n",
       "  'question': 'What is the subject of the memorandum?',\n",
       "  'image': 'documents/pfcn0226_1.png',\n",
       "  'docId': 751,\n",
       "  'ucsf_document_id': 'pfcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Recusal Statement'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1724,\n",
       "  'question': 'Why ACC developed a two-step quantitative and qualitative tool?',\n",
       "  'image': 'documents/jzbn0226_6.png',\n",
       "  'docId': 724,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['to \"proof test\" our prioritization principles',\n",
       "   'to \"proof test\" our prioritization principles (attachement B)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1725,\n",
       "  'question': 'What is the heading of the letter?',\n",
       "  'image': 'documents/jzbn0226_1.png',\n",
       "  'docId': 733,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['American Chemistry Council'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1726,\n",
       "  'question': 'What is the date mentioned?',\n",
       "  'image': 'documents/jzbn0226_1.png',\n",
       "  'docId': 733,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['March 20, 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1727,\n",
       "  'question': 'By whom is this letter written?',\n",
       "  'image': 'documents/jzbn0226_1.png',\n",
       "  'docId': 733,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Sarah Brozena'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1729,\n",
       "  'question': 'What is the main heading of the document?',\n",
       "  'image': 'documents/slcn0226_1.png',\n",
       "  'docId': 899,\n",
       "  'ucsf_document_id': 'slcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Scientific Review of the Proposed Risk Assessment Bulletin from the Office of Management and Budget'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1730,\n",
       "  'question': 'What is the abbreviation of Toxic Substances Control Act?',\n",
       "  'image': 'documents/jzbn0226_6.png',\n",
       "  'docId': 724,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['TSCA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1731,\n",
       "  'question': 'Where is The National Academic Press located?',\n",
       "  'image': 'documents/slcn0226_1.png',\n",
       "  'docId': 899,\n",
       "  'ucsf_document_id': 'slcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Washington, D.C.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1733,\n",
       "  'question': 'What did ACC strongly supported?',\n",
       "  'image': 'documents/jzbn0226_6.png',\n",
       "  'docId': 724,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': [\"supported Congress's efforts to update & reform TSCA\",\n",
       "   \"Congress's efforts to update and reform TSCA\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1734,\n",
       "  'question': 'what is the regulation for amended toxic substances control act?',\n",
       "  'image': 'documents/kzbn0226_1.png',\n",
       "  'docId': 720,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['7562'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1735,\n",
       "  'question': 'What is the first heading in the document?',\n",
       "  'image': 'documents/slcn0226_1.png',\n",
       "  'docId': 899,\n",
       "  'ucsf_document_id': 'slcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Prepublication Copy', 'PREPUBLICATION COPY'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1736,\n",
       "  'question': 'Why is it neccessary to consider IUR information within a particular priority grouping?',\n",
       "  'image': 'documents/jzbn0226_36.png',\n",
       "  'docId': 735,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '36',\n",
       "  'answers': ['for second tier rank ordering',\n",
       "   'for Second Tier rank ordering'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1737,\n",
       "  'question': 'In which number should Karyn M. Schmidt be contacted?',\n",
       "  'image': 'documents/kzbn0226_1.png',\n",
       "  'docId': 720,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['202-249-6130'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1738,\n",
       "  'question': 'Which age group foes the IUR definition target?',\n",
       "  'image': 'documents/jzbn0226_36.png',\n",
       "  'docId': 735,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '36',\n",
       "  'answers': ['targets children age 14 and younger',\n",
       "   'children age 14 and younger',\n",
       "   'age 14 and younger'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1739,\n",
       "  'question': 'What would have de minimis exposure potential by definition?',\n",
       "  'image': 'documents/jzbn0226_36.png',\n",
       "  'docId': 735,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '36',\n",
       "  'answers': ['non-isolated system intermediates'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1740,\n",
       "  'question': 'On what basis, an initial screening approach for chemical prioritization is done?',\n",
       "  'image': 'documents/jzbn0226_36.png',\n",
       "  'docId': 735,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '36',\n",
       "  'answers': ['based upon consistent application of specific hazard and exposure science elements that define risk potential',\n",
       "   'based upon consistent application of specific hazard and exposure science elements that define risk potential.',\n",
       "   'consistent application of specific hazard and exposure science elements that define risk potential'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1742,\n",
       "  'question': 'What does Section 26(h) set out?',\n",
       "  'image': 'documents/kzbn0226_17.png',\n",
       "  'docId': 736,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '17',\n",
       "  'answers': ['scientific standards that apply to every \"decision based on science\"'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1743,\n",
       "  'question': 'Under which section, EPA carries out risk evaluation?',\n",
       "  'image': 'documents/kzbn0226_17.png',\n",
       "  'docId': 736,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '17',\n",
       "  'answers': ['section 6', 'under Section 6'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1744,\n",
       "  'question': 'What is the fullform of SCIL?',\n",
       "  'image': 'documents/jzbn0226_18.png',\n",
       "  'docId': 737,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '18',\n",
       "  'answers': ['Safer Chemicals Ingredients List'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1745,\n",
       "  'question': 'What is the page no mentioned in this document?',\n",
       "  'image': 'documents/jzbn0226_18.png',\n",
       "  'docId': 737,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '18',\n",
       "  'answers': ['16'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1746,\n",
       "  'question': 'What is the subheading given in this document?',\n",
       "  'image': 'documents/jzbn0226_18.png',\n",
       "  'docId': 737,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '18',\n",
       "  'answers': [\"EPA's Abuse of Discretion Argument\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1747,\n",
       "  'question': 'Which agency can designate a chemical as a high priority?',\n",
       "  'image': 'documents/jzbn0226_18.png',\n",
       "  'docId': 737,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '18',\n",
       "  'answers': ['EPA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1751,\n",
       "  'question': 'What is the page no mentioned in this document?',\n",
       "  'image': 'documents/nlcn0226_16.png',\n",
       "  'docId': 738,\n",
       "  'ucsf_document_id': 'nlcn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['16'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1752,\n",
       "  'question': 'What is the date mentioned in this document?',\n",
       "  'image': 'documents/nlcn0226_16.png',\n",
       "  'docId': 738,\n",
       "  'ucsf_document_id': 'nlcn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['June 2006'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1753,\n",
       "  'question': 'Who prepared the comments for this document?',\n",
       "  'image': 'documents/nlcn0226_16.png',\n",
       "  'docId': 738,\n",
       "  'ucsf_document_id': 'nlcn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Jennifer Sass , Je nnife r Sa ss', 'Je nnife r Sa ss, Ph.D.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1754,\n",
       "  'question': 'What is the name of the council?',\n",
       "  'image': 'documents/nlcn0226_16.png',\n",
       "  'docId': 738,\n",
       "  'ucsf_document_id': 'nlcn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Natural Resources Defense Council',\n",
       "   'Natura l Re so urc e s De fe nse Co unc il'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1755,\n",
       "  'question': 'What is the issued date of this document?',\n",
       "  'image': 'documents/nlcn0226_1.png',\n",
       "  'docId': 739,\n",
       "  'ucsf_document_id': 'nlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['June 15, 2006'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1756,\n",
       "  'question': 'Who is the addressee of this letter?',\n",
       "  'image': 'documents/nlcn0226_1.png',\n",
       "  'docId': 739,\n",
       "  'ucsf_document_id': 'nlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Dr. Nancy Beck', 'Dr. Beck'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1757,\n",
       "  'question': 'What is the fullform of NRDC?',\n",
       "  'image': 'documents/nlcn0226_1.png',\n",
       "  'docId': 739,\n",
       "  'ucsf_document_id': 'nlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Natural Resources Defense Council'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1758,\n",
       "  'question': 'What kind of organization is NRDC?',\n",
       "  'image': 'documents/nlcn0226_1.png',\n",
       "  'docId': 739,\n",
       "  'ucsf_document_id': 'nlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['a national non-profit public interest organization'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1759,\n",
       "  'question': 'What is the subject line of this letter?',\n",
       "  'image': 'documents/nlcn0226_1.png',\n",
       "  'docId': 739,\n",
       "  'ucsf_document_id': 'nlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Re:    NRDC Comments on the OMB Proposed Risk Assessment Bulletin'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1761,\n",
       "  'question': 'which contact number is provided in this letter?',\n",
       "  'image': 'documents/kzbn0226_1.png',\n",
       "  'docId': 720,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['202-249-6130'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1762,\n",
       "  'question': 'who is senior director for regulatory and technical affairs american chemistry council?',\n",
       "  'image': 'documents/kzbn0226_1.png',\n",
       "  'docId': 720,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Karyn M. Schmidt', 'karyn m. schmidt'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1763,\n",
       "  'question': 'What is commonly used in the environmental toxicology field?',\n",
       "  'image': 'documents/kzbn0226_42.png',\n",
       "  'docId': 740,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '42',\n",
       "  'answers': ['it is common to use the 95th percentile under average exposure conditions.',\n",
       "   '95th percentile under average exposure conditions'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1764,\n",
       "  'question': 'Which field does not use the \"plausible maximum exposure\" ?',\n",
       "  'image': 'documents/kzbn0226_42.png',\n",
       "  'docId': 740,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '42',\n",
       "  'answers': ['environmental toxicology field'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1766,\n",
       "  'question': 'What does EPA cites as the source?',\n",
       "  'image': 'documents/kzbn0226_42.png',\n",
       "  'docId': 740,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '42',\n",
       "  'answers': [\"cites EPA's 2014 Human Health Risk Assessment Framework as the source.\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1767,\n",
       "  'question': \"what would be the EPA's final risk evaluation?\",\n",
       "  'image': 'documents/kzbn0226_16.png',\n",
       "  'docId': 743,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['suspect quality, integrity, and reliability'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1768,\n",
       "  'question': 'Which law is signed by President Obama?',\n",
       "  'image': 'documents/ylcn0226_1.png',\n",
       "  'docId': 745,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['the Frank R. Launtenberg Chemical Safety for 21st Century Act'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1769,\n",
       "  'question': 'What is the fullform of TSCA?',\n",
       "  'image': 'documents/ylcn0226_1.png',\n",
       "  'docId': 745,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Toxic Substances Control Act'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1770,\n",
       "  'question': 'When did president Obama amends the TSCA?',\n",
       "  'image': 'documents/ylcn0226_1.png',\n",
       "  'docId': 745,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['On June 22, 2016'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1771,\n",
       "  'question': 'What was the Mandatory requirement for EPA?',\n",
       "  'image': 'documents/ylcn0226_1.png',\n",
       "  'docId': 745,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['to evaluate existing chemicals with clear and enforceable deadlines'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1772,\n",
       "  'question': 'What is the page no mentioned in this document?',\n",
       "  'image': 'documents/kzbn0226_36.png',\n",
       "  'docId': 746,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '36',\n",
       "  'answers': ['31', '31/Page'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1775,\n",
       "  'question': 'What is the abbreviation for Chemical Safety Advisory Committee?',\n",
       "  'image': 'documents/kzbn0226_36.png',\n",
       "  'docId': 746,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '36',\n",
       "  'answers': ['CSAC'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1776,\n",
       "  'question': 'what does APA stands for?',\n",
       "  'image': 'documents/kzbn0226_16.png',\n",
       "  'docId': 743,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Administrative Procedure Act'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1777,\n",
       "  'question': 'Which component is used for the last completed draft TSCA Workplan RIsk Evaluation?',\n",
       "  'image': 'documents/kzbn0226_25.png',\n",
       "  'docId': 747,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '25',\n",
       "  'answers': ['1-bromopropane'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1778,\n",
       "  'question': 'which section is for judicial review provisions of TSCA?',\n",
       "  'image': 'documents/kzbn0226_16.png',\n",
       "  'docId': 743,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Section 19'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1779,\n",
       "  'question': 'When was the peer review report of this draft evaluation dated?',\n",
       "  'image': 'documents/kzbn0226_25.png',\n",
       "  'docId': 747,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '25',\n",
       "  'answers': ['August 22, 2016'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1780,\n",
       "  'question': 'Which section is for issue exhaustion provisions in environmentional statues?',\n",
       "  'image': 'documents/kzbn0226_16.png',\n",
       "  'docId': 743,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Section 307(d)(7)(b) of the Clean Air Act',\n",
       "   'Section 307(d)(7)(b)'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1781,\n",
       "  'question': 'Define Foreseeability.',\n",
       "  'image': 'documents/kzbn0226_13.png',\n",
       "  'docId': 748,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['is \"the determinant for the limits of duty under a conventional risk analysis\"'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1782,\n",
       "  'question': 'which act is for section 307(d)(7)(b)?',\n",
       "  'image': 'documents/kzbn0226_16.png',\n",
       "  'docId': 743,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '16',\n",
       "  'answers': ['Clean Air Act', 'the clean air act'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1783,\n",
       "  'question': 'What should EPA exclude from the Scopes of TSCA Risk Evaluations?',\n",
       "  'image': 'documents/kzbn0226_13.png',\n",
       "  'docId': 748,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['Exclude Low Exposure Conditions of Use',\n",
       "   'Low Exposure Conditions of use'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1784,\n",
       "  'question': 'Which Provision should be applied as a focusing tool by EPA?',\n",
       "  'image': 'documents/kzbn0226_13.png',\n",
       "  'docId': 748,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '13',\n",
       "  'answers': ['EPA Should Apply the \"Reasonably Foreseen\" Provision.',\n",
       "   'the \"Reasonably Foreseen\" Provision'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1785,\n",
       "  'question': 'why industry should be provided an opportunity ?',\n",
       "  'image': 'documents/jzbn0226_27.png',\n",
       "  'docId': 749,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '27',\n",
       "  'answers': ['to provide EPA additional data/information',\n",
       "   'to provide EPA additional data/information.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1787,\n",
       "  'question': 'What is the fullform of MCSA?',\n",
       "  'image': 'documents/ylcn0226_10.png',\n",
       "  'docId': 752,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['Motor Carrier Safety Act'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1788,\n",
       "  'question': 'how should be prioritization process ?',\n",
       "  'image': 'documents/jzbn0226_27.png',\n",
       "  'docId': 749,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '27',\n",
       "  'answers': ['dynamic, iterative process', 'a dynamic, iterative process.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1789,\n",
       "  'question': 'how many critical elements are included for prioritization to be successful ?',\n",
       "  'image': 'documents/jzbn0226_27.png',\n",
       "  'docId': 749,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '27',\n",
       "  'answers': ['three'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1790,\n",
       "  'question': 'What is the fullform of ACC?',\n",
       "  'image': 'documents/ylcn0226_2.png',\n",
       "  'docId': 757,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['The American Chemistry Council', 'American Chemistry Council'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1791,\n",
       "  'question': 'What does ACC represents?',\n",
       "  'image': 'documents/ylcn0226_2.png',\n",
       "  'docId': 757,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['represents the leading companies engaged in the business of chemistry.',\n",
       "   'leading companies engaged in the business of chemistry'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1792,\n",
       "  'question': 'Who is the director of office of Pollution Prevention and Toxics?',\n",
       "  'image': 'documents/ylcn0226_2.png',\n",
       "  'docId': 757,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Wendy Cleland-Hamnett'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1793,\n",
       "  'question': 'mention the first point of critical elements under prioritization to be successful',\n",
       "  'image': 'documents/jzbn0226_27.png',\n",
       "  'docId': 749,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '27',\n",
       "  'answers': ['reliable and up-to-date chemical data and information'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1794,\n",
       "  'question': 'Who is the sender of this letter?',\n",
       "  'image': 'documents/ylcn0226_2.png',\n",
       "  'docId': 757,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Nancy B. Beck, PhD, DABT', 'Nancy B. Beck'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1796,\n",
       "  'question': 'what is the title of this document?',\n",
       "  'image': 'documents/jzbn0226_27.png',\n",
       "  'docId': 749,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '27',\n",
       "  'answers': [\"ACC's General Principles on Prioritization\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1797,\n",
       "  'question': 'What is the date mentioned in this letter?',\n",
       "  'image': 'documents/ylcn0226_2.png',\n",
       "  'docId': 757,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['August 24, 2016'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1805,\n",
       "  'question': 'mention the date which is on right side top of the letter',\n",
       "  'image': 'documents/klcn0226_2.png',\n",
       "  'docId': 767,\n",
       "  'ucsf_document_id': 'klcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['JUNE 15, 2006', 'june 15,2006'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1806,\n",
       "  'question': 'what does IQA stands for?',\n",
       "  'image': 'documents/klcn0226_2.png',\n",
       "  'docId': 767,\n",
       "  'ucsf_document_id': 'klcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['INFORMATION QUALITY ACT', 'information quality act'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1807,\n",
       "  'question': 'who is assistant general counsel?',\n",
       "  'image': 'documents/klcn0226_2.png',\n",
       "  'docId': 767,\n",
       "  'ucsf_document_id': 'klcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['JAMES W. CONRAD,JR.', 'james w.conrad, Jr.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1808,\n",
       "  'question': 'who is the senior toxicologist/senior director?',\n",
       "  'image': 'documents/klcn0226_2.png',\n",
       "  'docId': 767,\n",
       "  'ucsf_document_id': 'klcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['RICHARD A. BECKER', 'Richard A. becker, Ph.D. DABT'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1809,\n",
       "  'question': \"which has strongly supported OMB's efforts through its information quality act IQA guidelines?\",\n",
       "  'image': 'documents/klcn0226_2.png',\n",
       "  'docId': 767,\n",
       "  'ucsf_document_id': 'klcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['ACC'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1810,\n",
       "  'question': 'What is the location of united states environmental protection agency ?',\n",
       "  'image': 'documents/lpbn0226_1.png',\n",
       "  'docId': 771,\n",
       "  'ucsf_document_id': 'lpbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Washington, D.C. 20460', 'WASHINGTON, D.C.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1811,\n",
       "  'question': 'Who is designated as agency ethics official and acting general counsel ?',\n",
       "  'image': 'documents/lpbn0226_1.png',\n",
       "  'docId': 771,\n",
       "  'ucsf_document_id': 'lpbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Kevin S. Minoli'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1814,\n",
       "  'question': 'What does ACC supports?',\n",
       "  'image': 'documents/kzbn0226_22.png',\n",
       "  'docId': 772,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '22',\n",
       "  'answers': ['A CLEAR DEFINITION OF \"REASONABLY AVAILABLE INFORMATION;\"',\n",
       "   'a clear definition of \"reasonably available information\"'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1815,\n",
       "  'question': 'What is the page no mentioned in this document?',\n",
       "  'image': 'documents/kzbn0226_22.png',\n",
       "  'docId': 772,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '22',\n",
       "  'answers': ['17', '17/Page'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1816,\n",
       "  'question': 'what does OCSPP stands for?',\n",
       "  'image': 'documents/lpbn0226_1.png',\n",
       "  'docId': 771,\n",
       "  'ucsf_document_id': 'lpbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['OFFICE OF CHEMICAL SAFETY AND POLLUTION PREVENTION',\n",
       "   'office of chemical safety and pollution prevention.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1817,\n",
       "  'question': 'What does CEQ stands for?',\n",
       "  'image': 'documents/mlcn0226_1.png',\n",
       "  'docId': 773,\n",
       "  'ucsf_document_id': 'mlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['COUNCIL ON ENVIRONMENTAL QUALITY',\n",
       "   'Council on Environmental Quality'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1818,\n",
       "  'question': \"what is the subject for this 'memorandum' ?\",\n",
       "  'image': 'documents/lpbn0226_1.png',\n",
       "  'docId': 771,\n",
       "  'ucsf_document_id': 'lpbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['PARTICIPATION IN SPECIFIC PARTY MATTERS INVOLVING YOUR FORMER EMPLOYER, THE AMERICAN CHEMISTRY COUNCIL',\n",
       "   'participation in specific party matters involving your former employer, the american chemistry council'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1819,\n",
       "  'question': 'What is the issued date of the letter?',\n",
       "  'image': 'documents/mlcn0226_1.png',\n",
       "  'docId': 773,\n",
       "  'ucsf_document_id': 'mlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['AUGUST 18, 2017', 'August 18, 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1822,\n",
       "  'question': 'Which authority is utilized by EPA to hire a number of non-Senate-confirmed political appointees?',\n",
       "  'image': 'documents/mlcn0226_1.png',\n",
       "  'docId': 773,\n",
       "  'ucsf_document_id': 'mlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['SDWA', 'SDWA authority'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1823,\n",
       "  'question': 'Who is the addressee of this letter?',\n",
       "  'image': 'documents/mlcn0226_1.png',\n",
       "  'docId': 773,\n",
       "  'ucsf_document_id': 'mlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['MR. DODARO', 'Mr. Dodaro', 'THE HONORABLE GENE L. DODARO'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1826,\n",
       "  'question': 'What does TSCA stands for?',\n",
       "  'image': 'documents/ylcn0226_5.png',\n",
       "  'docId': 776,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['TOXIC SUBSTANCES CONTROL ACT', 'Toxic Substances Control Act'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1827,\n",
       "  'question': 'What will help deliver the results intended by congress?',\n",
       "  'image': 'documents/ylcn0226_5.png',\n",
       "  'docId': 776,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Effective and efficient risk evaluations'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1828,\n",
       "  'question': 'who said that EPA\"is given the discretion to determine the conditions of use that the agency will address in its evaluation of the priority chemical\"',\n",
       "  'image': 'documents/kzbn0226_11.png',\n",
       "  'docId': 775,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['senator vitter'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1830,\n",
       "  'question': 'What is the abbreviation of The American Chemistry Council?',\n",
       "  'image': 'documents/ylcn0226_5.png',\n",
       "  'docId': 776,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['ACC'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1831,\n",
       "  'question': \"ACC strongly supported Congress' effort for which act?\",\n",
       "  'image': 'documents/ylcn0226_5.png',\n",
       "  'docId': 776,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '5',\n",
       "  'answers': ['Toxic Substances Control Act'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1833,\n",
       "  'question': 'On what , the EPA may rely when in need of additional data?',\n",
       "  'image': 'documents/kzbn0226_35.png',\n",
       "  'docId': 796,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '35',\n",
       "  'answers': ['on models and extrapolations.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1835,\n",
       "  'question': 'In which year atomic energy act came into force?',\n",
       "  'image': 'documents/kzbn0226_11.png',\n",
       "  'docId': 775,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['1954'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1836,\n",
       "  'question': 'What is the page no mentioned in this document?',\n",
       "  'image': 'documents/kzbn0226_35.png',\n",
       "  'docId': 796,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '35',\n",
       "  'answers': ['30/Page', '30'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1837,\n",
       "  'question': 'under which section the tax is imposed?',\n",
       "  'image': 'documents/kzbn0226_11.png',\n",
       "  'docId': 775,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['4181'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1838,\n",
       "  'question': 'What is the title of the document?',\n",
       "  'image': 'documents/jzbn0226_39.png',\n",
       "  'docId': 779,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '39',\n",
       "  'answers': ['HAZARD AND EXPOSURE CRITERIA FOR PRIORITIZATION APPROACH',\n",
       "   'Hazard and Exposure Criteria for Prioritization Approach'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1839,\n",
       "  'question': 'What is the date mentioned in this document?',\n",
       "  'image': 'documents/jzbn0226_39.png',\n",
       "  'docId': 779,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '39',\n",
       "  'answers': ['August 29,2011', 'August 29, 2011'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1840,\n",
       "  'question': 'which code is related to section 4181 tax is imposed?',\n",
       "  'image': 'documents/kzbn0226_11.png',\n",
       "  'docId': 775,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['internal revenue code'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1842,\n",
       "  'question': 'which excludes a number of chemical categories from its statutory scope?',\n",
       "  'image': 'documents/kzbn0226_11.png',\n",
       "  'docId': 775,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '11',\n",
       "  'answers': ['TSCA'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1844,\n",
       "  'question': 'What does APA stands for?',\n",
       "  'image': 'documents/jzbn0226_25.png',\n",
       "  'docId': 780,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '25',\n",
       "  'answers': ['ADMINISTRATIVE PROCEDURES ACT',\n",
       "   'Administrative procedures act'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1845,\n",
       "  'question': 'which urges EPA to remove this wavier requirement from the prioritisation rule ?',\n",
       "  'image': 'documents/jzbn0226_25.png',\n",
       "  'docId': 780,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '25',\n",
       "  'answers': ['ACC'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1846,\n",
       "  'question': 'what should be able to be modified-expanded or contracted ?',\n",
       "  'image': 'documents/jzbn0226_25.png',\n",
       "  'docId': 780,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '25',\n",
       "  'answers': ['low priority designations'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1848,\n",
       "  'question': 'mention the email Id of Dr. kimberly wise email id ?',\n",
       "  'image': 'documents/ngcn0226_3.png',\n",
       "  'docId': 790,\n",
       "  'ucsf_document_id': 'ngcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['Kimberly_Wise@americanchemistry.com',\n",
       "   'Kimberly_wise@americanchemistry.com'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1849,\n",
       "  'question': 'who is senior director for ARASP in this letter?',\n",
       "  'image': 'documents/ngcn0226_3.png',\n",
       "  'docId': 790,\n",
       "  'ucsf_document_id': 'ngcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['kimberly wise, Ph.D.', 'KIMBERLY WISE'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1850,\n",
       "  'question': 'Mention the first name in the CC?',\n",
       "  'image': 'documents/ngcn0226_3.png',\n",
       "  'docId': 790,\n",
       "  'ucsf_document_id': 'ngcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['VINCENT COGLIANO', 'vincent cogliano, Ph.D.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1851,\n",
       "  'question': 'who is selected for an appointment in this letter?',\n",
       "  'image': 'documents/npbn0226_1.png',\n",
       "  'docId': 793,\n",
       "  'ucsf_document_id': 'npbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Nancy beck', 'nancy beck'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1852,\n",
       "  'question': 'what does EPA stands for ?',\n",
       "  'image': 'documents/npbn0226_1.png',\n",
       "  'docId': 793,\n",
       "  'ucsf_document_id': 'npbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['ENVIRONMENTAL PROTECTION AGENCY',\n",
       "   'environmental protection agency'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1853,\n",
       "  'question': 'At what time does the orientation start on Monday, May 1, 2017?',\n",
       "  'image': 'documents/npbn0226_1.png',\n",
       "  'docId': 793,\n",
       "  'ucsf_document_id': 'npbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['8:30 am.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1854,\n",
       "  'question': \"Mention the compensation for beck's AD position has been set per annum\",\n",
       "  'image': 'documents/npbn0226_1.png',\n",
       "  'docId': 793,\n",
       "  'ucsf_document_id': 'npbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['$161,900'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1855,\n",
       "  'question': \"what is the effective date of beck's appointment?\",\n",
       "  'image': 'documents/npbn0226_1.png',\n",
       "  'docId': 793,\n",
       "  'ucsf_document_id': 'npbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['april 30, 2017', 'April 30,2017.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1856,\n",
       "  'question': 'What does the Figure 1 show?',\n",
       "  'image': 'documents/ylcn0226_8.png',\n",
       "  'docId': 798,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['A Two-step Process for Conducting Risk Evaluations',\n",
       "   'A Two-Step Process for Conducting Risk Evaluations'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1857,\n",
       "  'question': 'What is the next step in the diagram after Present an unreasonable risk?',\n",
       "  'image': 'documents/ylcn0226_8.png',\n",
       "  'docId': 798,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['Rulemaking', 'RULEMAKING'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1858,\n",
       "  'question': 'What is the name of STEP 2?',\n",
       "  'image': 'documents/ylcn0226_8.png',\n",
       "  'docId': 798,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['Refined Risk Evaluation', 'REFINED RISK EVALUATION'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1859,\n",
       "  'question': 'which are viewed as the indicators of exposure?',\n",
       "  'image': 'documents/jzbn0226_33.png',\n",
       "  'docId': 797,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '33',\n",
       "  'answers': ['persistence and bioaccumulation'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1860,\n",
       "  'question': 'What is the page number of this document?',\n",
       "  'image': 'documents/ylcn0226_8.png',\n",
       "  'docId': 798,\n",
       "  'ucsf_document_id': 'ylcn0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['7', 'page 7'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1861,\n",
       "  'question': 'What is the heading of the document?',\n",
       "  'image': 'documents/kzbn0226_6.png',\n",
       "  'docId': 799,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Executive Summary', 'EXECUTIVE SUMMARY'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1862,\n",
       "  'question': 'What is STEP 1 in the diagram?',\n",
       "  'image': 'documents/kzbn0226_6.png',\n",
       "  'docId': 799,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Scope/Screening', 'SCOPE/SCREENING'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1863,\n",
       "  'question': 'what does CMP stands for?',\n",
       "  'image': 'documents/jzbn0226_33.png',\n",
       "  'docId': 797,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '33',\n",
       "  'answers': ['chemical management program'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1865,\n",
       "  'question': 'What is the full form of TSCA?',\n",
       "  'image': 'documents/kzbn0226_6.png',\n",
       "  'docId': 799,\n",
       "  'ucsf_document_id': 'kzbn0226',\n",
       "  'ucsf_document_page_no': '6',\n",
       "  'answers': ['Toxic Substances Control Act'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1866,\n",
       "  'question': 'What is the page no mentioned in this document?',\n",
       "  'image': 'documents/jzbn0226_26.png',\n",
       "  'docId': 807,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '26',\n",
       "  'answers': ['24'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1867,\n",
       "  'question': 'P&B criteria of the proposed approach are targeted towards?',\n",
       "  'image': 'documents/jzbn0226_33.png',\n",
       "  'docId': 797,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '33',\n",
       "  'answers': ['organic chemicals'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1868,\n",
       "  'question': 'which can be defined using a vapour presure cut-off ?',\n",
       "  'image': 'documents/jzbn0226_33.png',\n",
       "  'docId': 797,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '33',\n",
       "  'answers': ['volatile chemicals'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1869,\n",
       "  'question': \"EPA might consider risk evaluations over time based on which century's tools and methods?\",\n",
       "  'image': 'documents/jzbn0226_26.png',\n",
       "  'docId': 807,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '26',\n",
       "  'answers': ['21st Century',\n",
       "   '21st century',\n",
       "   '21st Century tools and methods',\n",
       "   '21st'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1870,\n",
       "  'question': 'What is the heading of the second paragraph?',\n",
       "  'image': 'documents/jzbn0226_26.png',\n",
       "  'docId': 807,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '26',\n",
       "  'answers': [\"Summary of ACC's Recommendations:\",\n",
       "   \"Summary of ACC's Recommendations\",\n",
       "   \"VIII. Summary of ACC's Recommendations:\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1871,\n",
       "  'question': 'what does TMF stands for?',\n",
       "  'image': 'documents/jzbn0226_33.png',\n",
       "  'docId': 797,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '33',\n",
       "  'answers': ['trophic magnification factor'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1872,\n",
       "  'question': 'What is the heading of the first paragraph?',\n",
       "  'image': 'documents/jzbn0226_26.png',\n",
       "  'docId': 807,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '26',\n",
       "  'answers': ['Repopulation of High Priority Substances',\n",
       "   'E. Repopulation of High Priority Substances'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1874,\n",
       "  'question': 'What is the first day mentioned?',\n",
       "  'image': 'documents/npbn0226_2.png',\n",
       "  'docId': 802,\n",
       "  'ucsf_document_id': 'npbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['MONDAY, MAY 1, 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1877,\n",
       "  'question': 'In what case do they have to bring a Voided check?',\n",
       "  'image': 'documents/npbn0226_2.png',\n",
       "  'docId': 802,\n",
       "  'ucsf_document_id': 'npbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['if you will be moving your direct deposit to another financial institution'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1878,\n",
       "  'question': 'What is the first topic in table of contents?',\n",
       "  'image': 'documents/jzbn0226_3.png',\n",
       "  'docId': 801,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['EXECUTIVE SUMMARY'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1879,\n",
       "  'question': 'What is the first topic under introduction?',\n",
       "  'image': 'documents/jzbn0226_3.png',\n",
       "  'docId': 801,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': [\"ACC'S Vision for a TSCA Prioritization Process Consistent with the LCSA\"],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1881,\n",
       "  'question': 'The point VII is from which page?',\n",
       "  'image': 'documents/jzbn0226_3.png',\n",
       "  'docId': 801,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['22', 'page 22'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1882,\n",
       "  'question': 'What is the heading of the document?',\n",
       "  'image': 'documents/jzbn0226_30.png',\n",
       "  'docId': 806,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '30',\n",
       "  'answers': ['HUMAN HEALTH RANKING', 'Human Health Ranking'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1883,\n",
       "  'question': 'What is the Ranking of Health Rank Score: 1?',\n",
       "  'image': 'documents/jzbn0226_30.png',\n",
       "  'docId': 806,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '30',\n",
       "  'answers': ['LOW', 'Low'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1884,\n",
       "  'question': 'Health Rank Score of Ranking: Medium High?',\n",
       "  'image': 'documents/jzbn0226_30.png',\n",
       "  'docId': 806,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '30',\n",
       "  'answers': ['3'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1885,\n",
       "  'question': 'What is the date mentioned in this document?',\n",
       "  'image': 'documents/jzbn0226_30.png',\n",
       "  'docId': 806,\n",
       "  'ucsf_document_id': 'jzbn0226',\n",
       "  'ucsf_document_page_no': '30',\n",
       "  'answers': ['August 29, 2011'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1909,\n",
       "  'question': 'What is the critical tool used for American Crop production?',\n",
       "  'image': 'documents/nhcn0226_2.png',\n",
       "  'docId': 879,\n",
       "  'ucsf_document_id': 'nhcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Chlorpyrifos'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1913,\n",
       "  'question': 'Why do farmers rely on Chlorpyrifos?',\n",
       "  'image': 'documents/nhcn0226_2.png',\n",
       "  'docId': 879,\n",
       "  'ucsf_document_id': 'nhcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['because of its efficacy, broad spectrum control, low cost, and tank mix compatibility.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1916,\n",
       "  'question': 'When a outbreak of a new pest occurs, what do growers look to?',\n",
       "  'image': 'documents/nhcn0226_2.png',\n",
       "  'docId': 879,\n",
       "  'ucsf_document_id': 'nhcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Chlorpyrifos as a proven first-line of defense',\n",
       "   'Chlorpyrifos as a proven first-line of defense.',\n",
       "   'Chlorpyrifos'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1918,\n",
       "  'question': 'Which state of United States does Justiin Lynch belongs to?',\n",
       "  'image': 'documents/nhcn0226_2.png',\n",
       "  'docId': 879,\n",
       "  'ucsf_document_id': 'nhcn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['Washington'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1920,\n",
       "  'question': 'How much percentage of the work do the sponsors in the list comprise of?',\n",
       "  'image': 'documents/lmcn0226_3.png',\n",
       "  'docId': 880,\n",
       "  'ucsf_document_id': 'lmcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['2% OR MORE', '2% or more'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1923,\n",
       "  'question': 'What is the percentage of Government/Non-Profit project sponsors?',\n",
       "  'image': 'documents/lmcn0226_3.png',\n",
       "  'docId': 880,\n",
       "  'ucsf_document_id': 'lmcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['68%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1925,\n",
       "  'question': 'What is the percentage of For Profit Project Sponsors?',\n",
       "  'image': 'documents/lmcn0226_3.png',\n",
       "  'docId': 880,\n",
       "  'ucsf_document_id': 'lmcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['32%'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1928,\n",
       "  'question': 'What is the page no mentioned in this document?',\n",
       "  'image': 'documents/hzbn0226_51.png',\n",
       "  'docId': 886,\n",
       "  'ucsf_document_id': 'hzbn0226',\n",
       "  'ucsf_document_page_no': '51',\n",
       "  'answers': ['3'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1931,\n",
       "  'question': 'What is the subheading mentioned in this document?',\n",
       "  'image': 'documents/hzbn0226_51.png',\n",
       "  'docId': 886,\n",
       "  'ucsf_document_id': 'hzbn0226',\n",
       "  'ucsf_document_page_no': '51',\n",
       "  'answers': ['Comments on the RfD'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1932,\n",
       "  'question': 'What does Pg 81: 2nd and 3rd paragraphs, and the 1st paragraph on the next page discuss about?',\n",
       "  'image': 'documents/hzbn0226_51.png',\n",
       "  'docId': 886,\n",
       "  'ucsf_document_id': 'hzbn0226',\n",
       "  'ucsf_document_page_no': '51',\n",
       "  'answers': ['DEFICITS IN VISUAL PERCEPTION',\n",
       "   'all three of these paragraphs discuss on deficits in visual perception.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1933,\n",
       "  'question': 'What does each \"slice\" represent?',\n",
       "  'image': 'documents/lmcn0226_7.png',\n",
       "  'docId': 890,\n",
       "  'ucsf_document_id': 'lmcn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['INDIVIDUAL SPONSOR', 'An Individual Sponsor.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1934,\n",
       "  'question': 'What does the shading represent?',\n",
       "  'image': 'documents/lmcn0226_7.png',\n",
       "  'docId': 890,\n",
       "  'ucsf_document_id': 'lmcn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['SPONSOR SECTOR AFFILIATION', 'Sponsor sector affiliation.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1935,\n",
       "  'question': 'What does ARA stand for?',\n",
       "  'image': 'documents/lmcn0226_7.png',\n",
       "  'docId': 890,\n",
       "  'ucsf_document_id': 'lmcn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['Alliance for Risk Assessment'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1936,\n",
       "  'question': 'What does WERF stand for?',\n",
       "  'image': 'documents/lmcn0226_7.png',\n",
       "  'docId': 890,\n",
       "  'ucsf_document_id': 'lmcn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['WATER ENVIRONMENT RESEARCH FOUNDATION',\n",
       "   'Water Environment Research Foundation.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1938,\n",
       "  'question': 'Which was the court ordered deadline to issue a final rule on chlorpyrifos tolerances?',\n",
       "  'image': 'documents/yhcn0226_3.png',\n",
       "  'docId': 882,\n",
       "  'ucsf_document_id': 'yhcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['MARCH 31, 2017', 'March 31, 2017,', 'March 31, 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1939,\n",
       "  'question': 'What is the income type of Martha C. Dourson, LLC?',\n",
       "  'image': 'documents/jsbn0226_4.png',\n",
       "  'docId': 893,\n",
       "  'ucsf_document_id': 'jsbn0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['LEGAL FEES', 'Legal fees.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1940,\n",
       "  'question': 'What is the income type of Red River Gorgeous, LLC. ?',\n",
       "  'image': 'documents/jsbn0226_4.png',\n",
       "  'docId': 893,\n",
       "  'ucsf_document_id': 'jsbn0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['RENT OR ROYALTIES', 'Rent or Royalties.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1941,\n",
       "  'question': 'What is the value listed for Tomlinson, Dourson and Culler?',\n",
       "  'image': 'documents/jsbn0226_4.png',\n",
       "  'docId': 893,\n",
       "  'ucsf_document_id': 'jsbn0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['$50,001-$100,000', '$50,001 - $100,000'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1942,\n",
       "  'question': 'Who was responsible for educating other scientists on risk issues?',\n",
       "  'image': 'documents/jsbn0226_4.png',\n",
       "  'docId': 893,\n",
       "  'ucsf_document_id': 'jsbn0226',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['Director and President.', 'PROFESSOR'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1943,\n",
       "  'question': 'What does OIRA stand for?',\n",
       "  'image': 'documents/hzbn0226_2.png',\n",
       "  'docId': 897,\n",
       "  'ucsf_document_id': 'hzbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['OFFICE OF INFORMATION AND REGULATORY AFFAIRS',\n",
       "   'Office of Information and Regulatory Affairs.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1944,\n",
       "  'question': 'What does EPA stand for?',\n",
       "  'image': 'documents/hzbn0226_2.png',\n",
       "  'docId': 897,\n",
       "  'ucsf_document_id': 'hzbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['ENVIRONMENTAL PROTECTION AGENCY',\n",
       "   'Environmental Protection Agency.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1945,\n",
       "  'question': 'What does PBDE stand for?',\n",
       "  'image': 'documents/hzbn0226_2.png',\n",
       "  'docId': 897,\n",
       "  'ucsf_document_id': 'hzbn0226',\n",
       "  'ucsf_document_page_no': '2',\n",
       "  'answers': ['POLYBROMINATED DIPHENYL ETHERS',\n",
       "   'Polybrominated Diphenyl Ethers.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1947,\n",
       "  'question': 'Which part discloses agreements or arrangements that the filer had during the reporting period with an employer or former employer?',\n",
       "  'image': 'documents/jsbn0226_7.png',\n",
       "  'docId': 898,\n",
       "  'ucsf_document_id': 'jsbn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['PART 3', 'Part 3.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1948,\n",
       "  'question': 'Which part discloses the positions that the filer held at any time during the reporting period?',\n",
       "  'image': 'documents/jsbn0226_7.png',\n",
       "  'docId': 898,\n",
       "  'ucsf_document_id': 'jsbn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['PART 1', 'Part 1.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1949,\n",
       "  'question': 'What does EIF stand for?',\n",
       "  'image': 'documents/jsbn0226_7.png',\n",
       "  'docId': 898,\n",
       "  'ucsf_document_id': 'jsbn0226',\n",
       "  'ucsf_document_page_no': '7',\n",
       "  'answers': ['EXCEPTED INVESTMENT FUND', 'Excepted Investment Fund.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1950,\n",
       "  'question': 'Whose written statement does the document contain?',\n",
       "  'image': 'documents/zlcn0226_1.png',\n",
       "  'docId': 900,\n",
       "  'ucsf_document_id': 'zlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Nancy B. Beck, Ph.D., DABT'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1952,\n",
       "  'question': 'When is the Written Statement dated on?',\n",
       "  'image': 'documents/zlcn0226_1.png',\n",
       "  'docId': 900,\n",
       "  'ucsf_document_id': 'zlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['March 9, 2017'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1988,\n",
       "  'question': 'Who is the author of the blog page?',\n",
       "  'image': 'documents/gzbn0226_1.png',\n",
       "  'docId': 923,\n",
       "  'ucsf_document_id': 'gzbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['NANCY BECK, PH.D., D.A.B.T.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1997,\n",
       "  'question': \"Where was the Toxicology Forum's summer meeting held?\",\n",
       "  'image': 'documents/gzbn0226_1.png',\n",
       "  'docId': 923,\n",
       "  'ucsf_document_id': 'gzbn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['SALT LAKE CITY', 'Salt Lake City.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 1999,\n",
       "  'question': 'Which one is the first for profit sponsor listed?',\n",
       "  'image': 'documents/lmcn0226_3.png',\n",
       "  'docId': 880,\n",
       "  'ucsf_document_id': 'lmcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['AMERICAN CHEMISTRY COUNCIL', 'American Chemistry Council'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2000,\n",
       "  'question': 'Coca cola is under which category of sponsors?',\n",
       "  'image': 'documents/lmcn0226_3.png',\n",
       "  'docId': 880,\n",
       "  'ucsf_document_id': 'lmcn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['FOR PROFIT', 'For Profit'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2001,\n",
       "  'question': 'Which councils name is mentioned at the top?',\n",
       "  'image': 'documents/zlcn0226_1.png',\n",
       "  'docId': 900,\n",
       "  'ucsf_document_id': 'zlcn0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['American Chemistry Council'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2003,\n",
       "  'question': 'What is the assumed compliance rate by this analysis?',\n",
       "  'image': 'documents/gmcn0226_8.png',\n",
       "  'docId': 925,\n",
       "  'ucsf_document_id': 'gmcn0226',\n",
       "  'ucsf_document_page_no': '8',\n",
       "  'answers': ['75% POST-RULE COMPLIANCE'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2004,\n",
       "  'question': 'What does IRIS stand for?',\n",
       "  'image': 'documents/gzbn0226_3.png',\n",
       "  'docId': 926,\n",
       "  'ucsf_document_id': 'gzbn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['INTEGRATED RISK INFORMATION SYSTEM',\n",
       "   'Integrated Risk Information System.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2005,\n",
       "  'question': 'Where was the 53rd meeting of the Society of Toxicology held?',\n",
       "  'image': 'documents/gzbn0226_3.png',\n",
       "  'docId': 926,\n",
       "  'ucsf_document_id': 'gzbn0226',\n",
       "  'ucsf_document_page_no': '3',\n",
       "  'answers': ['PHOENIX, ARIZONA', 'Phoenix, Arizona.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2009,\n",
       "  'question': 'What is the invoice number for this invoice?',\n",
       "  'image': 'documents/ymph0227_1.png',\n",
       "  'docId': 928,\n",
       "  'ucsf_document_id': 'ymph0227',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['1338', '1338.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2010,\n",
       "  'question': 'What date was the invoice issued on?',\n",
       "  'image': 'documents/ymph0227_1.png',\n",
       "  'docId': 928,\n",
       "  'ucsf_document_id': 'ymph0227',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['OCT. 16, 1968', 'Oct. 16, 1968.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2011,\n",
       "  'question': 'What is the total amount in the invoice?',\n",
       "  'image': 'documents/ymph0227_1.png',\n",
       "  'docId': 928,\n",
       "  'ucsf_document_id': 'ymph0227',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['222', '222 00'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2013,\n",
       "  'question': 'Where is the Great Western Sugar Company located?',\n",
       "  'image': 'documents/ppnh0227_1.png',\n",
       "  'docId': 929,\n",
       "  'ucsf_document_id': 'ppnh0227',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['DENVER, COLORADO', 'Denver, Colorado.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2014,\n",
       "  'question': \"Where was the Phoenix Musical Theatre Guild's annual holiday luncheon held?\",\n",
       "  'image': 'documents/jgmk0226_1.png',\n",
       "  'docId': 930,\n",
       "  'ucsf_document_id': 'jgmk0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['Phoenix Country Club',\n",
       "   'Phoenix Country Club.',\n",
       "   'at the Phoenix Country Club'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2015,\n",
       "  'question': \"When was the Phoenix Musical Theatre Guild's annual holiday luncheon held?\",\n",
       "  'image': 'documents/jgmk0226_1.png',\n",
       "  'docId': 930,\n",
       "  'ucsf_document_id': 'jgmk0226',\n",
       "  'ucsf_document_page_no': '1',\n",
       "  'answers': ['At noon Dec.10', 'at noon Dec. 10'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2017,\n",
       "  'question': 'What is the NET WT.?',\n",
       "  'image': 'documents/ppnh0227_10.png',\n",
       "  'docId': 931,\n",
       "  'ucsf_document_id': 'ppnh0227',\n",
       "  'ucsf_document_page_no': '10',\n",
       "  'answers': ['5 POUNDS', '5 Pounds.'],\n",
       "  'data_split': 'train'},\n",
       " {'questionId': 2018,\n",
       "  'question': 'Who is the \"Good Wishes\" offer from?',\n",
       "  'image': 'documents/ppnh0227_4.png',\n",
       "  'docId': 932,\n",
       "  'ucsf_document_id': 'ppnh0227',\n",
       "  'ucsf_document_page_no': '4',\n",
       "  'answers': ['G W SUGAR', 'G W Sugar.'],\n",
       "  'data_split': 'train'},\n",
       " ...]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ann['data']"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "dl3.9",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.20"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
